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The Golgi apparatus of eukaryotes is a critical organizing center that is 
responsible for protein and lipid maturation, sorting, and trafficking. Because of the 
diverse population of proteins and lipids being modified at any given time, the Golgi is 
host to a large collection of resident enzymes and transporters that are required to achieve 
the necessary modifications. Many of the Golgi resident proteins, accounting for a large 
portion of the entire genome, are involved in the process and regulation of glycosylation, 
the process by which complex oligosaccharides are assembled on proteins and lipids. 
These oligosaccharides assist in folding, stability, and trafficking of the substrate 
molecule. The complex nature of the reactions and mechanisms taking place within the 
Golgi require careful maintenance of the homeostatic balance of all substrates, cofactors, 
and products, because failure of any single component could result in downstream 
consequences that compound to become very dangerous for the cell. The mechanisms 
and transporters of the Golgi apparatus are reviewed in Chapter 1. This dissertation aims 
to elucidate the roles of several transporters involved in Golgi homeostasis, which have 
roles in regulating the pH as well as concentrations of Ca2+, Mn2+, and inorganic 
phosphate (Pi), and identify a new method that may be used to screen antifungals for 
essential protein targets, including those affiliated with Golgi processes. 
In the second chapter, I identify a new highly conserved class of reversible 
H+/Ca2+ exchanger in the Golgi of yeast, Gdt1. Through genetic analysis, I demonstrate 
that Gdt1 functions alongside the secretory pathway Ca2+ ATPase, Pmr1, to supply Ca2+ 
to the Golgi apparatus and detoxify high levels of Ca2+ in the cytoplasm. I further show 





between the Golgi and cytoplasm. Interestingly, abolishment of this pH gradient by 
deletion of the V-ATPase resulted in Gdt1 instead removing Ca2+, supplied by Pmr1, 
from the Golgi, demonstrating the reversibility of the H+/Ca2+ exchange. I also identify 
and characterize another Golgi transporter of yeast, Erd1, which functions to recycle Pi 
from the Golgi to the cytoplasm, as it is otherwise lost to the environment through the 
secretory pathway. This Pi was produced from the breakdown of the GDP byproduct of 
glycosylation into Pi and GMP, which is recycled by Vrg4 for GDP-mannose, needed for 
further glycosylation reactions. 
In Chapter 3, I investigate the mammalian homolog of Gdt1, TMEM165, and its 
role in lactation in mice. I present evidence that TMEM165, the expression of which is 
highly upregulated in the mammary gland during lactation, supplies the Golgi with Mn2+, 
required for activity of lactose synthase, along with Ca2+, secreted into milk as a 
component of casein micelles, while removing H+, released by lactose synthesis and 
glycosylation, to prevent acidification of the Golgi. A mouse model, deficient for 
TMEM165 in the mammary gland, exhibited decreased secretion of lactose into milk, 
which reduced the osmotic potential of the milk, decreasing its volume, and concentrating 
the protein and nutritional metals it contains. This ultimately decreased the nutritional 
quality of the milk, resulting in low weight gain in pups nursed by these mothers. 
Chapter 4 develops and examines a new technology that can be used to study 
essential genes in yeast. A collection of yeast strains containing genes expressing proteins 
tagged with the auxin-inducible degron (AID) was generated. The AID tag enables 
proteins to be rapidly ubiquitylated and targeted for degradation after the addition of the 





strains for sensitivity or resistance to various drugs and inhibitors. Using co-varied 
concentrations of auxin and SDZ 90-215, I demonstrated that a yeast strain containing 
AID-tagged Vrg4 displayed synergistic sensitivity to the combination of drugs. Further 
analysis demonstrated that SDZ 90-215 inhibits the activity of Vrg4, blocking the 
transport of GDP-mannose into the Golgi of yeast, preventing glycosylation of proteins 
and lipids. This inhibition ultimately kills the yeast cell, allowing SDZ 90-215 to function 
as a fungicide. 
The final chapter provides a summary of the implications of the major findings in 
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 The eukaryotic Golgi apparatus functions as the central hub for the maturation, 
sorting, and trafficking of newly synthesized proteins and lipids. It therefore plays a 
critical role in providing the machinery required for nearly all cellular processes. The 
Golgi contains numerous resident enzymes, which carry out the required modifications to 
proteins and lipids, such as glycosylation, as well as transporters that supply these 
enzymes with the necessary resources to fulfil this task. There exists a complex and 
diverse population of proteins in the Golgi, with each enzyme requiring specific 
conditions, cofactors, and substrates to carry out its function. On account of this, 
mechanisms have been developed to maintain homeostasis within the Golgi of numerous 
factors. These homeostatically controlled factors include pH, metal cofactors for 
enzymes, nucleotide sugars, phosphates, and concentration and localization of the 
enzymes themselves. Described below is a review of the pathways and mechanisms by 
which the homeostasis of the Golgi is maintained and the negative downstream effects 
and disorders that result when this homeostasis is no longer regulated. 
 
GLYCOSYLATION 
A major function of the Golgi complex is to decorate proteins and lipids with 
elaborate oligosaccharide chains through a variety of coordinated glycosylation 
reactions.  This process requires numerous glycosyltransferases of different substrate 
specificities to be organized within the Golgi and continuously supplied. An estimated 
1% of the human genome is devoted to this purpose (Freeze 2006).  Almost all secretory 





folding, assembly, stability, solubility, and trafficking of the glycoproteins (Hebert et 
al. 2014). Glycoproteins and glycolipids on the cell surface can aid in cell-cell adhesion, 
and they are even used for recognition by immune cells (Varki 1993; Lowe 2003; Cobb 
and Kasper 2005).  
   
GLYCOPROTEINS 
Proteins can be glycosylated in several different ways. The two most common 
forms of glycosylation are N-linked and O-linked (Varki 1993). In N-linked 
glycosylation, carbohydrates are first added to the amide nitrogen of an asparagine 
residue within an N-x-S/T motif by an oligosaccharyl transferase in the endoplasmic 
reticulum (Marshall 1972). In O-linked glycosylation, sugars are instead added to the 
hydroxyl group of a serine and threonine in O-linked glycosylation (Wilson et al. 1991). 
In both cases, additional glycosyltransferases in the Golgi can elaborate further 
modifications.  
Due to the stereospecificity of glycosyltransferases, the sequence of carbohydrates 
added to a glycoprotein are dependent on the protein sequence and the sequence of 
carbohydrates already present, (Stanley 2011; Liang et al. 2015). In fact, 
glycosyltransferases that have the same specificity for donor nucleotide sugars could 
have unique acceptor specificity, meaning that a single sugar addition could completely 
alter the potential final sequence of carbohydrates on the glycoprotein (Reynders et 
al. 2011). The carbohydrate sequence is also regulated by the availability of 





that glycosylation can also be regulated at the transcriptional level or by modifications to 
the glycosyltransferases that alter the localization between the ER and Golgi apparatus.  
The process of N-linked glycosylation, outlined in Figure 1.1, begins within the 
rough ER, where a preformed oligosaccharide is transferred to the asparagine residue of 
the protein (Waechter and Lennarz 1976). The assembly of the oligosaccharide begins by 
adding two N-acetyl glucosamine and five mannose molecules to dolichol pyrophosphate 
embedded within the ER membrane on the cytoplasmic face (Helenius and Aebi 2001). 
At that point, the oligosaccharide is flipped to the luminal side of the membrane, where 
an additional four mannose and three glucose molecules are added to complete the 
oligosaccharide precursor, abbreviated as Glc3Man9(GlcNAc)2 (Hubbard and Robbins 
1980). Once this is transferred from the dolichol pyrophosphate to the nascient 
polypeptide, the glucose molecules and one of the mannose molecules are sequentially 
removed prior to transport of the glycoprotein to the Golgi, where processing is 
completed by further additional and/or removal of carbohydrates by Golgi lumen-
resident enzymes (Trombetta 2003).  
Alternatively, in O-linked glycosylation, all carbohydrates are instead added 
individually, with each addition being carried out by a unique glycosyltransferase, 
dependent on the carbohydrate being added (den Steen et al. 2008). These 
glycosyltransferases all operate within the luminal face of either the rough ER or the 
Golgi (Boulan et al. 1978). The initial carbohydrate in these reactions can differ, 
depending on the tissue in which the synthesis is occurring or the subcellular localization 
fate of the protein (Roth et al. 1986).  






Figure 1.1:  N-glycosylation structures within the ER and Golgi apparatus. 
The structure of the N-linked core oligosaccharide (A) is comprised of 2 GlcNAc, 9 
mannose, and 3 glucose sugars in the orientation shown, bound to the amine nitrogen of 
an asparagine residue of an N-x-S/T motif. As shown in (B), the assembly of this 
structure begins on the cytoplasmic face of the ER, prior to moving to the luminal face 
for completion. The resulting glycopeptide undergoes trimming and processing, prior to 
being sent to the Golgi apparatus for further modifications. This figure was adapted from 






Sphingolipids are the most abundant molecule in the plasma membrane of both 
mammals and yeast (Fröhlich et al. 2015). In the case of mammals, the major 
sphingolipids are sphingomyelin and glucosylceramides, while they are 
inositol phosphorylceramides (IPCs) in yeast (Levine et al. 2000). In either case, these 
sphingolipids are synthesized in the Golgi complex by glycosylation of ceramides that 
arrive from the ER mainly via vesicular transport (Levine et al. 2000). Ceramides are 
extremely toxic to both yeast and mammalian cells, so de novo ceramide synthesis is 
tightly coupled to ceramide conversion into sphingolipids (Daido et al. 2004; Guenther et 
al. 2008; Klug and Daum 2014). Therefore, the glycosylation of ceramides in the Golgi 
complex can be crucial for cell survival. These modifications assist in targeting these 
sphingolipids to the plasma membrane and the maintenance of their stability 
once there (Breslow and Weissman 2010).  
   
GLYCOSYLTRANSFERASES 
Glycosyltransferases with different substrate specificities can be differentially 
localized to the ER, cis-, medial-, and trans-Golgi compartments, and thus generate 
intricate patterns of glycosylation (Schoberer and Strasser 2011).  Almost all 
glycosyltransferases require Mn2+ as an essential cofactor, though Ca2+ is also utilized in 
some cases (Dürr et al. 1998).  Their activities are also highly sensitive to pH (Rivinoja et 
al. 2009; Hassinen et al. 2011).  Two categories of sugar transfer mechanism have been 





sugar changes stereochemistry, and retaining, where the configuration of the sugar 
is maintained (Lairson et al. 2008).   
In inverting glycosylation (see Figure 1.2), a catalytic base of the 
glycosyltransferase (usually from an aspartate, glutamate, or histidine side chain) 
removes a proton from the functional group of the target acceptor, allowing for it to 
conduct a nucleophilic attack on the primary carbon of the sugar from the donor 
nucleotide sugar, thus forming a glycosidic bond and freeing the sugar from the 
nucleotide phosphate (Krupicka and Tvaroska 2009). The exact mechanism of retaining 
glycosylation remains a matter of research and debate. One potential mechanism 
performs a two round of inverting glycosylation, where the sugar initially binds to the 
transferase in the inverted confirmation before being transferred to the acceptor, 
reclaiming the original confirmation (Ardevol et al. 2016). The other popular hypothesis 
proposes that there is no catalytic base in these transferases, and therefore 
glycosyltransferase instead serves to protect the sugar from nucleophilic attack on one 
side, forcing the acceptor to instead form the glycosidic bond with the sugar retaining its 
confirmation (Ardevol et al. 2016).  
   
NUCLEOTIDE-SUGAR TRANSPORTERS 
The key substrates used for glycosylation are nucleotide-sugars, which are 
synthesized in the cytoplasm and transported to the lumen of the ER and Golgi complex 
(Stanley 2011; Orellana et al. 2016).  Mammalian cells utilize a large repertoire of 
nucleotide-sugar molecules (Table 1.1) while yeast is much simpler (Hirschberg 1997). 






Figure 1.2:  Mechanisms of glycosyltransfer during glycosylation.  
The direct displacement mechanism used by inverting glycosyltransferases (A) and the 
hypothesized double-displacement mechanism used by retaining glycosyltransferases (B) 
are depicted. In either mechanism, a divalent cation, usually Mn2+ is utilized as a cofactor 
to stabilize the negative charge of the phosphate leaving group. This figure was adapted 








Table 1.1: Common nucleotide sugars utilized in glycosylation reactions 
 
Glycans Abbreviation Species Donor 
D-Glucose Glc Mammals, plants 
UDP-sugar 
D-Galactose Gal Mammals, plants 
N-Acetyl-D-
glucosamine 







D-Xylose Xyl Mammals, plants 
D-Mannose Man Yeast, mammals, plants, insects 
GDP-sugar 
L-Fucose Fuc Mammals, plants, insects 









and therefore only one nucleotide-sugar transporter is required in that organelle (Abeijon 
et al. 1989).  Nucleotide-sugar transporters (NST’s) of appropriate specificity supply the 
organelles with nucleotide-sugars and also counter-transport the nucleoside 
monophosphate byproduct of glycosylation. This nucleoside monophosphate is itself a 
product, along with inorganic phosphate and H+ byproducts, of the breakdown of 
nucleoside diphosphates by apyrase-like nucleoside diphosphatases (Figure 1.3) (Perez 
and Hirschberg 1985; Milla et al. 1992).  The counter-transport of nucleotide-sugars and 
nucleoside monophosphates is thought to be electroneutral, and thus both molecules 
constantly flow down their concentration gradients without the need for an energy 
source (Capasso and Hirschberg 1984).  The main NST of the yeast Golgi, the GDP-
mannose/GMP exchanger known as Vrg4, is essential for viability of multiple yeast 
species including the human pathogens Candida glabrata and Candida albicans (Poster 
and Dean 1996; Dean et al. 1997; Nishikawa et al. 2002a, 2002b).  In chapter 4, I identify 
the first specific inhibitor of Vrg4 and demonstrate its antifungal properties.  In 
mammals, the NSTs are classified into 7 subfamilies of the SLC35 superfamily, based on 
sequence similarity and then by the type of substrate transported (Hadley et al. 2014).    
  
TRANSPORT OF Mn2+ AND Ca2+  
In order to stabilize the negative charges of the phosphate groups during 
glycosylation, the glycosyltransferases require a cofactor of Mn2+ (Dürr et al. 1998). 
Mn2+ is a transition metal used as a cofactor in many redox reactions (Thielges et al. 
2005). A family of secretory pathway calcium ATPase (SPCA’s) that localize to the 






Figure 1.3: Model of transport of cofactors, donors, and byproducts of glycosylation 
into/out of the Golgi apparatus in yeast 
GDP-mannose is utilized as a sugar donor by a galactosyltransferase (GT) to transfer a 
mannose to modify a glycopeptide. This transfer requires a cofactor of Ca2+ or Mn2+, 
which is supplied by Pmr1, and results in the release of a proton and GDP as a byproduct. 
This GDP is cleaved to form GMP, which is recycled to the cytoplasm in exchange for 
GDP-mannose to continue additional glycosylation reaction by Vrg4, and inorganic 










(Lapinskas et al. 1995; Dürr et al. 1998; Ton et al. 2002). There are three SPCA’s in 
human, that each exhibit different patterns of expression, while there is only one in yeast 
(termed Pmr1) (Ton et al. 2002).  Unlike the SERCA-family and PMCA-family of 
Ca2+ ATPases that localize to the ER and plasma membrane (or fungal vacuole) 
respectively, SPCA’s cannot countertransport H+ during Ca2+ transport and therefore 
cannot serve as a channel for proton release from the Golgi lumen (Niggli et al. 1982; 
Dode et al. 2006; Hauser and Barth 2007).  The dual-ion selectivity of SPCA’s can be 
altered with amino acid substitutions.  The Q783A mutation in Pmr1 abolishes Mn2+ 
transport but not Ca2+ transport, resulting in glycosylation defects (Wei et al. 2000).  
In yeast, expression of Pmr1 and Pmc1 (the PMCA-family pump localized to the 
vacuole) can be up-regulated by the activation of the transcription factor Crz1. Crz1 is 
activated by the Ca2+/calmodulin-activated protein phosphatase known as calcineurin 
(Klee et al. 1979; Matheos et al. 1997).  Thus, when cytosolic free Ca2+ levels rise, the 
up-regulation of these Ca2+ ATPases helps restore the basal Ca2+ levels.  The pmr1∆ 
knockout mutant is viable because Pmc1 expression is up-regulated and the Ca2+ pump is 
partially mislocalized to the Golgi (Marchi et al. 1999).  The pmr1∆ pmc1∆ double 
mutant is not viable, suggesting a critical role for Ca2+ or Mn2+ in the secretory pathway 
(Cunningham and Fink 1994).  Indeed, the pmr1∆ mutant responds to depletion of Ca2+ 
and Mn2+ by activating a Ca2+ influx channel in the plasma membrane that helps resupply 
the depleted organelles (Locke et al. 2000).    
When cytoplasmic calcium levels increase, the resulting activation of calcineurin 
not only induces Pmr1 and Pmc1 expression but also inhibits the activity of the vacuolar 





1996). The precise mechanism by which calcineurin inhibits the activity of Vcx1 remains 
to be determined. Recent reports suggest that calcineurin can regulate the localization of 
the plasma membrane proton exporter, Pma1, decreasing the pH of the cytoplasm, and 
potentially limiting the pH gradient that Vcx1 utilizes for transport of Ca2+ (Velivela and 
Kane 2017). This also has the potential of developing a double-negative feedback loop, 
which stabilizes the state in which one pathway or the other is fully active, between 
calcineurin and Vcx1, since the sequestration of Ca2+ into the vacuole by Vcx1 would 
limit the activation of calcineurin. These regulatory mechanisms ensure proper Ca2+ and 
Mn2+ homeostasis in the organelles of yeast over a broad range of environmental 
conditions. 
Unlike the ER, which stores calcium at concentration between 400 and 700 μM, 
the Golgi apparatus has a gradient of Ca2+ storage concentrations, reaching as high as 
300 μM at the cis-Golgi and as low as 130 μM at the trans-Golgi (Pinton et al. 1998; 
Micaroni 2012). The differences in calcium storage within the different Golgi 
compartments is likely due to differences in localization of Ca2+ transporters across the 
Golgi apparatus (Pizzo et al. 2011). Interestingly, Golgi compartments that harbor 
SPCA1 are uniquely resistant to inositol triphosphate (IP3) signaling, which stimulates 
Ca2+ release from the ER and cis-Golgi compartments, due to a low abundance of the 
IP3 receptor (Lissandron et al. 2010). Furthermore, when Ca
2+ is released from both 
organelles, the release from the Golgi apparatus terminates more quickly than that from 
the ER (Missiaen et al. 2004). These differences in Ca2+ retention may be the result of the 
need to maintain Ca2+ stores within the Golgi, particularly at the trans-Golgi, for use in 





operates in mammalian cells to resupply the ER when it is depleted of Ca2+ and the 
responses to Golgi Ca2+/Mn2+ depletion have not been studied (Wuytack et al. 2002). 
Though there was no apparent need for any other Ca2+ transporter in the Golgi complex, 
we nonetheless discovered an entirely new class of Golgi-localized H+/Ca2+ exchanger 
that is conserved in yeast and mammals and most other eukaryotes.  These studies are 
described in chapter 2.  
The discovery of a Golgi-resident exchanger capable of transporting Ca2+ is 
interesting, because it adds a new dynamic to Ca2+ homeostasis. While ATPases like 
Pmr1 or Pmc1 utilize energy from the hydrolysis of ATP to transport Ca2+ 
unidirectionally across the membrane, exchangers are instead governed by relative 
concentrations of ions on either side of the membrane, as is the case with Na+/Ca2+ 
exchangers in animals (Harper and Sage, 2016). Exchangers start with the active site 
exposed to either the luminal or cytoplasmic side of the membrane, where a compatible 
ion will bind, triggering a confirmation shift that exposes the active site to the opposite 
side of the membrane, where the ion is released (Hilgemann et al., 1991). Any 
compatible ion can be transported in either direction across the membrane, so net 
transport is only positive or negative if there is a concentration gradient that increases the 
likelihood that one ion will be bound on one side of the membrane. If the concentration 
of an ion is equivalent on either side of the membrane, it is transported in both directions, 
results in no net change in the luminal/cytoplasmic concentrations. Low abundance of 
compatible ions on either side of the membrane halt transport, due to inavailability of 
substrate. An exchanger capable of transporting three or more different ion species would 





the complexity of the system. In the case of Vcx1, the low luminal pH within the vacuole 
means that, when the active site is exposed to the vacuolar lumen, it is far more likely to 
bind a proton than Ca2+ (Cunningham and Fink, 1996). The likelihood of binding Ca2+ 
increases when open to the cytoplasmic face, enabling unidirectional transport into the 
vacuole, against its concentration gradient, utilizing the pH-gradient of the vacuole.  
 
PROTON-ATPases  
The glycosylation reactions that occur within the Golgi cisternae require a pH that 
is more acidic than those of the cytoplasm, requiring the establishment of a pH gradient 
on either side of the membrane. In most cell types, the primary driver of protons from the 
cytoplasm to the Golgi is thought to be the V-ATPase (Forgac 2007). V-ATPases are 
multi-subunit proton pumps driven by the hydrolysis of ATP that acidify the various 
organelles of the cell, including the Golgi, endosome, and lysosome (or vacuole in fungi 
and plants) (Nelson and Harvey 1999).   
The V-ATPase is comprised of two sectors, each made up of multiple protein 
components. The catalytic sector, V1, is responsible for ATP hydrolysis, and the 
transmembrane sector, V0, functions as a proton turbine (Nelson and Taiz 1989). There 
are different isoforms of the V-ATPase that are specific to distinct organelles and/or 
tissues. In yeast, there are two isoforms for the major subunit of the V0 domain, Vph1 and 
Stv1 (Manolson et al. 1992, 1994). The Vph1 isoform localizes to the vacuole, while the 
Stv1 isoform localizes to the Golgi apparatus and endosome (Manolson et al. 1992; 
Kawasaki-Nishi et al. 2001). Vph1 is capable of suppressing stv1Δ mutations, 





mask the effects of vph1Δ mutations when overexpressed (Manolson et al. 1994). 
stv1Δvph1Δ double knockout strains are viable, but slow-growing, similar to knockout 
mutants of the other V1 and V0 subunits (Nelson and Nelson 1990). In mammalian cells, 
all the V-ATPase subunits are essential for survival (Nelson et al. 2000; Breton and 
Brown 2013).  The reason why yeast cells can survive without the V-ATPase is because a 
completely different H+-pumping ATPase, termed Pma1, becomes partially relocalized 
from the plasma membrane and serves to weakly acidify the intracellular secretory 
organelles (Mason et al. 1998).  Homologs of Pma1 are present in all fungi and plants, 
but not animals (Møller et al. 1996).  
The V-ATPase can be regulated by the reversible disassembly of V0 and V1 
subunits (Kane 1995; Sumner et al. 1995). This has been shown to occur in yeast during 
glucose deprivation, which interestingly does result in alkalization of the vacuole, raising 
the pH of the vacuolar lumen (Sautin et al. 2005). While dissociated, the V1 subunit 
remains in close proximity to the membrane, but neither ATP hydrolysis nor H+ transport 
occur (Zhang et al. 1992; Parra et al. 2000; Tabke et al. 2014). Subsequent re-addition of 
glucose causes a pH decrease and the reassembly of the V-ATPase (Sautin et al. 2005). 
The mechanism of this regulation is not fully understood. V-ATPase is also regulated by 
extracellular pH, as it remains assembled in high pH conditions, even during glucose 
deprivation (Diakov and Kane 2010).  
   
PROTON LEAK 
When the V-ATPase is inhibited, such adding the compound concanamycin, the 





al. 1996; Schapiro and Grinstein 2000). This demonstrates the existence of a constitutive 
mechanism by which protons leak from the Golgi, assumedly for the purpose of 
preventing overacidification of the Golgi by the V-ATPase. The leak was still evident 
after the cell membrane was permeabilized with streptolycin O (SLO) to remove 
cytoplasmic contents, demonstrating that it is not due to vesicular traffic, which might 
have delivered a higher pH buffer from the ER while removing lower pH buffers to the 
secretory pathway (Schapiro and Grinstein 2000). Instead, the proton leak can be 
attributed to either the existence of unknown uncouplers, which could dissipate the pH 
gradient, possibly as a proton channel, or transporters that couple H+ efflux to transport of 
other ions or organic molecules (Nakamura et al. 2005).  In yeast mutants that lack an 
endosomal Na+/H+ exchanger (Nhx1) or a vacuolar H+/Ca2+ exchanger (Vcx1), proton 
leakage from the Golgi still occurred while proton leakages from those organelles were 
significantly diminished (Cagnac et al. 2010).  While the source of the Golgi proton leak 
is not known, in later chapters I report the discovery and characterization of a novel 
Golgi-localized H+/Ca2+ exchanger in yeast (Gdt1) and mammals (TMEM165).   
   
GOLAC, AN ANION CHANNEL  
The electrogenic transport of protons to the Golgi by the V-ATPase not only 
creates a pH gradient between the Golgi lumen and the cytoplasm, but it also generates a 
positive electrical potential, or charge imbalance, that would inhibit further transport of 
positively charged ions if not corrected (Glickman et al. 1983; Rybak et al. 1997). This 
charge imbalance is largely reduced by the Golgi anion channel (GOLAC) (Nordeen et 





for Cl- than it is for K+, and it is open over 95% of the time (Thompson et al. 2002). This 
constitutively open state, combined with a lack of specificity for any particular anion 
size, has led to the hypothesis that GOLAC serves not only to balance the charge 
imbalance created by the V-ATPase, but also to allow the release of inorganic phosphate, 
created as a byproduct of reactions like glycosylation, from the Golgi (Nordeen et al. 
2000; Hirschberg 2001). This is supported by GOLAC being more permeant to H2PO4
- 
than HPO4
2-, because the acidic environment of the Golgi would make the former species 
more prevalent in the lumen, while the latter is more prevalent in the cytoplasm (Nordeen 
et al. 2000). GOLAC has even been shown to have the potential to allow movement of 
ATP into the Golgi lumen where it can be utilized to provide energy to various reactions 
(Thompson et al. 2006).    
Fungi do not possess homologs of GOLAC, but do express a voltage-gated 
chloride channel in the Golgi (Gef1 in yeast) that participates in acidification by 
dissipating the charge imbalances (Huang et al. 1994; Gaxiola et al. 1998).  As described 
in chapter 2, I discovered a homolog of phosphate transporters that recycles the Pi, 
produced in the Golgi through glycosylation reactions, back to the cytoplasm for reuse. 




Above, I have reviewed the basic mechanism by which the Golgi complex is 
supplied with the raw materials that are necessary for glycosylation.  The constant 1:1 





glycosyltransferases, which require an acidic pH and Mn2+ (Capasso and Hirschberg 
1984; Dürr et al. 1998). However, several questions remain about the homeostasis of this 
system.  First, it is not clear how the system can amplify itself during cell growth and 
proliferation since only stoichiometric exchange reactions are known.  What is missing 
from all textbook accounts is a transporter that increases nucleotide-sugar concentration 
above the 1:1 exchange to enable duplication of Golgi complex during cell division. 
Second, while the inorganic phosphate generated in the Golgi can be released to the 
extracellular fluids in metazoans without loss to the environment, this would be a costly 
loss of nutrients to yeasts, which often grow naturally in phosphate-poor environments. 
As mentioned earlier, in chapter 2 I will define a novel Golgi-localized Pi-recycling 
transporter in yeast, termed Erd1.  Third, there are 1 to 2 protons generated during each 
glycosylation cycle even after considering the buffering by Pi (Persson and Palcic 2008). 
In professional secretory cells, which function to rapidly synthesize, fold, and secrete 
numerous functional proteins, the need for glycosylation can be huge, meaning it may be 
necessary to actively transport H+ out of the Golgi to ensure proper pH management.  In 
chapters 2 and 3, I define a novel family of H+/Ca2+ exchangers in both yeast and mouse 
(Gdt1 and TMEM165) that fulfils this role.  
 
LACTATION 
Mammals are defined as a group by their ability to produce and secrete milk. 
Within their mammary glands, polarized alveolar epithelial cells develop and these 
professional secretory cells generate essentially all the components of milk (Boutinaud et 





lactose biosynthesis through a modified glycosylation reaction where the sugar from 
UDP-galactose is attached to glucose that has been imported from the cytoplasm (Coffey 
and Reithel 1968).  Additionally, the Golgi is the site of casein micelle biogenesis (Sasaki 
et al. 1978).  Caseins are major milk glycoproteins that receive modifications in the Golgi 
complex, and also bind to Pi and Ca2+ and other materials while aggregating into large 
nutrient-packed “micelles” (Aoki et al. 1987). Biosynthesis of these major milk 
constituents – lactose and casein micelles – are both highly sensitive to the pH of the 
Golgi (Permyakov and Kreimer 1986; Liu and Guo 2008).  Below I will summarize some 
key steps in these processes and highlight the potential need for H+/Ca2+ exchange in the 
Golgi, which in later chapters I show is dependent on TMEM165.  I will show that mouse 
mutants deficient in TMEM165 expression in the mammary gland produce low quality 
milk with a much reduced concentration of lactose, resulting in nutritional deficiencies in 
nursing pups.  
   
LACTOSE SYNTHESIS 
During the mammalian process of lactation, the Golgi complex collects and 
produces numerous products that are released into the milk via the secretory pathway 
(Silcock and Patton 1972). These products include proteins, metals, and fat, but one of 
the most crucial components is lactose (Silcock and Patton 1972). Lactose is not only the 
primary supply of sugar to a suckling infant, but it is also the primary osmotic driver of 
water into milk, providing the appropriate volume and viscosity required for nursing 
(Holt 1983). The reactions and mechanisms involved in lactose synthesis are not much 





for bringing in UDP-galactose and glucose, the primary substrates of the reaction 
(Mohammad et al. 2012; Zhang et al. 2018).   
Similar to glycosylation of proteins and lipids, a glycosyltransferase, β4-
galactosyltransferase (β4-GALT) frees the galactose from the UDP and attaches it to the 
glucose, forming a glycosidic bond (Fraser and Mookerjea 1976). The linked glucose and 
galactose form the disaccharide lactose. This process requires Mn2+ as a cofactor during 
the reaction (Fraser and Mookerjea 1976). Similar to the byproducts of protein 
glycosylation, UDP that is produced immediately during lactose synthesis reactions is 
quickly hydrolyzed by apyrases into UMP and Pi (Kuhn and White 1977). The UMP is 
then recycled into the cytoplasm by SLC35A2, in exchange for cytoplasmic UDP-
galactose (Mohammad et al. 2012). Because it is present in milk, the Pi byproduct may 
be incorporated into casein, clusters of protein held together by Ca2+/phosphate bridges, 
or it too can be recycled into the cytoplasm by an unknown mechanism, possibly through 
leakage through GOLAC (Nordeen et al. 2000). The fate of H+ byproducts of lactose 
biosynthesis has never been reported.  Because lactose concentrations in milk range from 
2 to 7% in different mammals (70 to 250 mM) and milk pH is typically near neutral, a 
great deal of H+ transport is likely to occur (Jenness and Holt 1987).  In chapter 3, I will 
show that a novel H+/Ca2+ exchanger termed TMEM165 is strongly up-regulated in the 
milk producing cells of the mammary gland and is necessary for proper lactose 
biosynthesis, likely by eliminating H+ that could feedback inhibit B-GALT.  





DISORDERS RELATED TO GOLGI HOMEOSTASIS 
There is a homeostatic balance of all the substrates, products, and cofactors of the 
various reactions within the Golgi apparatus. Disruption of any of these components or 
the reaction machinery often leads to downstream consequences for the cells. In the case 
of humans and other mammals, these consequences can manifest as serious disorders. 
Due to the difficulty of studying the reactions and regulation of the Golgi apparatus, there 
is still much that is unknown about the pathways and mechanisms involved. Therefore, 
many of the disorders affiliated with Golgi homeostatic imbalance have no cure and 
limited treatment, emphasizing the need for further research into the nature of the Golgi 
and the reactions within it.  
   
CANCER  
Alterations to glycosylation is a common identifier of cancerous cells (Kim and 
Varki 1997; Ono and Hakomori 2003). Some of these alterations are the result of changes 
in expression or activity of glycosyltransferases and/or NSTs due to mutations in those 
proteins (Rivinoja et al. 2012; Song 2013). Additionally, changes in pH of the Golgi have 
been found to result in defects in glycosylation (Rivinoja et al. 2009; Hassinen et al. 
2011). In fact, slight pH increases in the Golgi apparatus results in accumulation of some 
glycosyltransferases and other Golgi-resident proteins in the late endosomes, where they 
cannot carry out glycoprotein synthesis and other necessary reactions (Rivinoja et al. 
2009). Changes in pH can also affect protein sorting, which may result in changes in cell 
polarity (Caplan et al. 1987). In the case of hyper-acidification, it has been demonstrated 





within acidified compartments rather than reaching the cell structures required to trigger 
cell death (Lucien et al. 2017). This means that alterations of pH in the Golgi and other 
organelles can result in the formation of drug-resistant cancers (Lucien et al. 2017).  
    
CONGENITAL DISORDERS OF GLYCOSYLATION 
When a patient receives a mutant gene that negatively impacts glycosylation, it is 
called a congenital disorder of glycosylation (CDG) (Freeze 1998; Grünewald et al. 
2002). These inherited diseases are broken down into two categories, CDG-I, which 
results in a defect of assembly of the lipid-linked oligosaccharide and/or its subsequent 
transfer to a peptide, and CDG-II, which results in a defect of glycan processing after it is 
bound to a peptide (Grünewald et al. 2002). While CDG is rare, the number of identified 
patients and unique mutations and deficiencies leading to CDG has been increasing 
rapidly in recent years (Ng and Freeze 2018).  
CDG-I typically results from mutations to glycosylation-related genes that 
localize to the ER or cytoplasm.  For example, in the most prevalent form, CDG-Ia, is 
caused by a mutation in the gene for phosphomannomutase 2 (PMM2), a cytoplasmic 
protein responsible for converting mannose-6-phosphate to mannose-1-phosphate, 
allowing it to be subsequently converted to GDP-mannose by Mannose-1-phosphate 
guanyltransferase beta (GMPPB) (Schollen et al. 2000; Cline et al. 2012). By blocking 
synthesis of GDP-mannose, the mutation of PMM2 prevents the formation of the lipid-
bound oligosaccharide precursor, stopping N-glycosylation in infancy (Eklund et al. 
2005). O-glycosylation is also deficient, due to the absence of GDP-mannose. In this 





distribution, strabismus, and retracted nipples present during infancy (Jaeken and 
Matthijs 2001; Grünewald et al. 2002). More severe symptoms may also develop, 
including underdevelopment of the cerebellum, seizures, pericardial effusion, and blood 
clotting disorders (Grünewald et al. 2002). Of the infants affected, 20% die during the 
first year of life, due to multiple organ failure (Jaeken and Matthijs 2001).  
CDG-II can also result from mutations to genes localized in the ER, but it is far 
more prevalent for this type of CDG to be derived from mutations to Golgi-resident 
proteins (Reynders et al. 2009). Cutis laxa type II is an autosomal recessive form of 
CDG-II that results from mutations in the a2 subunit of the V0 complex of the V-ATPase 
(Kornak et al. 2007). These mutations cause complete loss of activity and therefore block 
the establishment of a pH gradient between the Golgi and the cytoplasm, as well as 
deficiencies in glycosylation and vesicular transport (Kornak et al. 2007). Ultimately, 
patients with this disease have severe and premature wrinkling of the skin at an early age 
(Kornak et al. 2007).   
Another form of CDG-II arises from a mutation in the gene for TMEM165, a 
transmembrane protein, localized to the Golgi apparatus that has been proposed to 
function as an exchanger of Ca2+/Mn2+ for H+ across the Golgi membrane (Foulquier et 
al. 2012; Demaegd et al. 2013; Rosnoblet et al. 2013; Potelle et al. 2016; Dulary et al. 
2017). Characterization of this gene began recently, as a result of its affiliation with 
CDG, so further study is required to fully understand its role. However, in addition to N-
glycosylation deficiencies, patients identified as having a mutation in TMEM165 present 
severe bone dysplasia and growth abnormalities, muscular hypotrophy, excess fat 





(Zeevaert et al. 2013). In chapter 3, I will demonstrate that loss of TMEM165 during 
lactation leads to similar deficiencies in lactose synthesis, further supporting the 
important role this protein plays in the maintenance of Golgi pH and Ca2+/Mn2+ 
homeostasis. 
   
HAILEY-HAILEY DISEASE 
Hailey-Hailey disease is an autosomal dominant disease that arises due to 
haploinsufficiencies in the SPCA1 gene, ATP2C1.  These patients have deficiencies in 
transport of Ca2+ and Mn2+ into the Golgi (Hu et al. 2000; Wuytack et al. 2003). The 
disease presents with low cell-cell adhesion, resulting in itchy and painful skin lesions, 
particularly in areas of frequent skin-to-skin contact, such as the groin and neck (Burge 
1992). This is because the added stress of friction and heat on the cells in these areas 
exacerbates the phenotypic problems that arise from the haploinsufficiency (Burge 1992; 
Missiaen et al. 2004). The inability to properly regulate the calcium concentrations 
causes deficiencies in glycosylation as well as protein folding and sorting, leading to 
improper desmosome and adherens assembly, causing the cells of the epidermis to have 
poor differentiation and weak contacts with one another (Pillai et al. 1990; Vasioukhin et 
al. 2000).   
   
TYPE 2 DIABETES 
Because glycosylation is required for appropriate protein sorting from the Golgi 
to the target membrane, improper glycosylation could result in mislocalization of critical 





1995). In the case of GLUT2, a transporter responsible for moving glucose into the 
cytoplasm from the extracellular matrix, proper glycosylation is required to target the 
protein to the plasma membrane (Ohtsubo et al. 2005). If expression and localization of 
GLUT2 is impaired in pancreatic β cells, the cells are unable to undergo glucose-
stimulated insulin secretion (Ohtsubo et al. 2005). Expression of one particular 
glycosyltransferase, N-acetylglucosaminyltransferase-IV isoenzyme A (GnT-IVa), 
coincides with expression of GLUT2 (Ohtsubo et al. 2011). This is because GnT-IVa is 
required for a critical step in the glycosylation of GLUT2, involving the transfer of 
GlcNAc from UDP-GlcNAc to the core N-linked oligosaccharide (Minowa et al. 1998). 
In the absence of GnT-IVa, GLUT2 has only 2 terminal sugars of the N-glycan, as 
opposed to 4 in normal cells (Ohtsubo et al. 2005). This change results in decreased 
stability of the presence of GLUT2 at the cell surface, meaning that the protein is 
internalized prematurely, decreasing the uptake of glucose (Ohtsubo et al. 2005). In mice, 
this change has been demonstrated to be sufficient for the presentation of type-II diabetes 
phenotypes (Orci et al. 1990).  
   
PERSPECTIVES AND CONCLUSIONS 
The Golgi apparatus plays a critical role in cellular dynamics. Central to its 
function are the glycosyltransferases that carry out the process of glycosylation, as this 
contributes to the other roles of the Golgi, including protein and lipid maturation and 
trafficking. Without the activity of the various transporters of the Golgi membrane, which 
supply the necessary substrates and/or remove the byproducts of glycosylation, the 





aspect of transport or mechanistic reactions within the Golgi have the potential to be 
incredibly detrimental to the cell and the organism as a whole. Even the deletion of a 
single transmembrane transporter, like TMEM165, can have massive consequences on 
glycosylation and protein sorting, ultimately throwing off the function of the entire cell, 
and potentially leading to a number of diseases (Foulquier et al. 2012; Zeevaert et al. 
2013; Bammens et al. 2015). Due to the delicate nature of the homeostasis required for 
the many functions of the Golgi apparatus, it is important to continue to investigate the 
roles and mechanisms of all the proteins and their processes within the Golgi apparatus.   
In Chapter 2, I characterize two Golgi transporters, Gdt1 and Erd1, which regulate 
the homeostasis of glycosylation byproducts, H+ and Pi, respectively. Through genetic 
analysis and growth assays, I demonstrate that Gdt1 removes H+ from the Golgi in 
exchange for Ca2+, which is required for glycosylation and protein sorting. I also 
demonstrate that, in the absence of Erd1, the Pi byproduct of glycosylation is lost to the 
environment through the secretory pathway. Gdt1 has a mammalian homolog, 
TMEM165, which carries out a similar function, exchanging H+ from the Golgi lumen 
for Ca2+ and Mn2+, to support both glycosylation and lactation. This protein is analysed in 
Chapter 3, where I analyse TMEM165-deficient lactating mothers to determine that in the 
absence of TMEM165, mothers produce milk with a low yield of lactose, leading to an 
osmotic defect that concentrates other milk components, such as protein and metals, 
ultimately resulting in decreased nutrition for nursing pups. In chapter 4, I establish a new 
method that can be utilized for the study of essential genes, many of which have a role in 
glycosylation, and I identify an inhibitor of the nucleotide sugar transporter Vrg4, which 
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H+ AND Pi BYPRODUCTS OF GLYCOSYLATION AFFECT Ca2+ 
HOMEOSTASIS AND ARE RETRIEVED FROM THE GOLGI BY HOMOLOGS 
OF TMEM165 AND XPR1 
 
Parts of this chapter were published in G3 (Bethesda) in December, 2017 
 
Contributions from Other Authors: 
The genetic screen of the Yeast Knockout Collection for Ca2+ Hypersensitivity (presented 
in Figure 2.1B) was conducted by Carlos Evangelista. Christopher P. Stefan, Camille T. 
Soroudi, and Adam Kim each conducted preliminary experimentation and generation of 
yeast and plasmid strains, as well as the BAPTA- and Mn2+-sensitivity assays presented 












Glycosylation reactions in the Golgi complex and the endoplasmic reticulum 
utilize nucleotide sugars as donors and produce inorganic phosphate (Pi) and acid (H+) as 
byproducts.  Here we show that homologs of mammalian XPR1 and TMEM165 (termed 
Erd1 and Gdt1) recycle luminal Pi and exchange luminal H+ for cytoplasmic Ca2+, 
respectively, thereby promoting growth of yeast cells in low Pi and low Ca2+ 
environments. As expected for reversible H+/Ca2+ exchangers, Gdt1 also promoted 
growth in high Ca2+ environments when the Golgi-localized V-ATPase was operational 
but had the opposite effect when the V-ATPase was eliminated.  Gdt1 activities were 
negatively regulated by calcineurin signaling and by Erd1, which recycled the Pi 
byproduct of glycosylation reactions and prevented the loss of this nutrient to the 
environment via exocytosis.  Thus, Erd1 transports Pi in the opposite direction from 
XPR1 and other EXS family proteins and facilitates byproduct removal from the Golgi 















Secretory proteins, lipids, and carbohydrates can undergo one or more cycles of 
glycosylation in the lumens of the Golgi complex and the endoplasmic reticulum, often 
resulting in elaborate glycan chains (Stanley, 2011).  The glycosyltransferases 
responsible for these reactions consume nucleotide sugars such as GDP-mannose and 
UDP-glucose and generate nucleoside diphosphates which are rapidly converted by 
luminal nucleoside triphosphate diphopshohydrolases (NTPDases, or apyrases) to GMP 
and UMP plus Pi and H+ as byproducts (Knowles, 2011).  Nucleotide sugar transporters 
embedded in the membranes of these organelles then exchange one luminal nucleoside 
monophosphate for one cytoplasmic nucleotide sugar to allow additional rounds of 
glycosylation to occur (Hirschberg et al., 1998).  However, the fates of Pi and H+ 
byproducts of glycosylation reactions are not fully understood, and it is possible that their 
buildup in secretory organelles could adversely affects glycosylation reactions, sorting 
and trafficking of secretory proteins, and cell physiology. 
 Glycosyltransferases usually depend on Ca2+ or Mn2+ ions for maximal activity 
(Dürr et al., 1998).  The SPCA-family of P-type ATPases, which is mutated in Hailey-
Hailey disease of humans (Hu et al., 2000; Sudbrak et al., 2000), directly transports Ca2+ 
and Mn2+ ions from the cytoplasm into the lumen of the Golgi complex to satisfy the 
needs of most glycosyltransferases, as well as the kexin-family of pro-protein 
convertases.  The first SPCA-family Ca2+/Mn2+ pump, termed Pmr1, was discovered in 
budding yeast (Rudolph et al., 1989) and the pmr1∆ knockout mutants exhibited strong 
defects in glycosylation and processing of secretory proteins in the Golgi complex, 





culture media (Antebi and Fink, 1992; Sorin et al., 1997; Dürr et al., 1998).  The pmr1∆ 
mutants also exhibited mild activation of the unfolded protein response, likely because 
yeast naturally lacks a SERCA-family Ca2+ pump that supplies the ER of most other 
species with Ca2+ necessary for folding of secretory proteins (Dürr et al., 1998; Strayle et 
al., 1999).  The deficiency of Ca2+ in the Golgi and ER of yeast leads to activation of the 
cell wall integrity MAP kinase Slt2/Mpk1, which induces expression of the K+ 
transporter Kch1 that depolarizes the cell membrane and activates a voltage-gated Ca2+ 
channel (also called HACS, and composed of Cch1, Mid1, Ecm7) to promote Ca2+ influx, 
elevation of cytosolic free Ca2+ concentrations, and replenishment of the secretory Ca2+ 
pools (Locke et al., 2000; Bonilla et al., 2002; Bonilla and Cunningham, 2003; Martin et 
al., 2011; Stefan and Cunningham, 2013; Stefan et al., 2013).  This mechanism of ER 
and Golgi Ca2+ homeostasis in yeast is analogous to, but mechanistically distinct from, 
store-operated Ca2+ entry mechanisms in animals (Smyth et al., 2010).  Elevated 
cytosolic free Ca2+ in yeast also activates calmodulin and the serine/threonine protein 
phosphatase calcineurin, which induces expression of Pmr1 via activation of the Crz1 
transcription factor (Matheos et al., 1997; Stathopoulos and Cyert, 1997).  Crz1 also 
induces a PMCA-family Ca2+ pump, termed Pmc1 (Cunningham and Fink, 1994), which 
localizes to the limiting membrane of lysosome-like vacuoles and partially mislocalizes 
to the Golgi complex and ER in mutants that lack Pmr1(Marchi et al., 1999).  Because 
the vacuole plays a major role in Ca2+ detoxification in yeast, mutants that lack Pmc1 or 
Crz1 exhibit strong growth defects in medium supplemented with high Ca2+ 





 The yeast vacuole, like lysosomes in animals, is strongly acidified by the action of 
the V-ATPase, which directly transports H+ from the cytoplasm to the lumen (Kane, 
2016)  The CAX-family H+/Ca2+ exchangers in the vacuolar limiting membrane utilize 
this pH gradient to power transport of Ca2+ from the cytoplasm to the vacuole lumen 
(Forster and Kane, 2000).  The first CAX-family H+/Ca2+ exchanger, termed Vcx1, was 
discovered in yeast based on its ability to confer Ca2+ or Mn2+ resistance when 
overexpressed (Cunningham and Fink, 1996; Pozos et al., 1996).  But surprisingly, vcx1∆ 
mutants exhibit little hypersensitivity to Ca2+ unless calcineurin was also eliminated with 
either mutations or inhibitors such as cyclosporine and FK506 (Cunningham and Fink, 
1996).  These studies suggest that activated calcineurin may somehow inhibit Vcx1 
function, while independently inducing Pmc1 and Pmr1 expression via Crz1 activation 
(see Figure 2.1A).  However, the molecular mechanism of Vcx1 inhibition by calcineurin 
has not been elucidated and the interaction could be indirect. 
 Here we rule out the V-ATPase as a necessary intermediate in the inhibition of 
Vcx1 by calcineurin and we search for possible intermediaries through a genome-wide 
screen of the yeast gene knockout collection.  While the gdt1∆ mutant closely resembled 
the vcx1∆ mutant in its hypersensitivity to Ca2+ when calcineurin was inhibited or 
mutated, calcineurin-dependent inhibition of Vcx1 still occurred in gdt1∆ mutants.  Gdt1 
localizes to the Golgi complex of yeast, promotes glycosylation in high Ca2+ conditions, 
and transports Ca2+ when expressed in heterologous systems (Demaegd et al., 2013; 
Colinet et al., 2016; Potelle et al., 2016).  The sole human ortholog of Gdt1, termed 
TMEM165, was previously shown to regulate pH and glycosylation in the Golgi complex 






Figure 2.1:  Model of Ca2+ homeostasis and Golgi glycosylation, with results from a 
genome-wide screen.  
(A) Model of known ion or nucleotide sugar transporters (yellow) in the vacuole and 





transcription factor, calcineurin, calmodulin, and high cytosolic Ca2+.  Gdt1 and Erd1 
(orange) are putative transporters of the byproducts of glycosylation reactions in the 
Golgi complex such as H+ (produced by mannosyltransferases [MTases]) and Pi 
(produced by nucleoside triphosphate diphosphatases [NTDPases]) that were identified in 
genetic screens.  (B) Results of a genetic screen for knockout mutants that specifically 
exhibit hypersensitivity to elevated Ca2+ and/or Ca2+ plus FK506 in the growth medium.  
The numbers indicate growth relative to wild-type controls (smaller numbers indicate 
slower growth) with the strongest effects highlighted (yellow).  The 23 filtered mutants 
were ranked from vcx1∆-like (orange) to pmc1∆-like (blue) based on the difference 

















al., 2012; Zeevaert et al., 2013; Potelle et al., 2016).  Below we show that Gdt1 and Vcx1 
both promote Ca2+ sequestration when their organelles are properly acidified by the V-
ATPase and both promote Ca2+ increases in the cytoplasm when acidification has been 
disrupted.   
 To investigate how calcineurin might regulate Gdt1 function, we isolated 
spontaneous mutations that exhibited elevated Gdt1 function even while calcineurin 
remained functional.  Mutants deficient in Erd1, a polytopic transmembrane protein 
important for glycosylation and sorting of proteins in the Golgi complex (Hardwick et al., 
1990), were recovered.  We show evidence that Erd1 recycles Pi byproducts of the 
glycosylation in the Golgi complex before this important nutrient is lost by exocytosis.  
Therefore, this study sheds new light on the mechanisms that sustain luminal 
glycosylation reactions in the Golgi complex and promote Pi, Ca2+, and H+ homeostasis 
in the cell. 
 
RESULTS 
Genetic screen for mutants with altered Ca2+ sensitivity: V-ATPase, Vcx1, and Gdt1. 
 The ability of yeast cells to proliferate in high Ca2+ environments depends mostly 
on the vacuolar Ca2+ ATPase (Pmc1) when calcineurin is functioning and mostly on the 
vacuolar H+/Ca2+ exchanger (Vcx1) when calcineurin has been inhibited or mutated 
(Cunningham and Fink, 1996).  To search for additional Ca2+ transporters or regulators of 
Vcx1, we screened a collection of 4,848 non-essential gene knockout mutants of yeast 
strain BY4741 for their ability to proliferate in media containing 200 mM CaCl2 with and 





cyclosporine instead of FK506 to inhibit calcineurin yielded partially overlapping results 
(Zhao et al., 2013).  After filtering all the mutants that were hypersensitive to FK506 
alone or control osmolyte (200 mM MgCl2), and then filtering out the candidates that had 
exhibited elevated Ca2+ uptake in response to FK506 in a previous study (Martin et al., 
2011), a total of 23 mutants were hypersensitive to Ca2+, Ca2+ plus FK506, or both while 
passing the stringent filters.  These 23 mutants were ranked on a scale ranging from 
“vcx1∆-like” to “pmc1∆-like” (Figure 2.1B).  As expected, the crz1∆ mutant ranked 
closest to the pmc1∆ mutant because the calcineurin-dependent transcription activator 
Crz1 strongly induces expression of Pmc1 (Matheos et al., 1997; Stathopoulos and Cyert, 
1997).  Two other mutants (gpd1∆, sga1∆) exhibited hypersensitivity to Ca2+ but not Ca2+ 
plus FK506, but were not studied further. 
 The three mutants closest to vcx1 (gdt1∆, rav1∆, rav2∆) may be deficient in 
positive regulators of Vcx1 or in novel Ca2+ transporters.  Rav2 forms a complex with 
Rav1 and promotes assembly of V1 and V0 sectors of the vacuolar form of the V-ATPase 
(Smardon et al., 2014).  The low residual vacuolar V-ATPase activity present in rav1∆ 
and rav2∆ mutants may be insufficient to power the H+/Ca2+ exchange activity of Vcx1, 
thereby producing the vcx1∆-like phenotype.  Complete loss of all V-ATPase forms, as 
observed in vma1∆ and other vma mutants, resulted in hypersensitivity to high Ca2+ and 
Ca2+ plus FK506, but these mutants were filtered out because of hypersensitivity to high 
Mg2+ and Mg2+ plus FK506.  Surprisingly, a mutant that specifically lacks only the 
vacuolar form of the V-ATPase (vph1∆) while preserving the Golgi/endosomal forms 







Figure 2.2:  Vacuolar V-ATPase determines directionality of Vcx1 operation.   
(A) Ca2+ tolerance assays were performed in duplicate in YPDS medium (black bars) or 
in the same medium containing 0.2 µg/mL FK506 (gray bars) as described in Methods, 
and the derived IC50 values (± S.D.) for the indicated mutants were plotted on a log 
scale.  (B) The indicated strains were transformed with plasmid pKC190 that bears the 
PMC1-lacZ reporter gene (Cunningham and Fink, 1996) and β-galactosidase activity was 
measured 4 hr after log-phase cells were shifted to YPDS medium containing 100 mM 


































high Ca2+ plus FK506 conditions (Figure 2.1B, line 11), as if the functions of Vcx1 and 
Pmc1 were both compromised.   
 To investigate how the vacuolar V-ATPase affects Pmc1 and Vcx1 function, a 
pmc1∆ vcx1∆ vph1∆ triple knockout mutant was constructed in the W303-1A strain 
background along with all possible double and single knockout mutants and the 
concentrations of CaCl2 that cause a 50% inhibition of total growth (i.e. the IC50) was 
compared for all eight strains.  Relative to the wild-type parent, the pmc1∆ vcx1∆ vph1∆ 
triple mutant was ~19-fold more sensitive to Ca2+ in the medium (Figure 2.2A, black 
bars).  In the absence of Vph1, restoring Pmc1 increased the IC50 for Ca2+ strongly (4.2-
fold) whereas restoring Vcx1 had little effect (1.1-fold) in the presence or absence of 
Pmc1.  Restoring Vph1 function had no significant effect in the cells that lack both Pmc1 
and Vcx1 (1.05-fold), but had strong effects on cells expressing only Vcx1 (2.2-fold) or 
Pmc1 (4.4-fold).  Therefore, Pmc1 activity was partially dependent on a functional V-
ATPase in the vacuolar membrane, and the relatively low Vcx1 activity detectable in 
pmc1∆ mutant backgrounds was totally dependent on the vacuolar V-ATPase.   
 To test whether the vacuolar V-ATPase mediates the interaction between 
calcineurin and Vcx1, the same eight mutant strains were reanalyzed in the presence of 
FK506 (Figure 2.2A, gray bars).  The pmc1∆ vcx1∆ vph1∆ triple mutant became 2.7-fold 
more sensitive to Ca2+ in the presence of FK506 than in the absence of FK506, 
presumably due to diminished function of the Crz1 transcription factor and therefore 
diminished expression of the Pmr1 Ca2+/Mn2+ ATPase in the Golgi complex when 
calcineurin is inhibited.  Restoring Vcx1 function alone had little effect (1.3-fold 





effects (5.2-fold increase) despite a lower expression of Pmc1 in the absence of 
calcineurin (Cunningham and Fink, 1994).  Importantly, restoring Vcx1 in the vph1∆ 
mutant actually lowered tolerance to environmental Ca2+ by a significant degree (2.5-fold 
decrease) in the absence of both calcineurin and only when Pmc1 was functioning.  These 
findings show, for the first time, that Vcx1 can antagonize the function of Pmc1 when the 
vacuoles lack acidification by the V-ATPase and when the cytoplasm lacks calcineurin 
signaling.  Such antagonism was expected because H+/Ca2+ exchangers are generally 
thought to operate in ‘reverse-mode’ in conditions where the luminal H+ concentration is 
low and the Ca2+ concentration is high, potentially causing futile cycles between Vcx1 
and Pmc1 in the absence of Vph1.  Reverse-mode operation of Na+/Ca2+ exchangers is 
well established (Harper and Sage, 2016).  That reverse-mode operation of Vcx1 
(observed in vph1∆ mutants with FK506) did not occur in the absence of FK506 suggests 
calcineurin regulates both forward and reverse modes of Vcx1 through a process that is 
independent of the V-ATPase. 
 Reverse-mode operation of Vcx1 is predicted to increase cytoplasmic free Ca2+ 
concentrations and enhance calcineurin signaling, while forward-mode operation 
achieves the opposite effects.  To test this prediction, we measured expression of a 
calcineurin-sensitive reporter gene PMC1-lacZ in vcx1∆ vph1∆ double mutants relative to 
the single mutants and control strain.  This experiment was performed in a pmc1∆ mutant 
background to improve the sensitivity of the reporter and enable detection of forward-
mode Vcx1 activity (Cunningham and Fink, 1996).  As predicted, the pmc1∆ vcx1∆ strain 
expressed PMC1-lacZ at significantly higher levels than the pmc1∆ strain after exposure 





lower levels of expression than the pmc1∆ vcx1∆ double mutant strain (Figure 2.2B).  
These findings show that Vcx1 can lower calcineurin signaling when the vacuole is 
properly acidified and increase calcineurin signaling when the vacuolar V-ATPase is 
inactivated, thus providing independent evidence that Vcx1 transports Ca2+ bi-
directionally similar to Na+/Ca2+ exchangers in animals. 
 
Calcineurin regulates independent functions of Gdt1 and Vcx1. 
 The gdt1∆ mutant, which lacks a probable Golgi-localized H+/Ca2+ exchanger 
(Demaegd et al., 2013; Colinet et al., 2016), clustered closest to the vcx1∆ mutant in our 
screening conditions (Figure 2.1B) and therefore is a potential regulator of Vcx1.  To test 
whether Gdt1 promotes Ca2+ resistance independent of Vcx1, the gdt1∆ knockout 
mutation was introduced into the pmc1∆ vcx1∆ double mutant and the single mutants in 
the W303-1A background and the IC50’s of Ca2+ were quantified in the presence and 
absence of FK506.  The gdt1∆ mutation weakly diminished Ca2+ tolerance in every strain 
background when calcineurin was functional (average decline of 1.35 ± 0.15 fold) but 
strongly diminished Ca2+ tolerance in WT, pmc1∆, vcx1∆, and pmc1∆ vcx1∆ 
backgrounds when FK506 was present (by 4.8, 2.9, 5.9, and 2.0 fold respectively; Figure 
2.3A).  Similar results were obtained when calcineurin was inactivated by a cnb1∆ 
knockout mutation (data not shown).  Thus, in the absence of calcineurin signaling, Gdt1 
strongly promoted Ca2+ tolerance independent of both Vcx1 and Pmc1, and likely 
represents a new class of Ca2+ transporter that is partially inhibited by calcineurin.   
 Calcineurin may directly or indirectly regulate Gdt1 function.  To test whether 






Figure 2.3:  Gdt1 promotes Ca2+ detoxification independent of Vcx1 and Pmc1.   
(A) A panel of S. cerevisiae strains lacking Gdt1, Vcx1, and Pmc1 in all possible 
combinations was assayed for Ca2+ tolerance in the presence (gray bars) or absence 
(black bars) of FK506 as described in Figure 2.2A.   (B) A strain expressing epitope-
tagged Gdt1-TAP was grown to log phase in YPDS medium containing 200 mM CaCl2 
and/or 1 µg/mL FK506, harvested, lysed, and analyzed by SDS-PAGE and western 












expression of Cmk2, we repeated the Ca2+ tolerance experiments described above in 
crz1∆ cmk2∆ double mutant and single mutant backgrounds.  This experiment ruled out 
Crz1 and Cmk2 as possible intermediaries in the inhibition of Gdt1 by calcineurin (see 
Table 2.1).  To test whether calcineurin signaling could diminish expression of Gdt1 or 
alter its mobility on SDS-PAGE, western blots were performed on cells containing a TAP 
epitope tag, integrated at the 3’ end of the chromosomal GDT1 gene (Ghaemmaghami et 
al., 2003), that were exposed to Ca2+ with and without FK506.  The TAP-tag did not alter 
the Ca2+ tolerance functions of Gdt1 or its responsiveness to FK506 (not shown).  After 
exposure of the cells to 200 mM CaCl2 with or without 1 µg/mL FK506 for 12 hr, the 
Gdt1-TAP band maintained the same intensity and migration on the gel (Figure 2.3B).  
Therefore, the inhibitory effects of calcineurin on Gdt1 function were not noticeably 
associated with changes in Gdt1 expression or modification and possibly dependent on 
unknown intermediaries.   
 
Gdt1 promotes H+/Ca2+ exchange in the Golgi complex 
 Recent studies also showed that Gdt1 localized to the Golgi complex of yeast 
(Demaegd et al., 2013), and we have independently confirmed those findings using 
immunofluorescence microscopy and sucrose gradient fractionation of a functional Gdt1-
3HA fusion protein (data not shown).  This finding led us to explore the possible 
interactions between Gdt1 and Pmr1, the secretory pathway Ca2+ ATPase of yeast.  To 
determine whether Gdt1 supplies essential Ca2+ or Mn2+ to the Golgi complex 
independent of Pmr1, we quantified the tolerance of gdt1∆ pmr1∆ double mutant and 





Table 2.1: Sensitivity of mutant strains to added CaCl2 (Experiment A) [a] 





[d] Performance Factor [e] 
LINE MATa MATα PMC1 VCX1 GDT1 CRZ1 CN CMK2 % mM PMC1 VCX1 GDT1 CRZ1 CN CMK2 
1 K1849 K1850 ∆      3 21  0.3 0.2 -0.1 -3.1 -0.3 
2 K1851 K1852 ∆   ∆   7 22  0.8 0.3  -3.2 -0.6 
3 K1857 K1858 ∆  ∆    0 18  0.6  0.1 -1.0 0.1 
4 K1859 K1860 ∆  ∆ ∆   11 18  0.9   -0.9 -0.4 
5 K1865 K1866 ∆ ∆     0 18   0.5 0.5 0.3 0.1 
6 K1867 K1868 ∆ ∆  ∆   7 12   0.4  0.2 0.4 
7 K1873 K1874 ∆ ∆ ∆    12 12    0.3 0.6 -0.2 
8 K1875 K1876 ∆ ∆ ∆ ∆   5 9     0.9 0.1 
9 K1849 K1850 ∆    +FK  2 179  3.7 2.3 -0.1  0.2 
10 K1851 K1852 ∆   ∆ +FK  1 197  4.3 2.6   0.6 
11 K1857 K1858 ∆  ∆  +FK  3 36  2.2  0.1  0.1 
12 K1859 K1860 ∆  ∆ ∆ +FK  1 33  2.7    0.4 
13 K1865 K1866 ∆ ∆   +FK  9 14   0.8 0.4  0.9 
14 K1867 K1868 ∆ ∆  ∆ +FK  7 10   1.0   1.3 
15 K1873 K1874 ∆ ∆ ∆  +FK  32 8    0.6  0.7 
16 K1875 K1876 ∆ ∆ ∆ ∆ +FK  4 5      1.0 
17 K1853 K1854 ∆     ∆ 4 25  0.6 0.5 -0.4 -2.6  
18 K1855 K1856 ∆   ∆  ∆ 14 33  1.8 0.5  -2.0  
19 K1861 K1862 ∆  ∆   ∆ 19 18  0.3  -0.4 -0.9  
20 K1863 K1864 ∆  ∆ ∆  ∆ 6 23  1.4   -0.1  
21 K1869 K1870 ∆ ∆    ∆ 2 16   0.2 0.8 1.2  
22 K1871 K1872 ∆ ∆  ∆  ∆ 1 10   0.1  1.2  
23 K1877 K1878 ∆ ∆ ∆   ∆ 4 14    0.7 1.5  
24 K1879 K1880 ∆ ∆ ∆ ∆  ∆ 4 9     1.8  
25 K1853 K1854 ∆    +FK ∆ 0 156  4.4 2.2 0.2   
26 K1855 K1856 ∆   ∆ +FK ∆ 1 134  5.0 2.4    
27 K1861 K1862 ∆  ∆  +FK ∆ 1 33  2.8  0.4   
28 K1863 K1864 ∆  ∆ ∆ +FK ∆ 15 25  3.3     
29 K1869 K1870 ∆ ∆   +FK ∆ 26 7   0.6 0.8   
30 K1871 K1872 ∆ ∆  ∆ +FK ∆ 7 4   0.7    
31 K1877 K1878 ∆ ∆ ∆  +FK ∆ 14 5    0.9   
32 K1879 K1880 ∆ ∆ ∆ ∆ +FK ∆ 16 3       
33 K1833 K1834       16 70 1.7  0.7 1.1 -1.8 -0.1 
34 K1835 K1836    ∆   17 32 0.6  0.1  -2.7 -0.5 
35 K1841 K1842   ∆    6 42 1.2   0.5 -0.1 0.0 
36 K1843 K1844   ∆ ∆   25 30 0.7    -0.4 -0.3 
37 K1833 K1834     +FK  6 244 0.4  2.4 0.2  0.3 
38 K1835 K1836    ∆ +FK  4 217 0.1  2.5   0.5 
39 K1841 K1842   ∆  +FK  9 45 0.3   0.2  0.3 
40 K1843 K1844   ∆ ∆ +FK  12 39 0.2     0.4 
41 K1837 K1838      ∆ 16 77 1.6  0.9 0.8 -1.3  
42 K1839 K1840    ∆  ∆ 12 45 0.4  0.2  -1.8  
43 K1845 K1846   ∆   ∆ 29 41 1.2   0.1 0.1  
44 K1847 K1848   ∆ ∆  ∆ 6 38 0.7    0.4  
45 K1837 K1838     +FK ∆ 5 192 0.3  2.4 0.3   
46 K1839 K1840    ∆ +FK ∆ 1 156 0.2  2.4    
47 K1845 K1846   ∆  +FK ∆ 13 38 0.2   0.4   







[a] Yeast were inoculated in YPD, supplemented with succinate and containing a dilution series of CaCl2, 
via a 1:1000 dilution from a saturated culture. Growth was measured by assessment of the optical 
density (OD650) after 24 hours. 
[b] addition of 0.2 µg/mL FK506 
[c] coefficient of variation between two strains (in %) or one strain 
[d] average of derived IC50 from two strains (in mM CaCl2) 







Figure 2.4:  Gdt1 supplies essential Ca2+ independent of Pmr1 and reverse-mode 
activity of Gdt1 is blocked by Golgi V-ATPase.   
Mn2+ (A) and BAPTA (B, C) tolerance assays were performed in YPD medium and raw 
data (A, B) or derived IC50 values (C; ± S.D.) were plotted on log scales.  (D) 
Expression of PMC1-lacZ reporter gene was measured as described in Figure 2.2B 






chelator of Ca2+, Mn2+, and other divalent cations (BAPTA, Fig 2.4B) in the culture 
medium.  The Mn2+ tolerance of gdt1∆ mutants and gdt1∆ pmr1∆ double mutants were 
indistinguishable from control strains (wild-type and pmr1∆, respectively), suggesting 
that Gdt1 cannot remove toxic Mn2+ from the cytoplasm.  The gdt1∆ mutant exhibited a 
strong hypersensitivity to BAPTA relative to the wild-type parent strain, and the gdt1∆ 
pmr1∆ double mutant exhibited extreme hypersensitivity to BAPTA that was 
significantly greater than the pmr1∆ mutant (Figure 2.4B).  Thus, Gdt1 appeared to 
supply essential Ca2+ ions to the Golgi complex independent of Pmr1.   
 Interestingly, FK506 blocked growth of gdt1∆ pmr1∆ double mutants in all 
growth media we tested (data not shown).  This lethality of FK506 suggests that 
calcineurin-dependent up-regulation of Pmc1 and relocalization to the Golgi complex 
(Marchi et al., 1999) is crucial to supply essential Ca2+ when Pmr1 and Gdt1 are absent, 
but further experiments are required to test this hypothesis.   
 If Gdt1 functions as a H+/Ca2+ exchanger in the Golgi, its contributions to 
BAPTA tolerance should depend on the Golgi/endosomal forms of the V-ATPase, which 
employ Stv1 rather than Vph1 in the V0-sector of the enzyme (Manolson et al., 1994).  
However, stv1∆ mutants alone behaved like wild-type in all conditions tested because the 
remaining Vph1-containing V-ATPase fully acidifies the Golgi even in the absence of 
Stv1 (Qi and Forgac, 2007). We therefore tested the BAPTA tolerance of gdt1∆ and 
stv1∆ mutations in a background that lacks Vph1 (and also Vcx1, which could complicate 
the analyses).  In this vph1∆ vcx1∆ double mutant background, the loss of Gdt1 caused 
more than 10-fold decrease in BAPTA tolerance and the further loss of Stv1 had little 





decrease in BAPTA tolerance, and this hypersensitivity was partially reversed (~2.5 fold) 
by the further loss of Gdt1.  Thus, like Vcx1, Gdt1 appeared to function in reverse-mode 
when the V-ATPase was completely eliminated and in forward-mode when the V-
ATPase was functional.   
 The ability of Gdt1 to decrease and increase cytosolic free Ca2+ was also 
examined by measuring expression of the calcineurin-dependent PMC1-lacZ reporter 
gene described earlier.  In the vph1∆ vcx1∆ double mutant background that acidifies the 
Golgi complex, the additional gdt1∆ mutation did not significantly alter expression of the 
reporter gene after addition of 50 mM CaCl2 (Figure 2.4D), and so forward-mode activity 
of Gdt1 was not detectable above the high influences of Pmc1 and Pmr1 in these 
conditions.  However, reverse-mode activity of Gdt1 was detected in the vph1∆ vcx1∆ 
stv1∆ triple mutant background because the additional gdt1∆ mutation significantly 
lowered expression of the reporter gene (Figure 2.4D).  Together with the earlier findings 
on Gdt1 and Vcx1 bi-directionality, these findings provide strong support for the 
hypothesis that Gdt1 functions as a reversible H+/Ca2+ exchanger of the Golgi complex in 
vivo. 
 
Erd1 recycles inorganic phosphate from the ER and Golgi complex and limits the 
functions of Pmr1 and Gdt1. 
 If activated calcineurin inhibits Gdt1 function, it may be possible to isolate 
variants of Gdt1 that are hyperactive when calcineurin is fully functional, similar to the 
hyperactive Vcx1-D mutants that have been isolated previously (Cunningham and Fink, 





generated strains simultaneously lacking Pmc1, Vcx1, and Crz1 and selected for rare 
spontaneous mutants that enabled growth in medium supplemented with high 
concentrations of CaCl2 (see Methods).  Of 36 independent spontaneous mutations, 26 
were found to be dominant in heterozygous diploids.  The GDT1 coding sequence from 
all 26 strains was amplified by PCR and sequenced.  No mutations were identified in the 
GDT1 coding sequences.  The mechanism of Gdt1 regulation by calcineurin remains 
unknown and may involve several unknown intermediary steps (see Discussion).   
 In addition to the 26 dominant mutants, 10 independent recessive mutants were 
recovered, and these mutants defined a single complementation group.  All of the 
recessive Ca2+-resistant mutants were found to be hypersensitive to tunicamycin, an 
inhibitor of N-glycosylation reactions in the ER (Lehle and Tanner, 1976), and we 
isolated two low-copy plasmids from a library of random genomic DNA fragments that 
complemented this phenotype.  The ERD1 gene was found to be necessary and sufficient 
for complementation of both phenotypes, and the erd1∆ knockout mutation was found to 
recapitulate both phenotypes in the starting strain background.  Though the precise 
function of Erd1 has not yet been determined, earlier studies show that Erd1 is a 
polytopic membrane protein important for two Golgi-localized processes: glycosylation 
of secretory proteins and for retrieval of escaped HDEL-containing proteins back to the 
ER (Hardwick et al., 1990).  To determine its role in Ca2+ homeostasis, the erd1∆ 
mutation was introduced into backgrounds that also lack Pmc1, Vcx1, Gdt1, and Crz1 
and the IC50s for CaCl2 were measured as before.  These experiments showed that Erd1 
significantly decreased Ca2+ tolerance of pmc1∆ vcx1∆ crz1∆ triple mutant (1.9 fold 





Table 2.2: Sensitivity of mutant strains to added CaCl2 (Experiment B)[a] 





[d] Performance Factor [e] 
LINE MATa MATα PMC1 VCX1 GDT1 CRZ1 CN CMK2 ERD1 % mM PMC1 VCX1 GDT1 CRZ1 CN CMK2 ERD1 
2 NS132 NS133 Δ   Δ    1 49  2.4 0.7  -2.6  -0.1 
3 NS136 NS137 Δ  Δ     4 30  1.0  0.0 -0.5  -0.1 
4 NS144 NS145 Δ  Δ Δ    12 30  1.9   -0.4  0.0 
5 NS154 NS155 Δ Δ      0 27   0.8 1.5 1.4  -0.1 
6 NS164 NS165 Δ Δ  Δ    4 9   0.2  0.2  -0.9 
7 NS168 NS169 Δ Δ Δ     1 15    0.9 1.6  -0.2 
8 NS176 NS177 Δ Δ Δ Δ    * 8     0.9  -0.3 
9 NS122 NS123 Δ    +FK   1 298  4.9 2.8 0.0   0.9 
10 NS132 NS133 Δ   Δ +FK   0 297  5.2 2.9    0.9 
11 NS136 NS137 Δ  Δ  +FK   5 42  3.0  0.1   1.2 
12 NS144 NS145 Δ  Δ Δ +FK   11 40  3.2     1.1 
13 NS154 NS155 Δ Δ   +FK   5 10   1.0 0.3   -0.9 
14 NS164 NS165 Δ Δ  Δ +FK   6 8   0.9    -0.5 
15 NS168 NS169 Δ Δ Δ  +FK   0 5    0.2   0.0 
16 NS176 NS177 Δ Δ Δ Δ +FK   * 4       0.1 
17 NS128 NS129 Δ      Δ 1 33  0.2 0.1 -0.7 -2.3   
18 NS138 NS139 Δ   Δ   Δ 0 53  1.6 0.8  -1.6   
19 NS140 NS141 Δ  Δ    Δ 4 32  0.8  0.1 0.8   
20 NS146 NS147 Δ  Δ Δ   Δ 1 29  1.6   0.7   
21 NS160 NS161 Δ Δ     Δ 1 30   0.7 0.8 0.7   
22 NS170 NS171 Δ Δ  Δ   Δ 0 17   0.8  0.6   
23 NS172 NS173 Δ Δ Δ    Δ 8 18    0.9 1.8   
24 NS178 NS179 Δ Δ Δ Δ   Δ 6 10     1.3   
25 NS128 NS129 Δ    +FK  Δ 1 158  3.1 3.1 0.0    
26 NS138 NS139 Δ   Δ +FK  Δ 7 161  3.8 3.1     
27 NS140 NS141 Δ  Δ  +FK  Δ 1 18  1.8  0.0    
28 NS146 NS147 Δ  Δ Δ +FK  Δ 1 18  2.2      
29 NS160 NS161 Δ Δ   +FK  Δ 0 19   1.8 0.7    
30 NS170 NS171 Δ Δ  Δ +FK  Δ 2 11   1.5     
31 NS172 NS173 Δ Δ Δ  +FK  Δ 16 5    0.3    
32 NS178 NS179 Δ Δ Δ Δ +FK  Δ 8 4        
33 NS116 NS117     -   3 245 3.0 0.0 0.3 1.8 -0.4  0.1 
34 NS120 NS121    Δ -   0 70 0.5 0.9 0.3  -2.2  0.3 
35 NS124 NS125   Δ  -   * 203 2.8 0.5  1.8 2.2  0.8 
36 NS134 NS135   Δ Δ -   1 57 0.9 0.8   0.0  0.7 
37 NS148 NS149  Δ   -   2 237 3.1  0.7 2.6 1.6  0.1 
38 NS152 NS153  Δ  Δ -   8 38 2.0  0.2  -1.1  0.0 
39 NS156 NS157  Δ Δ  -   6 146 3.2   2.1 2.0  0.2 
40 NS166 NS167  Δ Δ Δ -   3 34 2.1    0.5  0.1 
41 NS116 NS117     +FK   0 325 0.1 2.0 2.9 0.0   0.4 
42 NS120 NS121    Δ +FK   1 316 0.1 2.0 2.4    1.0 
43 NS124 NS125   Δ  +FK   * 44 0.1 0.2  -0.4   1.1 
44 NS134 NS135   Δ Δ +FK   1 59 0.6 1.3     1.3 
45 NS148 NS149  Δ   +FK   1 81 3.0  1.1 0.0   0.1 
46 NS152 NS153  Δ  Δ +FK   4 80 3.3  1.8    0.3 
47 NS156 NS157  Δ Δ  +FK   2 37 2.9   0.7   1.5 
48 NS166 NS167  Δ Δ Δ +FK   1 23 2.4      1.1 
49 NS118 NS119     -  Δ 2 223 2.8 0.0 1.0 1.9 -0.1   
50 NS126 NS127    Δ -  Δ 2 59 0.2 0.7 0.7  -1.5   
51 NS130 NS131   Δ  -  Δ 2 116 1.9 -0.2  1.7 2.5   





53 NS150 NS151  Δ   -  Δ 3 219 2.9  0.8 2.6 1.6   
54 NS158 NS159  Δ  Δ -  Δ 3 37 1.1  0.2  -0.8   
55 NS162 NS163  Δ Δ  -  Δ * 128 2.9   2.0 3.3   
56 NS174 NS175  Δ Δ Δ -  Δ 4 31 1.7    1.6   
57 NS118 NS119     +FK  Δ 2 244 0.6 1.7 3.6 0.6    
58 NS126 NS127    Δ +FK  Δ 4 163 0.0 1.3 2.7     
59 NS130 NS131   Δ  +FK  Δ 3 20 0.1 0.6  -0.3    
60 NS142 NS143   Δ Δ +FK  Δ 29 24 0.4 1.2      
61 NS150 NS151  Δ   +FK  Δ 1 74 2.0  2.5 0.2    
62 NS158 NS159  Δ  Δ +FK  Δ 3 64 2.5  2.6     
63 NS162 NS163  Δ Δ  +FK  Δ * 13 1.3   0.3    
64 NS174 NS175  Δ Δ Δ +FK  Δ 9 11 1.4       
 
Footnotes: 
[a] Yeast were inoculated in YPD, supplemented with succinate and containing a dilution series of CaCl2, 
via a 1:1000 dilution from a saturated culture. Growth was measured by assessment of the optical 
density (OD650) after 24 hours. 
[b] addition of 0.2 µg/mL FK506 
[c] coefficient of variation between two strains (in %) or one strain 
[d] average of derived IC50 from two strains (in mM CaCl2) 
















actually increased Ca2+ tolerance or was neutral in most other conditions.  These results 
are consistent with models where Erd1 selectively diminishes the forward function of 
Gdt1 in the Golgi complex.   
 Erd1 contains an EXS domain similar to that of human XPR1 and plant PHO1 
proteins, which recently have been shown to export inorganic phosphate (Pi) from the 
cell (Hamburger et al., 2002; Giovannini et al., 2013).  Because Pi is produced in the 
lumen of the Golgi complex and ER as a byproduct of glycosylation reactions (Figure 
2.1A), it is possible that erd1∆ mutants fail to recycle Pi to the cytoplasm and the backlog 
of Pi in the lumen increases the buffer capacity for Ca2+ while also interfering with 
normal glycosylation and sorting reactions.  To test the hypothesis that Erd1 recycles the 
Pi byproduct of glycosylation from the lumen of secretory organelles, several 
experiments were performed.   
 First, because Pi is an important nutrient to yeast, we explored the possibility that 
Erd1 is important for growth in low Pi environments.  Interestingly, the concentration of 
Pi in the medium required for 50% maximal growth (i.e. the ED50) was about 1.5-fold 
higher for erd1∆ mutants as compared to the wild-type control strain (Figure 2.5A).  The 
erd1∆ mutation caused a similar increase in the requirement for Pi when introduced into a 
pho84∆ mutant background, which lacks a high-affinity Pi transporter in the plasma 
membrane (Bun-Ya et al., 1991) and requires approximately 3-fold higher concentrations 
of Pi than wild-type for growth (Figure 2.5A).  The erd1∆ mutation strongly increased 
the ED50 of Pi nearly 3-fold when introduced into a pho84∆ pho87∆ pho89∆ pho90∆ 
pho91∆ quintuple mutant background (Figure 2.5B) that lacks all five of the known Pi 






Figure 2.5:  Erd1 supplies essential Pi.   
The indicated mutant strains were washed and inoculated into in SC medium containing 
various concentrations of Pi.  After 24 hr incubation, the concentration of Pi that enabled 
50% maximal growth (i.e. ED50) was derived and the averages (± S.D.) of triplicate 
measurements are plotted.  The erd1∆ mutation increased the ED50 by 1.5-fold, 1.4-fold, 
and 2.9-fold respectively in the wild-type, the pho84∆, and the pho-∆5 (pho84∆ pho87∆ 








Erd1 supplies essential Pi to the cytoplasm of yeast cells through a process that does not 
rely on any of the other Pi transporters. 
 Second, we tested whether erd1∆ mutants exhibited higher rates of Pi export into 
the culture medium via exocytosis, which would be predicted if Erd1 normally recycles 
this nutrient from the Golgi complex.  For this experiment, the erd1∆ and wild-type 
strains were cultivated for more than 10 generations in standard synthetic medium (7.35 
mM Pi) supplemented with tracer amounts of 32Pi, chilled, and the cells were washed 
extensively in fresh medium lacking Pi.  The temperature was then raised to 30°C and 
aliquots were removed at different times, centrifuged to pellet the cells, and the cell-free 
supernatants were collected and analyzed by liquid scintillation counting and by thin 
layer chromatography.  In the first 0.25 hr of incubation at 30°C, both erd1∆ and wild-
type strains exported similar amounts of radioactivity.  However, the erd1∆ mutant 
exported strikingly more Pi than wild-type over the next 1.75 hr of incubation (Figure 
2.6A, black curves).  Similar trends were obtained in the pho84∆ background (Figure 
2.6A, red curves), though these strains started with less than 30% of the wild-type levels 
of Pi due to their defect in Pi accumulation prior to the start of the experiment.  The large 
majority of radioactivity exported to the culture medium co-migrated with Pi standards 
on thin layer chromatography (Figure 2.6B).  When the chase experiment is repeated in 
SC medium containing 7.35 mM Pi, the influx of non-radioactive Pi permits sustained 
efflux of 32-Pi from wild-type cells for several hours and still the erd1∆ mutant exports 
more 32-Pi (Figure 2.6C).  If this Erd1-sensitive Pi efflux depends on exocytosis, such 
efflux may be diminished in a sec1-1ts mutant background, which quickly accumulates 






Figure 2.6:  Erd1 prevents Pi loss to the environment.   
The indicated mutant strains were grown to log phase in SC medium containing tracer 
levels of 32-Pi radioisotope, washed extensively in Pi-free SC medium, and then in the 
same medium (A, B) or in SC medium (C).  At the indicated times of incubation at 30°C, 
aliquots were removed and cell-free supernatants were analyzed by liquid scintillation 
counting (A, C) or by thin layer chromatography (B).  Charts illustrate the averages (± 





due to defects in the exocytotic machinery (Novick et al., 1981).  Remarkably, the Erd1-
sensitive efflux of Pi was markedly diminished in the sec1-1ts strain at 37°C but not the 
wild-type control strain (Figure 2.7A). These data suggest that Erd1 normally limits the 
export of Pi from cells via exocytosis.  
 If glycosylation reactions in the Golgi complex produce the Pi that is recycled by 
Erd1, the Erd1-sensitive Pi efflux may be diminished by inactivation of Vrg4, the main 
nucleotide sugar transporter of the Golgi complex that primarily supplies GDP-mannose 
in exchange for luminal GMP (Dean et al., 1997).  Vrg4 is essential for yeast growth and 
is not inhibited by any known molecules.  To render Vrg4 druggable, we introduced an 
auxin-inducible degron tag at its C-terminus along with a flag tag and an expression 
cassette for osTIR, an auxin-sensitive E3 ubiquitin ligase (Nishimura et al., 2009; 
Morawska and Ulrich, 2013).  Strains bearing Vrg4-AID-FLAG fusion protein grew as 
well as wild-type in the absence of auxin, but grew much more slowly than wild-type in 
the presence of 100 µM auxin (data not shown) suggesting that Vrg4 expression became 
growth-limiting in these conditions.  Indeed, just 1 hr exposure to 100 µM auxin resulted 
in 70% decline of Vrg4-AID-FLAG expression (Figure 2.7B).  The erd1∆ mutation was 
introduced into the Vrg4-AID-FLAG and wild-type control strains and Erd1-sensitive Pi 
efflux was measured as above.  After a 2 hr chase period in Pi-free culture medium, the 
Erd1-sensitive Pi efflux from wild-type cells was unaffected by exposure to auxin (Figure 
2.7C).  The Erd1-sensitive Pi efflux from the Vrg4-AID-FLAG strain was similar to 
wild-type in the absence of auxin, and was greatly reduced when the cells were exposed 











Figure 2.7:  Erd1-sensitive losses of Pi depend on exocytosis and on transport of 
GDP-mannose into the Golgi complex.   
(A) Pi losses were measured after 2 hr incubation as in Figure 2.6A except that sec1-1ts 
and sec1-1ts erd1∆ mutant strains were used at a permissive temperature (30°C; black 
bars) or a non-permissive temperature (37°C; gray bars) during the incubation in Pi-free 
medium.  (B) Western blot of Vrg4-AID-FLAG strains after 1 hr exposure to 100 µM 
auxin in SC medium.  (C) Erd1-sensitive losses of Pi (i.e. the difference between erd1∆ 
and ERD1 pairs of strains) were measured for wild-type and Vrg4-AID-FLAG strain 
backgrounds that were exposed to 100 µM auxin (grey bars) or not (black bars) starting 1 

















(Figure 2.7C).  These findings show that the GDP-mannose transporter Vrg4 is a major 
source of the Pi that is lost to the environment in erd1∆ mutants.  Altogether the results 
indicate that Erd1 recycles the Pi byproduct of glycosylation in the Golgi complex, which 
alters buffering of Ca2+ and performance of Gdt1. 
 
DISCUSSION 
 The Golgi complex of all eukaryotes is a hub for glycosylation, sorting, and 
processing of secreted proteins, transmembrane proteins, ceramides, and other lipids.  In 
yeast, the glycosylation system of the Golgi complex is essential for viability, as 
mutations that eliminate the major nucleotide-sugar transporter (Vrg4) or the luminal 
nucleoside triphosphate diphosphatases (Gda1 and Ynd1) are lethal (Dean et al., 1997; 
Gao et al., 1999).  While the nucleoside monophosphate byproduct of glycosylation is 
exchanged from the Golgi complex for another nucleotide sugar molecule, the fate of the 
other byproducts, Pi and H+, were elusive until now.  Our findings above suggest that 
Erd1 facilitates transport of the luminal Pi to the cytoplasm where it can be reutilized and 
that Gdt1 transports luminal H+ to the cytoplasm in exchange for cytoplasmic Ca2+.  
Because neither protein has been purified to homogeneity and analyzed in reconstituted 
liposomes, it remains possible that Erd1 and Gdt1 do not directly transport these 
byproducts of glycosylation and instead regulate unknown transporters that have these 
properties.  Nevertheless, the simplest model of inorganic ion homeostasis in the Golgi 
complex (summarized in Figure 2.1A) is consistent with numerous genetic observations 





opportunities for treating a congenital disorder of glycosylation in humans (Dulary et al., 
2017). 
 
Pi homeostasis in the Golgi complex 
 Our findings that Erd1 decreases the loss of Pi from the Golgi complex to the 
environment and promotes growth of yeast cells in low-Pi environments independent of 
all known Pi transporters suggest that yeast normally recycles this byproduct of 
glycosylation for reuse in the cytoplasm.  This function is somewhat surprising because 
XPR1, a homolog of Erd1 in the basolateral plasma membrane of humans, has been 
shown to promote export of cytoplasmic Pi from the cytoplasm rather than import 
(Giovannini et al., 2013).  XPR1 orthologs in zebra fish may have similar roles in Pi 
export, as knockout mutations resulted in failure to produce osteoclasts (Meireles et al., 
2014), which are thought to experience massive Pi uptake and efflux during resorption of 
bone.  PHO1, an ortholog of XPR1 in the plant Arabidopsis thaliana, has also been 
shown to promote Pi export from root stelar cells to the xylem, resulting in Pi 
deficiencies in the shoots (Hamburger et al., 2002; Wege and Poirier, 2014).  PHO1 
localizes primarily to the Golgi complex rather than the plasma membrane and thus may 
export Pi through exocytosis pathways (Arpat et al., 2012).  The transmembrane 
topologies of Erd1 (Kim et al., 2006) and PHO1 (Wege et al., 2016) are similar, so the 
directionality of net Pi transport by members of the ESX family may depend on other 
factors such as unknown ions or molecules that could be co- or counter-transported with 





 Though absent from Erd1, SPX domains are found at the N-termini of XPR1 and 
PHO1 and many other proteins that regulate Pi homeostasis (Secco et al., 2012).  
Deletion of the SPX domain did not diminish Pi transport activity or alter directionality 
(Wege et al., 2016).  The SPX domain can also be found at the N-termini of numerous 
other proteins involved in Pi homeostasis in yeast such as Pi transporters of the SL13 
family (Pho87, Pho90, Pho91), subunits of the vacuolar poly-Pi synthase (Vtc2, Vtc3, 
Vtc4, Vtc5), a cyclin-dependent kinase (Pho85) and its inhibitor (Pho81) that govern the 
response to Pi starvation, glycerophosphocholine phosphodiesterase 1 (Gde1), and 
another ESX domain protein of unknown function (Syg1) (Secco et al., 2012).  Several 
SPX domains have now been shown to bind inositol polyphosphates such as IP6 and IP7 
(Lee et al., 2007; Wild et al., 2016), which have important regulatory effects on Pi 
homeostasis.  The lack of an SPX domain in Erd1, and the inability of Pho4 to stimulate 
transcription of the ERD1 gene in Pi-limiting conditions, suggest that Erd1 may escape 
the conventional regulation imposed on other Pi homeostasis regulators.   
 The evolutionary origins of Erd1 also may be instructive about its functions in 
cell physiology.  Our searches of protein databanks and multiple sequence alignments 
(not shown) reveal orthologs of Erd1 in virtually all species of fungi, in a unicellular 
relative of fungi (the nuclearid Fonticula alba), and in a unicellular relative of metazoans 
(the choanoflagellate Monosiga brevicollis), but not in metazoans.  This suggests that 
Erd1-subfamily of ESX-domain proteins originated prior to the divergence of fungi and 
animals but were uniquely lost from the metazoan lineage.  This loss in metazoans could 
have been enabled by the gain of another Pi transporter in the Golgi complex.  





in metazoans where the loss of Pi to the extracellular fluids is not harmful or potentially 
even beneficial for Pi storage, for pH buffering, or for creating extracellular structures.   
 In addition to defects in Pi recycling, erd1∆ mutants of yeast exhibit striking 
deficiencies of secretory protein glycosylation and of sorting by the H/KDEL receptor 
(Erd2), which ordinarily retrieves many ER resident molecular chaperones and enzymes 
that have escaped the ER (Hardwick et al., 1990).  How elevated Pi in the lumen of Golgi 
complex can cause such disparate effects is not clear.  Conceivably, high luminal Pi may 
competitively inhibit the activities of NTPDases that produce it or the 
glycosyltransferases, nucleotide sugar transporters, other factors involved directly in 
promoting glycosylation.  The binding of H/KDEL peptides to their receptor is highly 
sensitive to the luminal pH (Wilson et al., 1993), which might be altered in erd1∆ 
mutants through accumulation of H2PO4
- and dissociation to H+ and HPO4
2-.  An inability 
of erd1∆ mutants to transport Pi out of the Golgi complex may increase the buffering of 
Ca2+, Mn2+, Mg2+ in the lumen as well, perhaps altering the structure of the organelle or 
decreasing the performance of glycosylation and ER retrieval systems.  Lastly, the 
concentration of some other molecules in the Golgi complex could be directly disrupted 
in erd1∆ mutants if Erd1 (or possibly its associated catalytic partner) also co- or counter-
transports some other molecule together with Pi.  Direct transport studies using liposomes 
with purified and reconstituted Erd1 protein and other biochemical experiments will be 
needed to test these possibilities. 
 





 Here we show that Gdt1 promotes growth of yeast cells in both low and high Ca2+ 
environments independent of the known Ca2+ transporters (Pmr1, Pmc1, Vcx1) and only 
when the Golgi complex receives sufficient acidification from the V-ATPase.  In the 
absence of all V-ATPase activity, Gdt1 seemed to partially undo the work of the other 
transporters and to have the opposite effects on cell growth and on calcineurin activation 
in the cytoplasm.  By showing Gdt1 can operate in reverse mode when the V-ATPase is 
eliminated, we add strong experimental support to the hypothesis that Gdt1 catalyzes 
H+/Ca2+ exchange in the Golgi complex (Demaegd et al., 2013; Colinet et al., 2016).  But 
unlike Pmr1, which transports both Ca2+ and Mn2+ to the Golgi complex, we did not 
detect any hypersensitivity of gdt1∆ mutants to elevated Mn2+ in the medium even in the 
absence of Pmr1 (data not shown), suggesting that Gdt1 may not transport significant 
levels of Mn2+.  Consistent with these findings, the partial rescue of glycosylation defects 
in pmr1∆ mutants by supplemental Ca2+ depended on Gdt1 but the partial rescue by 
supplemental Mn2+ occurred independent of Gdt1 (Colinet et al., 2016).  While these 
findings suggest that Gdt1 does not play a direct role in Mn2+ transport into the Golgi 
complex, direct transport of Mn2+ by Gdt1 was proposed to explain the observation that 
gdt1∆ mutants exhibit glycosylation defects in high Ca2+ conditions that can be rescued 
by supplemental Mn2+ and Pmr1 function (Potelle et al., 2016).  Our demonstration of 
reverse-mode operation of Gdt1 strengthens an alternative hypothesis to explain this 
observation:  in high Ca2+ conditions, Gdt1 may normally promote net Ca2+ efflux from 
the Golgi complex and thereby allows Pmr1 to cycle more rapidly and effectively 





 Findings from mammalian cells indicate broad conservation of Gdt1 and 
TMEM165 function in the Golgi complex.  Simultaneous knockouts of TMEM165 and 
SPCA1 genes (a homolog of Pmr1 encoded by ATP2C1) result in synthetic lethality in 
the human HAP1 cell line (Blomen et al., 2015), suggesting these Golgi proteins share 
important functions.  Deficiency of TMEM165 in human cells disrupts pH homeostasis 
of lysosomes and late endosomes (Demaegd et al., 2013), as expected if TMEM165 
normally catalyzes H+/Ca2+ exchange in the forward-mode in these cells.  Interestingly, 
knockdown of TMEM165 in human cell lines resulted in glycosylation defects that could 
be rescued by low concentrations of Mn2+ (Potelle et al., 2016).  Such rescue provides 
clues for therapies to treat rare deficiencies of TMEM165 in humans, which cause a type-
II congenital disorder of glycosylation that manifest with glycosylation defects, bone 
dysplasias, and other abnormalities (Dulary et al., 2017).  TMEM165 appears to be 
expressed in virtually all tissues, so understanding how such specific developmental 
abnormalities arise from defects in a housekeeping gene function will require much more 
work.  The recent identification of TMEM165 splice variants localized to the ER, rather 
than the Golgi, raises the possibility of additional functions of TMEM165 that have yet to 
be identified (Krzewinski-Recchi et al., 2017).  
 We also provide evidence that activated calcineurin can inhibit the forward mode 
activity of Gdt1 in vivo, similar to that of Vcx1: in the presence of the calcineurin 
inhibitor FK506, gdt1∆ and vcx1∆ mutants were far more hypersensitive to Ca2+ than in 
the absence of the calcineurin inhibitor, even when Pmc1 and Crz1 were eliminated.  
Gdt1 did not mediate the inhibition of Vcx1 by calcineurin, and Vcx1 did not mediate the 





one or the other transporter has been eliminated.  The molecular mechanism(s) by which 
calcineurin regulates the function of Gdt1 and Vcx1 remain unknown, as neither protein 
undergoes changes in expression or mobility on SDS-page upon activation/inhibition of 
calcineurin.  Our finding that calcineurin still inhibited reverse-mode activity of Vcx1 in 
the absence of Vph1 suggests that neither the vacuolar V-ATPase nor luminal H+ are key 
mediators of this regulation.  We also ruled out Erd1 as an intermediary of Gdt1 
inhibition by calcineurin, as this regulation persisted in erd1∆ vcx1∆ strains (Table 2.2).  
Because Gdt1 and Vcx1 both seem to promote H+/Ca2+ exchanger, it is tempting to 
speculate that calcineurin regulates pH of the cytoplasm or organelles in high Ca2+ 
conditions, which would alter the ability of transporters to bind Ca2+.  Indeed, new 
evidence suggests that calcineurin may down-regulate the plasma membrane H+ pump 
Pma1 (Patricia Kane, personal communication), potentially causing acidification of the 
cytoplasm and diminishing forward Ca2+ transport by H+/Ca2+ exchangers.   
 Because Gdt1 and Vcx1 may also inhibit calcineurin activation by removing Ca2+ 
from the cytoplasm, both proteins have the potential to form double-negative feedback 
loops with calcineurin (Figure 2.1A).  Double-negative feedback loops generate positive 
feedback in signaling networks, and tend to promote switch-like transitions between two 
stable states (Ferrell, 2002).  In such a scenario, calcineurin is less likely to become 
activated when Gdt1 and Vcx1 are fully functional, but as cytosolic Ca2+ concentrations 
rise and calcineurin becomes activated both Gdt1 and Vcx1 may become progressively 
inhibited, thus accelerating the activation of calcineurin and the further inhibition of 
H+/Ca2+ exchangers.  Double-negative feedback loops can contribute to heterogeneity in 





previously during the switching between high and low affinity Pi transporters in yeast 
(Wykoff et al., 2007).  In addition to these advantages, yeast cells may also inhibit the 
H+/Ca2+ exchangers in high Ca2+ conditions to avoid reverse-mode operation of Vcx1 and 
Gdt1 and possible futile cycling with the Ca2+ ATPases (Pmc1 and Pmr1, which are up-
regulated by calcineurin signaling).  It will be interesting to determine precisely how and 
why calcineurin inhibits Gdt1 and Vcx1 functions in vivo, and whether such regulation 
contributes to the unexplained “bursts” of free Ca2+ elevation and calcineurin signaling 
that have been observed through real-time imaging in single yeast cells (Cai et al., 2008; 
Carbo et al., 2017).   
 A better understanding of H+, Ca2+, and Pi homeostasis in the Golgi complex may 
help explain how this organelle can operate so differently in different tissues of humans.  
In addition to a general housekeeping function in non-secretory cells, specialized 
secretory cells may require huge increases in glycosylation and corresponding increases 
in byproduct production.  In the case of alveolar epithelial cells of mammary gland, 
which can produce massive quantities of lactose (a product of glycosylation) and casein 
micelles (rich in Ca2+ and Pi) in the Golgi complex during lactation (Neville, 2005), 
retrieval of the Pi byproduct may not be beneficial and removal of the H+ byproduct in 
exchange for Ca2+ may be exceptionally important.  Interestingly, to potentially meet this 
demand, expression of TMEM165 mRNA and protein becomes massively increased in 
alveolar epithelial cells just as milk production begins (Reinhardt et al., 2014).  The full 
repertoire of functions carried out by the Gdt1 and the Erd1 families of proteins will be 






MATERIALS AND METHODS 
Yeast strains and genetic screens 
 The yeast knockout collection in strain BY4741 background (Giaever et al., 1999) 
was inoculated into 200 µL YPD medium in 96-well dishes and grown to stationary 
phase (2 days incubation at 30°C).  Dishes were vortexed briefly to suspend the settled 
cells, then pinned onto noble agar medium containing YPD medium plus 5 mM succinic 
acid and supplemented with either 200 mM CaCl2, 200 mM MgCl2, 1 µg/mL FK506, or 
combinations of thereof.  After incubation for 3 days at 30°C, each strain was scored 
manually for growth relative to wild-type controls that were included in the arrays, using 
a scale ranged from +2 (increased growth) to 0 (wild-type growth) to -5 (greatly 
decreased or no growth).  The screen was repeated twice independently.  Of the 107 
mutant strains that consistently exhibited a significant response to at least one condition, 
84 were found to exhibit elevated Ca2+ influx in YPD medium or YPD medium plus 
FK506 (Martin et al., 2011).  The remaining 23 mutants contained vcx1∆ and pmc1∆ and 
were ranked on a scale from vcx1∆-like to pmc1∆-like based on their distinct behaviors in 
media containing Ca2+ and Ca2+ plus FK506.  A gdt1∆ mutation was generated in W303-
1A strain background and crossed with strains bearing vcx1∆, pmc1∆, crz1∆, and pmr1∆ 
to produce a panel of isogenic strains bearing many combinations of these mutations in 
both mating types.  Genotypes were confirmed by marker analyses and by PCR 
confirmations.   
 To identify spontaneous mutants that increase Ca2+ tolerance of crz1∆ pmc1∆ 
vcx1∆ triple mutants, two strains of opposite mating types and with different selectable 





and 36 single colonies were picked, grown further on the same medium to allow 
spontaneous mutations to accumulate, and then incubated on noble agar YPD medium 
containing 5 mM succinic acid and 111 mM CaCl2 for several days.  A single Ca
2+-
tolerant colony was picked in each case, purified by re-streaking, and then mated with 
one another in all possible combinations.  The resulting diploids were reanalyzed for Ca2+ 
tolerance.  This complementation test indicated 26 haploid strains contained dominant 
mutations in unknown genes and 10 haploid strains contained recessive mutations all in 
the same gene.  The 10 recessive mutants were fortuitously found to exhibit 
hypersensitivity to tunicamycin.  One recessive mutant was transformed with a low-copy 
plasmid library containing fragments of yeast genomic DNA and 9 transformants were 
replica plated to YPD plus 2 µg/mL tunicamycin to select for strains bearing 
complementing plasmids.  Two different plasmids overlapping the ERD1 gene and 
several nearby genes were recovered and found to reverse both tunicamycin 
hypersensitivity and the Ca2+ tolerance phenotypes upon retransformation into the 
recessive mutant strains.  ERD1 was identified as the defective gene in the recessive 
mutants by (1) introducing an erd1∆ null mutation into the K1357 strain and obtaining 
both tunicamycin hypersensitivity and Ca2+ resistance phenotypes and (2) demonstrating 
non-complementation between the erd1∆ null strain and the spontaneous recessive 
mutant strains.  Similar erd1∆ knockout mutations were also introduced by 
transformation into several other strains, and all strains utilized here are listed in Table 
2.2.   
 





 Yeast strains were grown to saturation at 30°C, typically overnight, in YPD 
medium for ion tolerance assays or in SC medium for Pi dependence assays.  They were 
then diluted 1:1000 into fresh media containing 5 mM succinic acid and various 
concentrations of CaCl2 in 96-well dishes without 1 µg/mL FK506, mixed, and incubated 
at 30°C for 24 hr without shaking.    The cells were resuspended by vortex mixing and 
optical density was measured at 650 nm using a microplate spectrophotometer 
(Molecular Devices).  The concentration of Ca2+ causing a 50% decrease in maximal 
optical density (the IC50) and the concentration of Pi causing permitting growth to 50% 
maximal optical density (the ED50) were calculated for each strain by non-linear 
regression using the sigmoid equation with 4 parameters (maximum OD650, minimum 
OD650, IC50 or ED50, and slope factor).  The averages from two independently 
generated strains of the same genotype (± S.D.) were calculated and plotted. 
 
PMC1-lacZ expression assays 
 The PMC1-lacZ reporter gene carried on the high copy plasmid pKC190 
(Cunningham and Fink, 1996) was transformed into the indicated strains and three 
independent transformants were grown to log-phase in SC-ura medium, pelleted briefly, 
and suspended in YPD medium with 5 mM succinic acid containing 0, 50, or 100 mM 
CaCl2.  After 4 hr incubation at 30°C, cells were pelleted, resuspended in Z-buffer, 
permeabilized with SDS and chloroform, and assayed for β-galactosidase activity using 







Pi export assays 
 Yeast strains were grown overnight to saturation in SC medium (7.35 mM Pi) and 
then diluted 1000-fold into fresh SC medium containing tracer quantities (~30 µCi per 
mL) of fresh 32-Pi (Perkin Elmer).  After 12 hr of incubation with shaking, the log-phase 
cells were pelleted and washed 5 times with 5 mL of ice-cold Pi-free SC media to remove 
all unincoprated 32-Pi from the medium.  The cells were then resuspended in Pi-free SC 
media and incubated on ice or at 30°C and sampled at various times.  After centrifugation 
at 15,000 rpm for 1 min, the cell-free supernatant was analyzed by liquid scintillation 
counting and by thin layer chromatography, by spotting 3 μL of sample supernatant onto 
polyethylenimine (PEI)-cellulose TLC plates, which was then developed in 1 M LiCl 
with 10 mM HEPES, pH 7.5.  The TLC plate was imaged by autoradiography. 
 
Antibodies and Western Blotting 
 Cells were lysed via fast alkaline lysis in 0.5 M NaOH with 1.85% beta-
mercaptoethanol (BME) in ice water for 10 minutes. The protein was then isolated 
through precipitation by addition of trichloracetic acid (TCA) to a final concentration of 
10% (w/w). Equal volumes of protein isolate and 2X SDS sample buffer (0.1 M Tris-
HCl, pH 6.8, 4% SDS, 0.2% bromophenol blue, 20% glycerol, 2% BME) were then 
combined, and the samples were incubated at 37 °C for 30 minutes. Proteins were 
processed by separation on a 10% SDS/PAGE gel and western blotting, as described 
previously (Mehta, 2009). Blots were probed with anti-TAP polyclonal antibodies from 
rabbit at 1:10,000 dilution (ThermoFisher, CAB1001) or anti-FLAG polyclonal 





probed with anti-glucose-6-phosphate dehydrogenase polyclonal antibodies from rabbit at 
1:10,000 dilution (Sigma, A9521), or anti-tubulin monoclonal antibodies at 1:10,000 
























Table 2.3: Strains used in Chapter 2 
Strain Background Genotype Source 
K601 W303 [a] MATa 
Cunningham and Fink 
(1996) 
K605 W303 MATa pmc1::TRP1 
Cunningham and Fink 
(1996) 
K661 W303 MATa vcx1Δ 
Cunningham and Fink 
(1996) 
K665 W303 MATa pmc1::TRP1 vcxΔ 
Cunningham and Fink 
(1996) 
AK053 W303 MATa vph1::NatR This Study 
AK054 W303 MATa pmc1::TRP1 vph1::NatR This Study 
AK055 W303 MATa vcx1Δ vph1::NatR This Study 
AK056 W303 MATa pmc1::TRP1 vcxΔ vph1::NatR This Study 
K1811 W303 MATa  vcx1Δ vph1::NatR This Study 
K1812 W303 MATa  vcx1Δ vph1::NatR stv1::KanR This Study 
K1815 W303 MATa  vcx1Δ gdt1::HIS3 vph1::NatR This Study 
K1816 W303 
MATa  vcx1Δ gdt1::HIS3 vph1::NatR 
stv1::KanR This Study 
K1827 W303 MATα  vcx1Δ vph1::NatR This Study 





K1831 W303 MATα  vcx1Δ gdt1::HIS3 vph1::NatR This Study 
K1832 W303 
MATα  vcx1Δ gdt1::HIS3 vph1::NatR 
stv1::KanR This Study 
K1833 W303 MATa This Study 
K1834 W303 MATα This Study 
K1835 W303 MATa crz1::KanR This Study 
K1836 W303 MATα crz1::KanR This Study 
K1837 W303 MATa cmk2::TRP1 This Study 
K1838 W303 MATα cmk2::TRP1 This Study 
K1839 W303 MATa crz1::KanR cmk2::TRP1 This Study 
K1840 W303 MATα crz1::KanR cmk2::TRP1 This Study 
K1841 W303 MATa gdt1::HIS3 This Study 
K1842 W303 MATα gdt1::HIS3 This Study 
K1843 W303 MATa gdt1::HIS3 crz1::KanR This Study 
K1844 W303 MATα gdt1::HIS3 crz1::KanR This Study 
K1845 W303 MATa gdt1::HIS3 cmk2::TRP1 This Study 
K1846 W303 MATα gdt1::HIS3 cmk2::TRP1 This Study 
K1847 W303 
MATa gdt1::HIS3 crz1::KanR 
cmk2::TRP1 This Study 
K1848 W303 
MATα gdt1::HIS3 crz1::KanR 





K1849 W303 MATa pmc1::LEU2 This Study 
K1850 W303 MATα pmc1::LEU2 This Study 
K1851 W303 MATa pmc1::LEU2 crz1::KanR This Study 
K1852 W303 MATα pmc1::LEU2 crz1::KanR This Study 
K1853 W303 MATa pmc1::LEU2 cmk2::TRP1 This Study 
K1854 W303 MATα pmc1::LEU2 cmk2::TRP1 This Study 
K1855 W303 
MATa pmc1::LEU2 crz1::KanR 
cmk2::TRP1 This Study 
K1856 W303 
MATα pmc1::LEU2 crz1::KanR 
cmk2::TRP1 This Study 
K1857 W303 MATa pmc1::LEU2 gdt1::HIS3 This Study 
K1858 W303 MATα pmc1::LEU2 gdt1::HIS3 This Study 
K1859 W303 
MATa pmc1::LEU2 gdt1::HIS3 
crz1::KanR This Study 
K1860 W303 
MATα pmc1::LEU2 gdt1::HIS3 
crz1::KanR This Study 
K1861 W303 
MATa pmc1::LEU2 gdt1::HIS3 
cmk2::TRP1 This Study 
K1862 W303 
MATα pmc1::LEU2 gdt1::HIS3 
cmk2::TRP1 This Study 
K1863 W303 
MATa pmc1::LEU2 gdt1::HIS3 






MATα pmc1::LEU2 gdt1::HIS3 
crz1::KanR cmk2::TRP1 This Study 
K1865 W303 MATa vcx1Δ pmc1::LEU2 This Study 
K1866 W303 MATα vcx1Δ pmc1::LEU2 This Study 
K1867 W303 MATa vcx1Δ pmc1::LEU2 crz1::KanR This Study 
K1868 W303 MATα vcx1Δ pmc1::LEU2 crz1::KanR This Study 
K1869 W303 MATa vcx1Δ pmc1::LEU2 cmk2::TRP1 This Study 
K1870 W303 MATα vcx1Δ pmc1::LEU2 cmk2::TRP1 This Study 
K1871 W303 
MATa vcx1Δ pmc1::LEU2 crz1::KanR 
cmk2::TRP1 This Study 
K1872 W303 
MATα vcx1Δ pmc1::LEU2 crz1::KanR 
cmk2::TRP1 This Study 
K1873 W303 MATa vcx1Δ pmc1::LEU2 gdt1::HIS3 This Study 
K1874 W303 MATα vcx1Δ pmc1::LEU2 gdt1::HIS3 This Study 
K1875 W303 
MATa vcx1Δ pmc1::LEU2 gdt1::HIS3 
crz1::KanR This Study 
K1876 W303 
MATα vcx1Δ pmc1::LEU2 gdt1::HIS3 
crz1::KanR This Study 
K1877 W303 
MATa vcx1Δ pmc1::LEU2 gdt1::HIS3 
cmk2::TRP1 This Study 
K1878 W303 
MATα vcx1Δ pmc1::LEU2 gdt1::HIS3 






MATa vcx1Δ pmc1::LEU2 gdt1::HIS3 
crz1::KanR cmk2::TRP1 This Study 
K1880 W303 
MATα vcx1Δ pmc1::LEU2 gdt1::HIS3 
crz1::KanR cmk2::TRP1 This Study 
CTS05 W303 MATa  This Study 
CTS06 W303 MATα  This Study 
CTS09 W303 MATa  gdt1::HIS3 This Study 
CTS10 W303 MATα  gdt1::HIS3 This Study 
CTS13 W303 MATa  pmr1::LEU2 This Study 
CTS14 W303 MATα  pmr1::LEU2 This Study 
CTS17 W303 MATa  pmr1::LEU2 gdt1::HIS3 This Study 
CTS18 W303 MATα  pmr1::LEU2 gdt1::HIS3 This Study 
NS001 W303 MATa  vcx1Δ This Study 
NS002 W303 MATα  vcx1Δ This Study 
NS009 W303 MATa  vcx1Δ gdt1::HIS3 This Study 
NS010 W303 MATα  vcx1Δ gdt1::HIS3 This Study 
NS116 W303 MATa This Study 
NS117 W303 MATα This Study 
NS118 W303 MATa erd1::NatR This Study 
NS119 W303 MATα erd1::NatR This Study 





NS121 W303 MATα crz1::KanR This Study 
NS122 W303 MATa pmc1::LEU2 This Study 
NS123 W303 MATα pmc1::LEU2 This Study 
NS124 W303 MATa gdt1::HIS3 This Study 
NS125 W303 MATα gdt1::HIS3 This Study 
NS126 W303 MATa crz1::KanR erd1::NatR This Study 
NS127 W303 MATα crz1::KanR erd1::NatR This Study 
NS128 W303 MATa pmc1::LEU2 erd1::NatR This Study 
NS129 W303 MATa pmc1::LEU2 erd1::NatR This Study 
NS130 W303 MATα gdt1::HIS3 erd1::NatR This Study 
NS131 W303 MATα gdt1::HIS3 erd1::NatR This Study 
NS132 W303 MATa pmc1::LEU2 crz1::KanR This Study 
NS133 W303 MATα pmc1::LEU2 crz1::KanR This Study 
NS134 W303 MATa gdt1::HIS3 crz1::KanR This Study 
NS135 W303 MATα gdt1::HIS3 crz1::KanR This Study 
NS136 W303 MATa pmc1::LEU2 gdt1::HIS3 This Study 
NS137 W303 MATα pmc1::LEU2 gdt1::HIS3 This Study 
NS138 W303 
MATa pmc1::LEU2 crz1::KanR 
erd1::NatR This Study 
NS139 W303 
MATα pmc1::LEU2 crz1::KanR 






MATa pmc1::LEU2 gdt1::HIS3 
erd1::NatR This Study 
NS141 W303 
MATα pmc1::LEU2 gdt1::HIS3 
erd1::NatR This Study 
NS142 W303 
MATa gdt1::HIS3 crz1::KanR 
erd1::NatR This Study 
NS143 W303 
MATα gdt1::HIS3 crz1::KanR 
erd1::NatR This Study 
NS144 W303 
MATa pmc1::LEU2 gdt1::HIS3 
crz1::KanR This Study 
NS145 W303 
MATα pmc1::LEU2 gdt1::HIS3 
crz1::KanR This Study 
NS146 W303 
MATa pmc1::LEU2 gdt1::HIS3 
crz1::KanR erd1::NatR This Study 
NS147 W303 
MATα pmc1::LEU2 gdt1::HIS3 
crz1::KanR erd1::NatR This Study 
NS148 W303 MATa vcx1Δ This Study 
NS149 W303 MATα vcx1Δ This Study 
NS150 W303 MATa vcx1Δ erd1::NatR This Study 
NS151 W303 MATα vcx1Δ erd1::NatR This Study 
NS152 W303 MATa vcx1Δ crz1::KanR This Study 





NS154 W303 MATa vcx1Δ pmc1::LEU2 This Study 
NS155 W303 MATα vcx1Δ pmc1::LEU2 This Study 
NS156 W303 MATa vcx1Δ gdt1::HIS3 This Study 
NS157 W303 MATα vcx1Δ gdt1::HIS3 This Study 
NS158 W303 MATa vcx1Δ crz1::KanR erd1::NatR This Study 
NS159 W303 MATα vcx1Δ crz1::KanR erd1::NatR This Study 
NS160 W303 MATa vcx1Δ pmc1::LEU2 erd1::NatR This Study 
NS161 W303 MATα vcx1Δ pmc1::LEU2 erd1::NatR This Study 
NS162 W303 MATa vcx1Δ gdt1::HIS3 erd1::NatR This Study 
NS163 W303 MATα vcx1Δ gdt1::HIS3 erd1::NatR This Study 
NS164 W303 MATa vcx1Δ pmc1::LEU2 crz1::KanR This Study 
NS165 W303 MATα vcx1Δ pmc1::LEU2 crz1::KanR This Study 
NS166 W303 MATa vcx1Δ gdt1::HIS3 crz1::KanR This Study 
NS167 W303 MATα vcx1Δ gdt1::HIS3 crz1::KanR This Study 
NS168 W303 MATa vcx1Δ pmc1::LEU2 gdt1::HIS3 This Study 
NS169 W303 MATα vcx1Δ pmc1::LEU2 gdt1::HIS3 This Study 
NS170 W303 
MATa vcx1Δ pmc1::LEU2 crz1::KanR 
erd1::NatR This Study 
NS171 W303 
MATα vcx1Δ pmc1::LEU2 crz1::KanR 






MATa vcx1Δ pmc1::LEU2 gdt1::HIS3 
erd1::NatR This Study 
NS173 W303 
MATα vcx1Δ pmc1::LEU2 gdt1::HIS3 
erd1::NatR This Study 
NS174 W303 
MATa vcx1Δ gdt1::HIS3 crz1::KanR 
erd1::NatR This Study 
NS175 W303 
MATα vcx1Δ gdt1::HIS3 crz1::KanR 
erd1::NatR This Study 
NS176 W303 
MATa vcx1Δ pmc1::LEU2 gdt1::HIS3 
crz1::KanR This Study 
NS177 W303 
MATα vcx1Δ pmc1::LEU2 gdt1::HIS3 
crz1::KanR This Study 
NS178 W303 
MATa vcx1Δ pmc1::LEU2 gdt1::HIS3 
crz1::KanR erd1::NatR This Study 
NS179 W303 
MATα vcx1Δ pmc1::LEU2 gdt1::HIS3 
crz1::KanR erd1::NatR This Study 
NS185 W303 MATa  pho84::TRP1 This Study 
NS186 W303 MATα  pho84::TRP1 This Study 
NS187 W303 MATa  erd1::NatR pho84::TRP1 This Study 






MATa  pho84Δ::HIS3 pho87Δ::CgHIS3 
pho89Δ::CgHIS3 pho90Δ::CgHIS3 
pho91Δ::KlURA3 
Wykoff and O'Shea 
(2001) 
NS229 W303 
MATa  pho84Δ::HIS3 pho87Δ::CgHIS3 
pho89Δ::CgHIS3 pho90Δ::CgHIS3 
pho91Δ::KlURA3 erd1::NatR This Study 
TSA36 BY4741 [b] MATa  sec1-1::KanR Li et al. (2011) 
NS227 BY4741 MATa  sec1-1::KanR erd1::NatR This Study 
LM001 BY4741 
MATa  VRG4-TAP-AID-
6xFLAG::TIR1::URA3 This Study 
NS228 BY4741 
MATa  VRG4-TAP-AID-
6xFLAG::TIR1::URA3 erd1::NatR This Study 
YSC1178-
202229973 BY4741 MATa GDT1-TAP::HIS3MX6 




[a] background mutations in W303 (leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15) 
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CHAPTER 2 APPENDICES 
 
Appendix 2.1:  Gdt1 is required for growth in acidic or neutral pH. 
Growth of wild-type (black circles) and gdt1Δ (white circles) yeast was measured by 
comparing the optical density (OD650) every 45 minutes for 9 hours in YPD media 
buffered with HEPES and succinic acid to pH 3 (A), pH 5 (B), and pH 7 (C). Mid-log 
phase cultures were diluted to a starting OD of 0.05 to begin the time course. At both pH 
3 and pH 7, the gdt1Δ strain grew at a slower rate than wild-type, while at pH 5, the 






















Appendix 2.2: Sensitivity of mutant strains to added ZnCl2 in YPD  
The data demonstrate that GDT1 is required for tolerance of high concentrations of Zn2+, 
independent of the two known major Zn2+ transporters, Cot1 and Zrc1. This effect is 
surprisingly also independent of calcineurin activity. 
Genotypes and Conditions [a] IC50 [b] CV [c] Performance Factor (PF) [d] 
GDT1 COT1 ZRC1 FK506 (mM) (%) GDT1 (+/∆) COT1 (+/∆) ZRC1 (+/∆) FK506 (-/+) 
. . . - 1.02 0.2 1.3 1.1 3.5 1.1 
∆ . . - 0.81 2.1  1.1 2.7 1.6 
. ∆ . - 0.89 1.1 1.2  85.1 1.1 
∆ ∆ . - 0.76 2.2   133.5 1.7 
. . ∆ - 0.29 1.2 1.0 27.8  1.0 
∆ . ∆ - 0.30 2.9  52.4  1.3 
. ∆ ∆ - 0.011 2.8 1.8   1.0 
∆ ∆ ∆ - 0.006 10.9    1.1 
. . . + 0.95 2.1 1.9 1.2 3.4  
∆ . . + 0.50 4.7  1.1 2.2  
. ∆ . + 0.82 2.4 1.8  77.5  
∆ ∆ . + 0.45 5.1   84.8  
. . ∆ + 0.28 3.4 1.3 26.8   
∆ . ∆ + 0.22 6.3  42.0   
. ∆ ∆ + 0.011 0.3 2.0    
∆ ∆ ∆ + 0.005 7.7     
 
Footnote 
[a] addition of 0.2 µg/mL FK506 
[b] average of derived IC50 from two strains (in mM ZnCl2), determined by measurement of the optical 
density (OD650) after 24 hours of growth from a 1:1000 dilution of saturated culture. 
[c] coefficient of variation (CV) between two strains (in %) 













TMEM165 DEFICIENCY IN LACTATING MAMMARY GLAND CAUSES 




Histological analysis was conducted by Mitchell V. Palmer and TUNEL staining and 
determination of milk creamatocrit concentrations were conducted by Timothy A. 
















Milk is a hallmark of mammals that is critical for normal growth and development 
of offspring. Here we demonstrate that TMEM165, a Golgi-localized ion exchanger, is 
required for normal lactose biosynthesis in the lactating mammary gland of mice. Mutant 
mice lacking TMEM165 in the mammary gland produced milk that was unable to sustain 
normal growth rates of litters. The milk contained elevated concentrations of fat, protein, 
calcium, iron, and zinc likely caused by decreased biosynthesis of lactose and diminished 
dilution by osmosis. Manganese/protein ratios were significantly lower in this milk, 
suggesting TMEM165 supplies essential Mn2+ to lactose synthase in the Golgi complex, 
which may be driven by counter-transport of H+ that is a byproduct of lactose synthesis 


















Deficiencies in the Golgi transmembrane protein TMEM165 cause a type-II 
congenital disorder of glycosylation in humans (Foulquier et al. 2012). Recent reports 
have shown that this protein, along with its yeast homolog Gdt1, can transport Ca2+ in 
vitro and promote normal homeostasis of Ca2+, Mn2+ and H+ in the Golgi complex 
(Colinet et al. 2016; Potelle et al. 2016; Thines et al. 2018). These findings suggest that 
TMEM165 supports glycosylation by maintaining proper pH and supplying Mn2+ and 
Ca2+ that are required as cofactors in the glycosyltransferases responsible for protein and 
lipid glycosylation (Kaufman et al. 1994; Dürr et al. 1998). Disruption of the homeostasis 
of pH or the concentrations of Ca2+ or Mn2+ have been demonstrated to result in 
deficiencies in glycosylation (Dürr et al. 1998; Axelsson et al. 2001; Kornak et al. 2007; 
Park et al. 2015).  The incidence of identified cases of congenital disorders of 
glycosylation (CDG) among humans is increasing, now including more than 125 unique 
disorders (Ng and Freeze 2018).  
TMEM165 mRNA, formerly Tpar1, is expressed in virtually all tissues and cell 
types, including the mammary gland (BioGPS).  However, TMEM165 mRNA and 
protein levels increase dramatically, by 7- and 25-fold respectively, in the mammary 
gland during the secretory activation phase of lactation (Stein et al. 2003; Reinhardt et al. 
2014).  TMEM165 protein levels accumulate in the Golgi complexes of alveolar 
epithelial cells (Reinhardt et al. 2014) along with α-lactalbumin subunit of lactose 
synthase, which together with β4-galactosyltransferase I (β4-GALT-I) synthesizes lactose 
in the lumen from transported UDP-galactose and glucose (Fraser and Mookerjea 1976).  





1976).  The secretory pathway Ca2+/Mn2+ ATPase 1 (SPCA1) supplies the Golgi with 
much of the Mn2+ required for lactose synthase and other glycosyltransferases (Ton et al. 
2002; Reinhardt et al. 2000) and much of the Ca2+ that is complexed with inorganic 
phosphate and casein proteins to form micelles in the Golgi complex (Aoki et al. 1987).  
While there is no obvious requirement for a H+/Ca2+/Mn2+ exchanger in this scheme of 
milk production in Golgi complex, H+ is produced as a byproduct of all glycosylation 
reactions including lactose biosynthesis, and there is no known mechanism for 
eliminating excess H+ from the Golgi and maintaining pH within a physiological range.  
In milk producing cells, TMEM165 may deacidify the Golgi while supplying Ca2+ and 
Mn2+ as both enzyme cofactors and nutrients. 
In this study, we test the role of TMEM165 in the lactating mammary gland of 
mice by examining mouse mutants bearing a conditional knockout of TMEM165.  Using 
a Cre-recombinase that is driven by the whey acid protein (WAP) promoter, which is 
only expressed in milk producing alveolar epithelial cells during late pregnancy, an 85% 
depletion of TMEM165 protein was achieved and strong defects in milk quality were 
observed.  Unexpectedly, calcium, iron, zinc, fat, and total protein concentrations were 
elevated in the milk of TMEM165-deficient animals.  However, lactose accumulation 
was strongly diminished, and this likely resulted in decreased osmosis and concentrated 
other components of in the milk. We show that the catalytic subunit of lactose synthase, 
in vitro, is highly sensitive to acidic pH, and we propose that the reduced quality of milk 
in TMEM165-deficient animals is due to a failure to remove the H+ byproduct of lactose 
biosynthesis, a diminished supply of Mn2+ in the Golgi, or both, which then diminishes 





homeostasis in the Golgi complex of professional secretory cells and the unique role of 
TMEM165 in exchanging H+, Ca2+, and Mn2+. 
 
RESULTS 
Conditional knockout mouse displays normal histology in the lactating mammary gland 
A condition-ready TMEM165 knockout mouse was generated by transfecting 
embryonic stem cells with a recombinant plasmid from EUCOMM, blastocyst injecting, 
germ-line screening, and cross-breeding to C57BL/6 wild-type mice, as described in 
Materials and Methods. In order to study the effect of TMEM165 on lactation, we 
crossed this mouse line to a mouse line expressing Cre recombinase under control by the 
whey acid protein (WAP) promoter (Wagner et al. 1997). In the experiments below, all 
nursing mice were heterozygous for WAP-Cre (i.e. WAP+/Cre) and either homozygous or 
heterozygous for the floxed allele of TMEM165 (henceforth referred to as TMEM165Δ/Δ 
and TMEM165Δ/+) or homozygous for the natural allele (TMEM165ctrl). To determine the 
efficacy of this TMEM165 conditional knockout, western blots were performed on 
mammary tissue harvested from mothers after 12 days of lactation. The TMEM165Δ/Δ 
mice demonstrated an 85% knockdown of TMEM165 expression in mammary tissue, and 
there was a 43% knockdown in TMEM165Δ/+ mammary tissue, relative to TMEM165ctrl 
tissue (Figures 3.1A and 3.1B). Histological analysis via H&E sections of mammary 
tissue from these mothers demonstrated no significant visible difference between 
genotypes (Figure 3.1C).  However, TUNEL staining of mammary tissue sections 
demonstrated a small but significant increase in apoptotic cells in both TMEM165Δ/Δ and 






Figure 3.1:  TMEM165Δ/Δ Mammary Gland Displays Normal Histology. 
 (A) Western blots of total protein extracted from mammary glands on day 12 of lactation 
were performed using anti-TMEM165 and anti-tubulin antibodies. (B) The ratios of 
TMEM165 to tubulin were calculated from quantified bands, averaged among replicates, 
and the heterozygous and homozygous samples were normalized to TMEM165ctrl animals 












Figure 3.2:  TMEM165Δ/Δ Tissue Exhibits Premature Cell Death. 
TUNEL staining (A) of the tissues identifies cells that have undergone cell death. 
Analysis of the intensity (B) shows a statistically significant increase in TUNEL-positive 
cells in both heterozygous and homozygous-knockout mice, relative to the wild-type. * P 














that even a partial decrease in expression of TMEM165 may occasionally affect cell 
survival in this tissue.  
Immunostaining revealed high TMEM165 expression in the Golgi complexes of 
alveolar epithelial cells that surround the lumen of the TMEM165ctrl mammary tissue 
(Figure 3.3). 
Interestingly, the tissue from the TMEM165Δ/Δ mouse expressed TMEM165 in a 
patchy mosaic pattern, where a fraction of the alveolar epithelial cells maintained 
expression and therefore escaped elimination by WAP-Cre (Figure 3.3). One possible 
reason for the mosaic expression is incomplete deletion of TMEM165 exons from some 
cells within the developing mammary gland that later populate a small portion of the 
tissue. Similar mosaic expression of TMEM165 was seen in mice expressing Cre under 
control of the MMTV promoter (not shown). These findings demonstrated that WAP-Cre 
produced a large, yet incomplete, decrease in TMEM165 expression in the milk 
producing cells of the mammary glands of TMEM165Δ/Δ animals. 
 
Litters nursed by TMEM165Δ/Δ mothers exhibit low weight gains 
To determine whether TMEM165 deficiency affected the overall quantity or 
quality of milk production, mothers nursed litters of 6 pups each and litter weight was 
measured every 2 days for 2 weeks.  While all the pups and mothers appeared healthy 
and behaved normally, pups nursed by TMEM165Δ/Δ mothers displayed significantly 
lower litter weights than pups nursed by TMEM165ctrl mothers on all days measured 
(Figure 3.4A). By day 14, litters from TMEM165Δ/Δ dams weighed only 78% of those 






Figure 3.3: TMEM165Δ/Δ Mammary Tissue has Mosaic Expression. 
In situ immunostaining of fixed and sectioned tissue demonstrates that TMEM165 (red) 
colocalizes with GM130 (green). DAPI (blue) identifies cell nuclei. Some cells within the 















Figure 3.4:  Milk from TMEM165Δ/Δ mothers exhibits low nutritional quality and 
low lactose.  
(A) Litters of 6 pups per mother were weighed every 2 days following birth. Data shown 





(B) Milk collected from mothers of the specified genotype on day 12 of lactation were 
assayed for lactose as described in methods. (C) Galactosyltransferase activity, 
representing β4-GALT-1 subunit of lactose synthase, was measured in detergent-
solubilized crude membrane extracts prepared from the indicated nursing mothers on day 
12 of lactation.  The assay method is described in Methods.  * P < 0.05, ** P < 0.01, *** 






















Lactose deficiency in milk from TMEM165-deficient dams. 
Because TMEM165-deficiency leads to deficiencies of glycosylation in humans 
(Foulquier et al. 2012), we hypothesized that TMEM165Δ/Δ mice may have a deficiency in 
lactose biosynthesis. To test this possibility, milk samples were collected from dams after 
12 days of lactation with 6 pups per dam, and the lactose concentration was measured.  
Strikingly, we observed a 36% decrease in lactose concentration in the TMEM165Δ/Δ 
dams relative to the TMEM165Δ/+ and TMEM165ctrl dams (Figure 3.4B).  The 
corresponding decline in osmosis would serve to concentrate the residual lactose and thus 
partially mask a larger decline in the actual rate of lactose biosynthesis. 
To determine whether the decline in lactose biosynthesis is caused by a decline in 
lactose synthase activity, mammary glands from TMEM165ctrl and TMEM165Δ/Δ dams 
were dissected and homogenized.  Crude membrane fractions were isolated by 
differential centrifugation, washed to remove lactose, permeabilized with non-denaturing 
detergent, and assayed in vitro for galactosyltransferase activity using a protocol that 
monitors liberation of inorganic phosphate from UDP-galactose in the presence of 
GlcNAc and added Mn2+ (see Materials and Methods). These conditions measure β4-
GALT-I activity directly and do not rely on the potentially unstable association of α-
lactalbumin and Mn2+ with the catalytic subunit of lactose synthase.  At physiological pH 
of 6 for the lumen of the Golgi complex, galactosyltransferase activity was 
indistinguishable in TMEM165ctrl and TMEM165Δ/Δ samples (Figure 3.4C). Omission of 
glucose (Figure 3.4C) or UDP-galactose (not shown) resulted in total loss of 
galactosyltransferase activity, indicating the specificity of the assay method. 





decreased to 5.  However, the activity declined to background levels when the pH was 
lowered to 4 or less (Figure 3.4C).  Thus, the TMEM165Δ/Δ and TMEM165ctrl samples 
appeared to contain equivalent activities of the lactose synthase catalytic subunit when 
assayed in vitro in the presence of excess of Mn2+, and this activity was somewhat 
sensitive to the acidity of the buffer.  These results suggest that lactose synthase enzyme 
levels are unaffected by TMEM165 deficiency, and instead suggest the activity of 
enzyme may be severely diminished in the Golgi complexes of TMEM165Δ/Δ cells.  Since 
TMEM165 is hypothesized to export luminal H+ in exchange for cytoplasmic Mn2+, 
TMEM165 deficiency may diminish lactose synthase activity by increasing luminal H+, 
decreased luminal Mn2+, or both, resulting in lower lactose production and diminished 
milk quality. 
 
Lactose deficiency may concentrate other milk components due to lower dilution by 
osmosis 
Lactose concentrations in mouse milk can reach 250 mM and thus serves as the 
major osmolyte of milk, and perhaps even in the Golgi complex where lactose is 
synthesized. To investigate the possibility that the deficiency of lactose secretion in 
TMEM165-deficient mammary glands produced milk with an osmotic defect, milk 
samples were treated with concentrated nitric acid to eliminate organic components, and 
then analyzed by inductively coupled plasma mass spectrometry (ICP-MS) alongside 
calibration standards (see Materials and Methods).  Surprisingly, the concentration of 
calcium did not decline in milk from TMEM165Δ/Δ dams and actually increased by 23.9% 






Figure 3.5:  Milk from TMEM165Δ/Δ Mothers has Osmotic Deficiency Causing 
Increased Metal Concentrations. 
Measurements of metal content in milk from TMEM165Δ/Δ and control mothers were taken. 
Concentrations of calcium, manganese, iron, and zinc in skimmed milk samples from day 
12 of lactation were measured by ICP-MS as described in Methods. * P < 0.05, ** P < 










The concentrations of iron and zinc also increased significantly by 21.6% and 34.2% 
respectively (Figures 3.5C and 3.5D).  Because these metals are mostly bound as ions by 
milk proteins, we also measured the concentration of total protein in untreated portions of 
the milk samples.  Milk from TMEM165Δ/Δ dams contained approximately 45% increase 
in total protein relative to that of TMEM165Δ/+ and TMEM165ctrl dams (Figure 3.6B).  
Analysis of milk proteins by SDS-PGE and staining with Coomassie brilliant blue also 
suggested increased protein concentration in the milk from TMEM165Δ/Δ dams without 
any noticeable difference in the pattern of the bands (Figure 3.6A). In addition, we 
estimated the fat composition of the milk by measuring the creamatocrit composition, 
which is the percent of milk made up of cream. TMEM165Δ/Δ dams exhibited a 52% 
increase in creamatocrit concentration, similar to the increase in total protein 
concentration (Figure 3.6C). These findings indicate milk from TMEM165Δ/Δ dams 
contains significantly higher concentrations of calcium, iron, zinc, total protein, and 
lipids, none of which are likely to diminish the milk quality.  When the metal 
concentrations were normalized to total protein instead of volume, iron and zinc to 
protein ratios were similar in milk from TMEM165Δ/Δ and TMEM165ctrl dams (Figures 
3.7C and 3.7D).  However, milk from TMEM165Δ/Δ dams did exhibit a significant 
decrease in the calcium and manganese to protein ratios (Figures 3.7A and 3.7B), which 
could lower the activity of Mn2+-dependent glycosyltransferases such as lactose synthase, 
causing a decrease in lactose synthesis and secretion into milk, lower osmosis, and lower 













Figure 3.6:  Protein and Lipid Concentrations in Milk from TMEM165Δ/Δ Mothers is 
Increased. 
Milk collected from mothers of the specified genotype on day 12 of lactation was skimmed 
and analyzed by SDS-PAGE and staining with Coomassie blue (A) and quantified using 
Bradford stain (B). Identified protein bands include lactoferrin (LF), serum albumin (SA), 
and alpha-, beta-, and gamma-casein (αC, βC, and γC, respectively). Whole milk was also 





















Figure 3.7:  Normalized metal content in milk indicates significant deficiency of 
calcium and manganese from TMEM165Δ/Δ mothers. 
Data from Figure 5 was normalized to total protein levels measured in Figure 6B. * P < 












TMEM165 is a Golgi-localized trans-membrane protein that is expressed in 
virtually all mammalian tissue and is strongly conserved throughout animals, plants, 
fungi, and even prokaryotes.  The data obtained up to now suggest that TMEM165 and its 
homologs transport H+, Ca2+, and Mn2+ across the Golgi membrane and therefore directly 
influence the homeostasis of these ions, which indirectly affects the activities of Golgi-
localized glycosyltransferases and other enzymes.  The strong up-regulation of 
TMEM165 expression in the alveolar epithelial cells of the mammary gland immediately 
before parturition when secretory activation is occurring (Stein et al. 2003) suggests an 
important role for this ion exchanger in milk biosynthesis in these prolific secretory cells.  
Here we show that indeed TMEM165 deficiency in these cells decreases 
manganese/protein ratio and lactose accumulation in the milk, likely by diminishing Mn2+ 
transport into the Golgi that is critical for lactose synthase activity.  This results in lower 
osmotic dilution of protein, fat, and other constituents and lower milk quality, as detected 
by growth rates of litters.   
Lactose is the major osmolyte in milk (Holt 1983). In addition to this, the process 
of lactose biosynthesis is carried out by a galactosyl-transferase and therefore requires 
many of the same substrates and conditions as glycosylation (Figure 3.8, and Berliner and 
Robinson 1982). Since TMEM165-deficiency is known to cause congenital disorders of 
glycosylation, it was hypothesized that disruption of expression of TMEM165 during 
lactation would similarly inhibit the creation of lactose, thereby decreasing the osmotic 
potential of milk by reducing the lactose composition. This loss of glycosyltransferase 






Figure 3.8:  Model of Lactose Synthesis in the Golgi Apparatus. 
In order to synthesize lactose, UDP-Galactose is transported into the Golgi apparatus in 
exchange for UMP. A galactosyltransferase (β4-GALT) then covalently links the 
galactose to glucose, releasing a proton and UDP, the latter of which is cleaved by a 
phosphatase into inorganic phosphate and UMP. The inorganic phosphate can then be 
secreted into milk as a part of casein, and the UMP is exchanged for additional UDP-
galactose substrate. Once in the milk, lactose serves as the major osmotic driver of water 








cofactor in both lactose synthesis and glycosylation (Powell and Brew 1976), and/or a 
decrease in pH, resultant from accumulation of protons released during lactose synthesis 
that would otherwise be released to the cytoplasm by TMEM165. 
Lactose is synthesized from UDP-galactose and glucose in the Golgi lumen by 
lactose synthase, an enzyme that depends on Mn2+ and is inhibited by acidic pH.  Though 
the expression of the regulatory subunit of lactose synthase (α-lactalbumin) is far greater 
than the catalytic subunit (β4-GALT-I), the heterozygous knockout mutants of α-
lactalbumin exhibited 10 to 30% declines of lactose concentration in milk, which 
decreased osmolarity and increased total protein concentration by 20-50% (Stinnakre et 
al. 1994, Stacey et al. 1995).  Milk yield also declined in these heterozygotes (Stacey et 
al. 1995), homozygous knockout mutants produced little milk with no lactose and very 
high concentration of protein and viscosity.  The consequences of TMEM165 deficiency 
appeared to be similar to the heterozygous α-lactalbumin deficiency, resulting in 
moderately decreased lactose and increased total protein, fat, and ion concentrations in 
the milk. 
Upon normalizing Ca2+, Mn2+, Zn2+, and Fe2+ concentrations in milk to total 
protein, only Ca2+ Mn2+ appeared to be significantly decreased in the TMEM165Δ/Δ 
animals.  The remaining calcium and manganese in milk is probably transported into the 
Golgi by the secretory pathway Ca2+/Mn2+ ATPase SPCA1 (Dürr et al. 1998, Ton et al. 
2002, Lapinskas et al. 1995), though SPCA2 may also contribute from a non-Golgi 
organelle (Xiang et al. 2005).  These SPCA pumps contribute about 40% of the Ca2+ 
found in milk with the remaining 60% transported by the plasma membrane Ca2+ ATPase 





in milk than Mn2+, SPCA and TMEM165 likely transport much more Ca2+ than Mn2+ 
during lactation.  The deficiency of Ca2+ transport in TMEM165Δ/Δ animals was not as 
great as Mn2+ in the milk, possibly because of compensatory effects of the PMCA2 pump 
which has been shown to be the primary milk calcium transporter (Reinhardt et al. 2004).  
The SPCA pumps appeared unable to fully compensate for the Mn2+ transport defects in 
the TMEM165Δ/Δ animals, and Mn2+ depletion in the Golgi may lower the activity of 
lactose synthase and potentially other glycosyltransferases responsible for protein 
glycosylation despite the fact that both are significantly upregulated in lactation 
(Reinhardt et al. 2000).  It is not yet clear whether TMEM165 alters the pH of the Golgi 
of the milk producing cells, but a failure to counter-transport H+ from the lumen to the 
cytoplasm in the knockout animals could lead to hyper-acidification and additional loss 
of lactose synthase and glycosyltransferase activities.  H+ accumulation and Mn2+ 
depletion in the Golgi of these mutant cells could also alter transport of UDP-galactose 
and other nucleotide-sugars instead of, or in addition to, glycosyltransferase activities.  
Therefore, defects associated with TMEM165Δ/Δ Golgi may be broader yet milder than 
simple deficiency of α-lactalbumin. 
TMEM165 is expressed throughout the body of mammals, and humans with 
homozygous mutations in TMEM165 exhibit a congenital disorder of glycosylation that 
ultimately manifests with skeletal and growth abnormalities (Foulquier et al. 2012, 
Rosnoblet et al. 2016). TMEM165-deficient zebrafish similarly exhibit glycosylation 
defects and have problems with cartilage development (Bammens et al. 2015). 
Interestingly, supplementation of culture medium with Mn2+ was found to partially 





Mn2+ presumably increases Golgi Mn2+ concentration by out-competing Ca2+ as a 
substrate for SPCA’s.  This rationale was first tested in yeast cells lacking a homolog of 
TMEM165 known as Gdt1.  The residual partial defect in glycosylation in gdt1∆ yeast 
cells was exacerbated by elevated Ca2+ and then ameliorated by supplementation with 
Mn2+ in a fashion that depended on the SPCA known as Pmr1 (Potelle et al. 2016). 
Furthermore, when heterologously expressed in bacteria, Gdt1 has been demonstrated to 
transport Mn2+, though it exhibited a lower affinity for Mn2+ than for Ca2+ (Thines et al. 
2018). Presumably, the mechanism of Mn2+ transport by Gdt1 is similar to that of Ca2+, 
which has been demonstrated to be coupled to the pH gradient established by the V-
ATPase, the deletion of which causes Gdt1 to function in reverse-mode, instead releasing 
Ca2+ from Golgi lumen (Snyder et al. 2017). Transport studies using the purified and 
reconstituted TMEM165-family proteins will be necessary to ascertain their specific 
substrate specificities.    
In summary, the findings reported here support the hypothesis that TMEM165 
exchanges H+, Mn2+, and Ca2+ in the Golgi complex of professional secretory cells and 
thereby supports glycosyltransferases such as lactose synthase that may be sensitive to H+ 
and dependent on Mn2+.  The extremely high rates of lactose synthesis could generate H+ 
as a byproduct, and thus drive Mn2+ and Ca2+ uptake into the Golgi via TMEM165.  
Imbalanced ion homeostasis in TMEM165-deficient cells leads to defects in lactose 
biosynthesis through increased inhibition or decreased activation of lactose synthase. 
 
MATERIALS AND METHODS 





Procedures relating to animal care and treatment conformed to Johns Hopkins 
University Animal Care and Use Committee (ACUC), National Animal Disease Center 
ACUC, and NIH guidelines. Mice, maintained in a C57BL/6 or mixed C57BL/6 and 
129P background, were housed in a standard 12:12 light-dark cycle. Embryonic stem 
cells (129/SvEv Tac) were transfected with 30 μg of the TMEM165 Knockout First 
targeting vector (PATHP0001_A_1_B01) from EUCOMM. After insertion of the 
complete targeting vector was confirmed by PCR of both homology arms, karyotypically 
normal clones were subjected to blastocyst injection and implantation into 
pseudopregnant females. The integration of the 5’-homology arm was confirmed using 
the forward primer 5’-GTGGTGATCAAAGGACACCGTGTGG-3’ and the reverse 
primer 5’-TGTTAGTCCCAACCCCTTCCTCC-3’, producing a 5,233 bp band, while the 
integration of the 3’-homology arm was confirmed using the forward primer 5’-CAACA 
GCAAGTGGTTTCAGGG-3’ and the reverse primer 5’-CTCTGGTCTTGATATAGAC 
GTGGTCC-3’ to produce a 5,177 bp band. The resultant chimeric mice were crossed to 
C57BL/6 wild-type mice and screened for germ-line transmission of the Knockout First 
allele by PCR of the resultant progeny, using the forward primer 5’-GTACCGCGTCGA 
GAAGTTCC-3’ and the reverse primer 5’-GATAGCCTAAGCTCGTGTTACAATC-3’ 
to produce a 303 bp band. The wild-type allele was identified by a separate PCR using 
the same reverse primer but a new forward primer, 5’CCCTGGATTCTACTTAGTCCCC 
C-3’ which produced a 362 bp band.  
ROSA-Flp mice were a gift from Dr. Rejji Kuruvilla (Johns Hopkins University). 
Mice containing the ROSA-Flp allele were identified by PCR, using the forward primer 





TAGTGATCAGG-3’. These mice were crossed to the mouse containing the Knockout 
First allele to remove the portions of the cassette contained within the two Frt sites. This 
resulted in removal of all modifications except the two loxP sites flanking Exon 2 of 
TMEM165. Backcrossing was then conducted to generate mice that tested positive for the 
floxed allele of TMEM165, but not the ROSA-Flp allele. Mice were genotyped for the 
floxed allele of TMEM165 by PCR using the forward primer, 5’AACTTTGGGGAGGCC 
AGTTAAG-3’ and the reverse primer 5’GATAGCCTAAGCTCGTGTTACAATC-3’. 
Using these primers, the floxed allele of TMEM165 produces a 635 bp band while the 
unfloxed allele produces a 541 bp band. The founder TMEM165fl/+ mice were back-
crossed multiple times to C57BL/6 and then inbred to generate TMEM165fl/fl before 
breeding to C57BL/6 bearing WAP-Cre, which were a gift from Dr. Zhe Li (Harvard). 
WAP-Cre TMEM165fl/+ males were bred to TMEM165fl/+ and TMEM165fl/fl females and 
the resulting females were used in experiments. 
For experimentation, females bearing WAP-Cre and either TMEM165fl/fl, 
TMEM165fl/+, or TMEM165+/+ were bred, respectively, to males bearing TMEM165+/+, 
TMEM165fl/+, or TMEM165fl/fl and the resulting litters were equalized to 6 pups per 
mouse mother on day one of lactation. This breeding program maximized uniformity 
among the nursing pups. Mice were euthanized at 12 days postpartum for tissue 
collection, using a 50:50 mix of CO2:O2 followed by cervical dislocation. Mammary 
tissue was removed, flash frozen in liquid nitrogen, and stored at -80°C until membranes 







Litter Weight Analysis 
On the day of birth, litters were adjusted to 6 pups per nursing mother. The litters 
were then weighed every two days for the first 14 days of lactation. 
 
Histological, Immunofluorescent, and TUNEL Stain Microscopy 
Tissue slides were prepared as described previously (Cross et al. 2013). Briefly, 
mammary tissue fixed in Tellyesniczky’s fixative (a 20:2:1 ratio of 70% ethanol, 
formalin, and glacial acetic acid) for 5 hours before being stored in 70% ethanol before 
paraffin embedding and creation of 4 μm sections. For histological analysis, paraffin-
embedded sections were treated with eosin and hematoxylin stain as described in 
Sheehan and Hrapchak (Sheehan and Hrapchak 1980). Images were obtained using a 
Leica Aperio AT2 at 20X magnification. For immunofluorescence, methods were 
conducted as described previously (Reinhardt et al. 2014). Briefly, tissue sections were 
immersed in H-3300 (Vector Laboratories; Burlingame, CA) in a preheated pressure 
cooker for 20 minutes after pressure normalized. The sections were cooled and washed 
three times with distilled, deionized water, followed by PBS for 5 minutes. Sections were 
permeabilized and blocked in PBS containing 0.5% Triton X-100, 0.01 g sodium azide 
and 50 mg/ml BSA prior to addition of primary antibodies at 4°C overnight. The primary 
antibodies used were anti-TMEM165-aminoterminal end (Abcam, Cambridge, MA) and 
anti-GM130 #610822 (BD Transduction Laboratories, San Jose, CA). The sections were 
washed 3 times with blocking buffer before incubating at 37°C for 2 hours with 
secondary antibodies, Green antimouse Alexa Fluor A11017 488 F(ab’)2 fragment of 





fragment of goat anti-rabbit IgG (H + L) (Molecular Probes/Life Technologies, Grand 
Island, NY). Slides were again washed 3 times with blocking buffer and mounted with 
VectaShield (Vector Laboratories) and DAPI. Finally, TUNEL staining was conducted 
using the In Situ Cell Death Detection Kit, TMR Red (Catalog #12156792910) from 
Roche (Basel, Switzerland), according to kit instructions. All confocal microscopic 
analysis was conducted using a Nikon A1+ confocal scanning microscope with 2 GaAsP 
multi-detector and 2 normal PMTs, utilizing NIS-Elements C imaging software (Nikon, 
Tokyo, Japan). TUNEL stain images captured using the 561 nm laser and GaAsP detector 
unit, collecting emissions from 570-620 nm. 
 
Milk Analysis for Lactose, Creamatocrit, and Total Protein 
Milk collection was done as described previously (Reinhardt et al. 2004). Briefly, 
on day 12 of lactation, mothers were separated from their size-normalized litters for 4 
hours to allow them to produce sufficient milk for collection. The mothers were then 
anesthetized with avertin prior to being given an intraperitoneal injection of 0.1 IU of 
oxytocin. After 10 minutes, milk was collected in a 1.5 mL microcentrifuge tube 
connected by small tubing to a low vacuum that was pulsed. After collection, the pups 
were returned to their mother. The milk that was collected was centrifuged for 5 minutes 
at 4000g, and the floating fat layer was removed. The remaining skimmed milk was 
frozen and stored at -80°C for future analysis. The concentration of lactose in the 
skimmed milk was determined using the Enzychrom Lactose Assay Kit (ELAC-100) 





protein in the skimmed milk was determined with a Bradford assay, using the Coomassie 
Plus (Bradford) Assay Reagent from Pierce, according to kit instructions. 
 
Determination of Metal Composition by ICP-MS 
A 125 μL aliquot of skimmed milk was prepared for metal composition analysis 
by conducting acid digestion in 300 mm long Pyrex digestion tubes using 5 mL of 
concentrated (70%) HNO3 and 2 mL of 30% H2O2 as a catalyst. Digestion was 
conducted by gradually heating the samples to 150°C in a heat block, and allowing the 
reaction to go to completion (sample became clear and colorless). The samples were then 
allowed to cool to room temperature before normalizing the volume and adjusting the 
final HNO3 concentration to 6%. The samples were stored in 15 mL metal-free 
polypropylene tubes from VWR until the compositions of the identified metals were 
analyzed using an Agilent 7700x inductively coupled plasma mass spectrometer (Agilent 
Technologies, Santa Clara, CA). Detection of metals was completed using an octopole 
reaction system (ORS) cell in He mode to remove interference. The parameters utilized 
included a radio frequency (RF) power of 1,550 W, an argon carrier gas flow of 1.01 
L/min, an argon make-up gas flow of 0.1 L/min, a helium gas flow of 4.3 mL/min, an 
octopole RF of 200V, and an OctP bias of 18V. Samples were infused using the model 
7700X peristaltic pump with a speed of 0.1 rotations per second and micromist nebulizer. 
Metal concentrations were derived from a calibration curve generated from a dilution 
series of the atomic absorption standards of each metal (Fluka Analytical, St. Louis, 
MO), prepared in the same matrix as the samples. Data analysis was performed using 





Galactosyltransferase Activity Assay 
Mammary tissue collected from sacrificed mothers on day 12 of lactation was 
homogenized by 25 passes with dounce A in 5 mL of a buffer containing 25 mM Tris, 
150 mM NaCl, 1% Triton X-100, and 2 mM EDTA at pH 7.5 with a protease inhibitor 
cocktail (Roche, Basel, Switzerland). The homogenate was transferred to a 15 mL conical 
tube and centrifuged at 3000g for 10 minutes to remove cellular debris. The supernatant 
was then centrifuged in a 10kDa filtration tube at 3000g to remove small molecule 
substrates and products as well as the EDTA. A total of 50 mL of 25 mM Tris-citrate 
buffer containing 150 mM NaCl, 1% Triton X-100, 5 mM MgCl2, and 5 mM MnCl2, pH 
7.5 with a protease inhibitor cocktail (Roche, Basel, Switzerland) was added to the 
samples over multiple spins in the filtration tube. The samples were then removed from 
the filtration tube, and appropriately diluted to normalize the total protein concentration, 
as determined a Bradford assay. The samples were then aliquoted, and the pH was 
adjusted in individual aliquots by addition of citrate buffer. The volumes were 
normalized using Tris-citrate buffer that was previously adjusted to the appropriate pH. 
Samples were then assayed by the methods described in Wu, et al. (2011) except UDPase 
was not added because the samples already expressed excess UDPase activity. Briefly, 
samples were transferred to a 96-well plate in 25 μL aliquots. Substrates were then added 
to achieve a final concentration of 1 mM UDP-galactose and 20 mM GlcNAc. Controls 
had UDP-galactose alone or neither substrate. After 30 minutes, the concentration of free 
phosphate was determined, using the Malachite Green Phosphate Detection Kit from Cell 






Gel Electrophoresis and Western Blotting 
Mammary gland microsomes were prepared as previously described (Reinhardt et 
al. 2004). Briefly, the tissue was homogenized in 10 volumes of Buffer A (10 mM Tris-
HCl, 2 mM MgCl2, 1 mM EDTA and protease inhibitor cocktail (Roche, Basel, 
Switzerland), pH 7.5). The homogenate was mixed with an equal volume of Buffer B 
(Buffer A containing 0.3 M KCl) and centrifuged at 10,000g for 10 min. The supernatant 
was collected, adjusted to 0.7 M KCl by the addition of solid KCl, before centrifugation 
at 100,000g for 1 h. The supernatant was discarded, and the pellets were resuspended in 
Buffer C (Buffer A containing 0.15 M KCl). Protein concentrations were determined 
using the Bio-Rad Protein Assay kit using a bovine serum albumin standard, and buffer 
was added accordingly to normalize concentration of protein across samples. Equal 
volumes of microsomes and 2X SDS sample buffer (0.1 M Tris-HCl, pH 6.8, 4% SDS, 
0.2% bromophenol blue, 20% glycerol, 2% BME) were combined, and the samples were 
incubated at room temperature for 30 minutes. Proteins were processed by separation on 
a 10% SDS/PAGE gel and western blotting, as described previously (Mehta et al. 2009). 
Blots were probed with anti-TMEM165 polyclonal antibodies from rabbit at 1:5,000 
dilution (Sigma, HPA038299). Protein standards were probed with anti-α-tubulin 
polyclonal antibodies from mouse at 1:10,000 dilution (Sigma). 
 
Statistical tests of significance  
Student’s t-tests were implemented on many datasets, as indicated in the figures 
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AUXIN-INDUCIBLE DEPLETION OF THE ESSENTIALOME REVEALS 
INHIBITION OF TORC1 BY AUXINS AND INHIBITION OF VRG4 BY SDZ 90-




Adam Kim and Louis Kester generated the collection of AID-tagged yeast, and 
established preliminary methods for inducing and interpreting AID-dependent protein 
degradation. The cyclopeptolide SDZ 90-215 was provided by Novartis, courtesy of 













Gene knockout and knockdown strategies have been immensely successful probes 
of gene function, but small molecule inhibitors (SMIs) of gene products allow much 
greater time resolution and are particularly useful when the targets are essential for cell 
replication or survival.  SMIs also serve as lead compounds for drug discovery.  
However, discovery of selective SMIs is costly and inefficient.  The action of SMIs can 
be modeled simply by tagging gene products with an auxin-inducible degron (AID) that 
triggers rapid ubiquitylation and proteasomal degradation of the tagged protein upon 
exposure of live cells to auxin.  To determine the broad effectiveness of this approach, we 
AID-tagged over 750 essential proteins in Saccharomyces cerevisiae and observed over 
66% efficiency of growth inhibition by low concentrations of auxin.  Polytopic 
transmembrane proteins in the plasma membrane, Golgi complex, and endoplasmic 
reticulum were efficiently depleted if the AID-tag was exposed to cytoplasmic OsTIR1 
ubiquitin ligase.  The auxin analog 1-napthylacetic acid (NAA) was less potent than 
auxin on AID-tags and, surprisingly, both molecules inhibited TORC1 signaling at high 
concentrations.  Auxin also synergized with known SMIs when acting on the same 
essential protein, indicating that AID-tagged strains can be useful for SMI screening.  A 
natural cyclic peptide of unknown function (SDZ 90-215) was found to inhibit an 
essential GMP/GDP-mannose exchanger in the Golgi complex (Vrg4) as determined by 
auxin synergy, glycosylation assays, and resistance mutations.  These findings suggest 
that AID-tagging can efficiently model the action of SMIs before they are discovered and 







One of the most powerful approaches for experimental determination of gene 
function involves the identification of phenotypes that appear in the cells of interest upon 
introduction of mutations that decrease function.  Such loss-of-function mutations can be 
produced easily in many eukaryotic cell types using CRISPR/Cas9-based technologies 
and earlier methods involving homologous recombination, insertional mutagenesis, and 
random mutagenesis have been very useful in a wide variety of model organisms.  Nearly 
complete arrays of gene knockout mutants have been produced in budding yeast 
Saccharomyces cerevisiae (Winzeler et al., 1999) and the fission yeast 
Schizosaccharomyces pombe (Kim et al., 2010), with several additional species of 
pathogenic fungi currently in progress (Roemer et al., 2003; Schwarzmuller et al., 2014; 
Liu et al., 2008).  Though such collections offer enormous potential for understanding 
diverse biological processes, the general approach is hampered by the inability to 
knockout essential genes, which typically constitute 10-20% of the genome.  Most 
essential genes in S. cerevisiae were successfully rendered hypomorphic by introducing 
knockout mutations in heterozygous diploids or by introducing mutations in the 3’ 
untranslated regions of haploids (Breslow et al., 2008).  However, in all these cases the 
cells are studied long after the mutation was created and therefore discriminating primary 
defects from secondary adaptations is very challenging.  In addition to such epigenetic 
effects, secondary mutations often arise that compensate for or obscure the phenotypes of 
primary mutations (Teng et al., 2013).   
 Conditional knockout or knockdown of gene function can eliminate some of the 





about 75% of essential genes have been mutated in such a way to render the protein 
product non-functional at high temperature but functional at low temperature (Ben-Aroya 
et al., 2008; Li et al., 2011).  Such temperature-sensitive mutations allow easy and often 
reversible inactivation of gene function, but are relatively difficult to produce and often 
difficult to interpret because the level of gene function may be abnormal even at the 
permissive temperature and incompletely or slowly inactivated at the non-permissive 
temperature, and it can be difficult to ascertain these problems.  Additionally, the 
temperature shifts themselves may cause undesirable biological consequences that could 
confound interpretations.  Alternatively, essential genes can be placed under control of 
regulatory systems that enable tight shut-off of gene transcription (for example, glucose-, 
methionine-, and tetracycline-repressible promoters), which allows phenotypic analyses 
as the mRNA and protein products decay at their natural rates (Roemer et al., 2003).  
CRISPRi using dCas9 can achieve similar repression without altering gene sequences (Qi 
et al., 2013).  Other approaches enable ligand-responsive de-capping, de-tailing, or 
translational frameshifting of targeted mRNAs (Klauser et al., 2015; Anzalone et al., 
2016).  These mRNA knockdown approaches may be combined for improved 
performance, but still the long cellular lifespans of many proteins will delay the 
appearance of phenotypes.   
 Several approaches have enabled rapid conditional destruction or mislocalization 
of targeted proteins.  One approach involves N-terminal tagging of the proteins of interest 
with a temperature-sensitive degron that enables misfolding, ubiquitylation, and 
degradation of the fusion protein by the 26S proteasome (Dohmen and Varshavsky, 





also may interfere to some extent with protein function even under the permissive 
condition.  Similarly, C-terminal tagging of proteins with the auxin-inducible degron 
(AID) sequence from plants can enable rapid ubiquitylation and proteasomal degradation 
of the protein upon addition of a small molecule auxin (indole-3-acetic acid) (Nishimura 
et al., 2009; Morawska and Ulrich, 2013).  This latter approach requires co-expression of 
an E3 ubiquitin ligase from plants such as OsTir1 that recognizes AID-tagged proteins 
bound to auxin.  Though the AID-tagging and destruction system works very well in 
plant, animal, and fungal cell types and shows great promise for functional genomics 
research, it has not yet been implemented genome-wide and its limitations are not fully 
known.   
 In this study, we AID-tag the C-termini of 758 essential and 313 non-essential 
gene products of S. cerevisiae and simultaneously introduce the OsTIR1 expression 
cassette together with a selectable marker.  The effects of auxin and a non-metabolizable 
auxin analog (1-naphthaleneacetic acid; NAA) on cell growth were analyzed carefully.  
Surprisingly, we find that auxin and especially NAA both have off-target inhibitory 
effects on the TORC1 protein kinase.  At low concentrations, auxin was highly specific 
for on-target AID-tagged proteins that have C-termini were exposed to the cytoplasm or 
nucleoplasm, including many transmembrane proteins of endoplasmic reticulum, Golgi 
complex, plasma membrane, and mitochondrial outer membrane.  We then explore the 
possibility that auxins synergize with other small molecules that are known to bind and 
inhibit particular target proteins.  Finally, we show that SDZ 90-215, a potent antifungal 
cyclopeptide produced naturally by the filamentous fungus Septoria, synergizes with 





within the substrate-binding pocked of Vrg4 protein confer strong resistance to the 
compound.  These findings validate the use of AID-tagged strains for functional 
genomics research and for discovery of novel SMIs and antifungals. 
 
RESULTS 
High concentrations of auxin and NAA can inhibit TORC1 signaling in S. cerevisiae.  
 To study the effectiveness of AID-tagging as a tool for functional genomics, we 
first converted the C-terminal TAP-tags (Ghaemmaghami et al., 2003) on 758 essential 
genes and 313 non-essential genes of S. cerevisiae into AID-tags using a one-step gene 
replacement strategy (Figure 4.1A).  Briefly, the stop codon, transcription terminator, and 
HIS3 selectable marker in each TAP-tagged strain was replaced with a short spacer, a 
minimal AID-tag, a 6xFLAG-tag with stop codon, a transcription terminator, an OsTIR1 
expression cassette, and a URA3 selectable marker.  Each AID-tagged strain was purified, 
validated, arrayed in 96-well dishes, and stored frozen until use.  To determine sensitivity 
to auxin and NAA, the arrayed collection was grown overnight at room temperature in 
SCD medium containing 0, 25, 100, or 400 µM auxin or 100 µM NAA (a non-
metabolizable auxin analog) and the optical density was quantified in a microplate reader 
at 650 nm after 20 hr and 40 hr incubation at room temperature.  At 25 µM auxin, growth 
was significantly inhibited in approximately 66% of essential and 16% of non-essential 
AID-tagged proteins relative to 0 µM auxin (Figure 4.1B), and these percentages 
increased slightly as auxin was increased to 100 or 400 µM or when instead 100 µM 











Figure 4.1:  AID-tagging and growth defects caused by auxin and NAA.   
(A) Schematic of the MfeI-linearized pAIDA2(6FLAG) plasmid that was transformed 
into individual strains of S. cerevisiae with a TAP-tag already present in the gene of 
interest (GOI).  The minimal AID-tag and 6xFLAG-tag are labeled “A” and “F” and the 
OsTIR1 expression cassette is also indicated. (B) Optical densities of 756 essential (red) 
and 315 non-essential (black) AID-tagged strains after diluting stationary phase 36-fold 
into fresh SCD medium with and without 25 µM auxin and incubating for 20 hr at 23°C. 
(C) Optical densities of AID-tagged strains after culturing in 100 or 400 µM auxin or 100 
µM NAA as compared to 25 µM auxin.  (D) Box plots of non-essential AID-tagged 
strains grown in different conditions (centerline = median, X = average, box = middle 
















deplete most essential AID-tagged proteins and higher concentrations or analogs of auxin 
only rarely increased susceptibility.   
 By focusing first on just the non-essential AID-tagged proteins, we noticed that 
25, 100, and 400 µM auxin progressively lowered the final cell density in the stationary 
phase cultures, with 100 µM NAA as the most toxic of all.  After a 20 hr growth period, 
the median optical densities declined by 2, 5, 13, and 19% (Figure 4.1D).  These declines 
persisted even after 40 hr growth period (data not shown).  Similar declines were seen in 
the wild-type parental strain that lacked AID-tag and the OsTIR1 expression cassette, and 
yet there was no detectable change in its exponential growth rate in any of the conditions 
(data not shown).  These findings confirm earlier results (Nishimura et al., 2009; 
Morawska and Ulrich, 2013) that auxin and NAA have little effect on growth rate at these 
concentrations, and also suggest possible off-target effects can become significant as 
cultures approach the stationary phase.   
 To explore the possible off-target effects of auxin and NAA, we examined the 
median-normalized dataset for clear instances of selective toxicity to only the highest 
concentrations of auxin or to NAA.  Four non-essential AID-tagged proteins (Gtr1, Gtr2, 
Ego1, Ego3) exhibited unusual hypersensitivity to 100 µM NAA and 400 µM auxin 
relative to 25 µM auxin, a pattern that was not observed elsewhere in the collection of 
AID-tagged strains.  All four proteins bind to each other and function together as positive 
regulators of the rapamycin-sensitive protein kinase known as TORC1 (Loewith and 
Hall, 2011).  A negative regulator of this GTR-EGO complex (Npr2) exhibited 
significant resistance to high auxin and NAA when AID-tagged.  One potential 





and depletion of the GTR-EGO proteins thus causes hypersensitivity to inhibitors of 
TORC1.  To test this idea, the sensitivities of gtr1∆, gtr2∆, ego1∆, and ego3∆ knockout 
mutants to auxin and NAA were evaluated in growth assays spanning a large range of 
concentrations (Figure 4.2A).  All four EGO-GTR-deficient knockout mutants exhibited 
strong hypersensitivity to auxin (3.7- to 4.7-fold) and NAA (8.6- to 10.5-fold) relative to 
the wild-type parent strain BY4741.  These effects of auxin and NAA were similar to 
those of caffeine, a direct inhibitor of TORC1 activity (Reinke et al., 2006).  A single 
amino acid substitution (Tor1-S1954L) that hyperactivates TORC1 (Kim and 
Cunningham, 2015) largely reversed the hypersensitivity of gtr1∆ mutants to auxin, 
NAA, and caffeine in gtr1∆ strains to almost the same level as the strain expressing Gtr1 
(Figure 4.2A).  Auxin and NAA probably do not inhibit Pib2, an activator of TORC1 that 
operates independent of GTR-EGO (Kim and Cunningham, 2015; Michel et al., 2017; 
Tanigawa and Maeda, 2017; Varlakhanova et al., 2017), because the pib2∆ knockout 
mutants still exhibited mild hypersensitivity to auxin, NAA, as well as caffeine (Figure 
4.2A) as expected for mildly reduced TORC1 activity.  To test whether auxin and NAA 
can inhibit TORC1 function, the phosphorylation of two indirect targets of TORC1 (Rps6 
and Par32) was measured by western blotting after 1 hr incubation of wild-type cells with 
these compounds.  Auxin and NAA strongly decreased phosphorylation of Rps6 similar 
to caffeine and rapamycin (Figure 4.2B) as shown previously (Gonzalez et al., 2015).  
Auxin increased phosphorylation of Par32-HA similar to caffeine and rapamycin as 
expected (Huber et al., 2009) but NAA was seemingly less effective than auxin (Figure 
4.2C).  Collectively, these findings suggest that auxin and NAA can inhibit TORC1 itself 






Figure 4.2:  Auxin and NAA inhibit TORC1 signaling.   
(A) The concentrations of auxin, NAA, and caffeine that cause 50% inhibition of growth 
(IC50) of the indicated strains in SCD medium are shown as bars (average ± SD of 3 
biological replicates).  Chemical structures are shown as insets.  Crude cell lysates of a 
wild-type (B) and wild-type expressing Par32-3xHA from plasmid pMS034 [31] (C) 
strains were prepared from log-phase cultures that had been exposed for 1 hr to 0.2 





western blotting using polyclonal antibodies that recognize phospho-eEF1B-
monoclonal antibodies that recognize HA (C).  Blots were stripped and re-exposed to 
























 While off-target effects of auxin and NAA on TORC1 can explain why several 
non-essential AID-tagged proteins were susceptible to growth inhibition, 44 additional 
non-essential AID-tagged proteins exhibited growth inhibition at 25 µM auxin and there 
was little additional effect of higher concentrations and of NAA.  Interestingly, many of 
these responders can be grouped by function and structure.  For example, seven proteins 
required for biosynthesis of cysteine, serine, and threonine (Cys3, Cys4, Hom2, Hom3, 
Hom6, Ser2, Thr4) exhibited slow growth rate when AID-tagged and exposed to auxin 
even though these amino acids were present in SCD culture medium.  Additionally, eight 
of eleven AID-tagged proteins that form the non-essential V-ATPase exhibited slow 
growth in low auxin.  Last, the COG complex consists of three essential subunits (Cog2, 
Cog3, Cog4) and five non-essential subunits (Cog1, Cog5, Cog6, Cog7, Cog8), and 
surprisingly 25 µM auxin strongly inhibited growth of AID-tagged Cog1 and Cog8 in 
addition to Cog4 strains.  These observations may reveal additional off-target effects of 
auxin and NAA that are independent of TORC1, or alternatively suggest the possibility of 
acute growth inhibition upon rapid depletion of specific non-essential proteins that lasts 
until compensatory adaptive processes become fully engaged.   
 When the AID-tag is sequestered within membrane-bound organelles, the tagged 
protein is expected to be inaccessible to the ubiquitin proteasome system and thus 
insensitive to auxin.  Of 32 essential proteins with C-termini localized within 
mitochondria, only 2 AID-tagged strains (Tim50, Tim17) were significantly sensitive to 
low auxin.  Of 16 essential proteins with C-termini localized within the lumens of the 
endoplasmic reticulum or Golgi complex, 5 strains (Brr6, Stt3, Cdc1, Tre2, Smx3) were 





depletion at some point during biogenesis before the C-terminus is sequestered, or may 
have incorrectly assigned topologies.  When these 48 proteins are excluded, the overall 
susceptibility of essential proteins to depletion with auxin rose from 66% to 70%.   
 Interestingly, 42 out of 53 essential transmembrane proteins of the secretory 
pathway with C-termini facing the cytoplasm (79%) exhibited significant sensitivity to 
auxin after AID-tagging.  This group includes polytopic transmembrane proteins that 
localize to the plasma membrane (Alr1, Pma1, Hip1), the Golgi complex (Vrg4, Kei1, 
Lsm8), the nuclear pore complex that spans the nuclear envelope (Nup192), in addition to 
the endoplasmic reticulum which contains numerous essential proteins that participate in 
biosynthesis of lipids and glycoproteins.  Additionally, 3 essential proteins associated 
with the mitochondrial outer membrane and with C-termini exposed to the cytoplasm 
(Sen2, Sen54, Sam35) also conferred sensitivity to auxin when AID-tagged while 2 
others (Tom20, Tom22) did not.  Excluding the secretome and mitochondriome, we find 
450 out of 652 (69%) of the remaining AID-tagged essential proteins exhibited 
significant sensitivity to auxin, a population that included proteins in the cytoplasm, 
nucleus, nucleolus, spindle pole body, as well as peripheral associations with the 
membrane-bound organelles listed earlier.  These data show that auxin can frequently 
induce depletion of essential AID-tagged proteins to levels that become growth limiting 
as long as the tag is exposed to the cytoplasm or nucleoplasm.  A minority of AID-tagged 
essential proteins did not exhibit growth inhibition by auxin in these conditions for 
unknown reasons. 
 





 The effects of auxin on expression of several AID-tagged and TAP-tagged 
essential transmembrane proteins involved in sphingolipid biosynthesis (Figure 4.3A) 
were investigated by western blotting (Figures 4.3B and 4.3C).  Surprisingly, in the 
absence of auxin, AID-tagging slightly, but reproducibly, diminished log-phase 
expression of Lcb1, Lcb2, Aur1, Kei1, and Vrg4 relative to the TAP-tagged parent 
strains.  The addition of 100 µM auxin for 60 minutes strongly depleted the AID-tagged 
variants but not the TAP-tagged proteins.  These findings suggest that AID-tags confer 
sensitivity to auxin even for transmembrane proteins in the endoplasmic reticulum (Lcb1, 
Lcb2) and Golgi complex (Aur1, Kei1, Vrg4) and can slightly dampen expression of the 
attached protein relative to the parental TAP-tags. 
 To investigate the degree of functional damping by AID-tags, we quantitatively 
measured the hypersensitivities of AID-tagged and TAP-tagged strains to known on-
target inhibitors.  Myriocin blocks the essential enzyme serine palmitoyltransferase that is 
composed of essential proteins Lcb1 and Lcb2 (Nagiec et al., 1994) and lcb1∆/+ and 
lcb2∆/+ heterozygous diploid strains are more sensitive to myriocin than +/+ wild-type 
diploid strains in growth assays (Hillenmeyer et al., 2008; Hoepfner et al., 2014; Lee et 
al., 2014).  Interestingly, the concentration of myriocin that causes a 50% decrease in 
growth (the IC50) was diminished slightly (by 1.3- and 1.2-fold) in Lcb1-TAP and Lcb1-
AID strains and diminished strongly (by 3.8- and 7.3- fold) in Lcb2-TAP and Lcb2-AID 
strains, respectively, relative to the wild-type parent strain (Figure 4.4A).  Similarly, 
resistance to aureobasidin A was diminished moderately (by 1.4- and 2.6-fold) in Aur1-
TAP and Aur1-AID strains and diminished very strongly (by 17- and 29-fold) in Kei1-






Figure 4.3:  Transmembrane proteins involved in sphingolipid biosynthesis are 
susceptible to depletion.   
(A) Schematic representation of sphingolipid biosynthesis pathway from serine (ser) to 





luminal GDP-mannose is depicted along with proteins that catalyze the reactions and 
their regulators (TORC1, Pib2, GTR-EGO).  (B,C) A polyclonal antibody that recognizes 
a common segment of TAP- and AID-tags was used in western blot analyses of the 
indicated strains that had been grown to log phase and exposed to 100 µM auxin for 1 hr 
as indicated. 
Footnotes: 
[a] Marks relative position of 100 kDa protein molecular weight marker 
[b] Marks relative position of 75 kDa protein molecular weight marker 















Figure 4.4:  TAP- and AID-tagged become hypersensitive to on-target inhibitors 
that can synergize.   
(A) Three replicate cultures of the indicated strains were diluted into fresh SCD medium 
containing varying concentrations of myriocin, aureobasidin A (AbA) or SDZ 90-215 and 
average IC50 was charted relative to the wild-type control strain (±SD).  (B) The IC50 
for auxin was determined for several AID-tagged strains, and the combination index (CI) 
with myriocin, aureobasidin A, and SDZ 90-215 was determined from checkerboard 
assays.  Synergy is evident when CI is less than 1.  Shaded boxes indicate on-target 





enzyme inositolphosphoryl-ceramide synthase of the Golgi complex that is composed of 
essential Aur1 and Kei1 proteins (Hashida-Okado et al., 1996; Sato et al., 2009).  Last, 
resistance of Vrg4-TAP and Vrg4-AID strains to SDZ 90-215, a novel compound that 
targets the essential GDP-mannose transporter of the Golgi complex (see next section), 
was moderately diminished (by 2.6- and 2.1-fold).  In summary, TAP-tagging alone 
caused hypersensitivity to on-target inhibitors by 1.3- to 17-fold while AID-tagging 
conferred additional hypersensitivity of ~1.8-fold in three of five instances.  Though C-
terminal TAP-tagging was shown to have little effect on expression of client proteins 
(Ghaemmaghami et al., 2003), our findings suggest the TAP-tag often diminishes their 
function.  Thus, TAP-tagged and AID-tagged proteins often behave like untagged 
“DAmP” strains that lack a 3’ transcription terminator (Breslow et al., 2008), which 
usually decreases mRNA stability and thus protein expression.   
 The AID-tagged essential proteins generated here may allow tunable damping of 
expression at sub-phenotypic concentrations of auxin, and thus may offer new 
opportunities for discovery and characterization of novel on-target small molecule 
inhibitors.  We tested this possibility using AID-tagged variants of Lcb1, Lcb2, Aur1, 
Kei1, and Vrg4 that were simultaneously exposed to varying concentrations of auxin and 
varying concentrations of myriocin, aureobasidin A, and SDZ 90-215 that span the IC50 
for each strain.  From these checkerboard assays, the IC50 of each drug alone can be 
measured for each strain and also the degree of synergism can be estimated by calculating 
the combination index (CI; see Methods).  A CI less than 1 indicates synergism, a CI 
equal to 1 indicates additivity, and a CI greater than 1 indicates antagonism between the 





Lcb1-AID strain (CI = 0.16), weak synergism was observed for the Lcb2-AID strain (CI 
= 0.83), and no synergism was observed for the Aur1-, Kei1-, and Vrg4-AID strains (CI 
> 1; Figure 4.4B).  Aureobasidin A and auxin synergized on the Aur1- and Kei1-AID 
strains (CI = 0.43 and 0.82) but not the Lcb2- and Vrg4-AID strains (CI = 1.51 and 1.23).  
SDZ 90-215 synergized with auxin on the Vrg4-AID strain (CI = 0.36) and not the Lcb2-
AID strain (CI = 1.01).  Though aureobasidin A and SDZ 90-215 both synergized with 
auxin for several off-target AID-tagged proteins, all three molecules synergized with 
auxin for all their on-target AID-tagged strains.  Thus, low concentrations of auxin can be 
used to sensitize many AID-tagged strains to on-target inhibitors.   
 
SDZ 90-215 targets Vrg4 
 Peptolide SDZ 90-215 is a cyclic peptide secreted by Septoria species that 
exhibits strong antifungal activity toward several pathogenic yeasts (Emmer et al., 1994) 
but the essential target of SDZ 90-215 has not been identified.  In a large chemical 
genomics screen involving thousands of compounds and a panel of heterozygous 
knockout mutants (Hoepfner et al., 2014), only the vrg4∆/+ and yor1∆/+ diploid strains 
of S. cerevisiae were significantly hypersensitive to SDZ 90-215 (Figure 4.5A).  Yor1 is 
a non-essential multidrug transporter in the plasma membrane that mediates export of 
many different organic anions from the cytoplasm.  The yor1∆/∆ diploids were also 
extremely hypersensitive to SDZ 90-215 (Hoepfner et al., 2014) probably caused by 
defects in export of the compound from the cytoplasm.  Vrg4 is an essential GDP-
mannose transporter in the Golgi complex (Dean et al., 1997) and a good candidate for 










Figure 4.5:  SDZ 90-215 targets Vrg4.   
(A) The responses of each heterozygous knockout mutant of S. cerevisiae to 3, 4, and 6 
µg/mL SDZ 90-215 (inset) was charted as a function of Z-score and sensitivity score as 
described previously (Hoepfner et al., 2014).  The heterozygous vrg4∆/+ and yor1∆/+ 
mutant strains are circled.  (B) A wild-type strain was transformed with high-dosage 
plasmids bearing VRG4 or several derivatives and the relative IC50 to SDZ 90-215 was 
determined (empty plasmid set to 1.0).  Bars represent the average ±SD from three 
biological replicates.  (C) The SDZ 90-215-resistant Vrg4-A286T strain and wild-type 
control strain were grown to log phase in SCD medium, then shifted to the same medium 
(-i) or to invertase-inducing medium containing sucrose instead of glucose that also 
contained 0 to 5 µM SDZ 90-215.  After 3 hr, lysates were prepared, subjected non-
denaturing PAGE, and stained for invertase activity.  Faster migrating bands represent 
hypo-glycosylated forms.  (D)  The wild-type and Vrg4-A286T strains were diluted into 
fresh SCD medium containing the indicated concentrations of SDZ 90-215, incubated for 
24 hr at 30°C, then stained with propidium iodide and analyzed by flow cytometry for 
live and dead cells.  Dots represent average of 3 biological replicates and best-fit curves 
represent non-linear regression to the standard sigmoid equation.  The 50% lethal dose 










hypersensitive to SDZ 90-215 (Figure 4.4A) and a haploid Vrg4-AID strain was 
synergistically affected by auxin and SDZ 90-215 but not Myriocin or Aureobasidin 
(Figure 4.4B).  Additionally, overexpression of Vrg4 from a high dosage plasmid 
(YEpGAP-VRG4) increased resistance to SDZ 90-215 by 9-fold relative to an empty 
control plasmid (YEpGAP) whereas overexpression of catalytically inactive variants of 
Vrg4 (G285A, A286D, L287A, K289D substitutions) (Gao et al., 2001) did not alter 
resistance and a partially inactive variant (N288A) caused weak resistance (Figure 4.5B).   
 If SDZ 90-215 directly inhibits Vrg4, it may be possible to isolate Vrg4 variants 
that are catalytically active but resistant to SDZ 90-215.  To test this possibility, a haploid 
yeast strain lacking Yor1 and seven other drug-resistance proteins was mutagenized and 
plated on medium containing 2.5 µM SDZ 90-215.  Of 60 independent colonies that 
proved resistant to SDZ 90-215, 24 expressed a C29Y variant of Vrg4 and 36 expressed a 
A286T variant of Vrg4.  When integrated into the high-copy plasmid-based VRG4 gene, 
the overexpressed C29A and A286T variants increased resistance to SDZ 90-215 by over 
10-fold relative to the wild-type Vrg4 plasmid (Figure 4.5B).  Integration of the A286T 
substitution mutation into the VRG4 locus of wild-type cells increased resistance to SDZ 
90-215 by 9.0-fold (not shown).  SDZ 90-215 also caused a dose-dependent inhibition of 
outer chain mannosylation of a secreted protein (invertase) in wild-type cells, but not in 
Vrg4-A286T mutant cells, as indicated by alterations in native gel mobility (Figure 
4.5C).  The Vrg4-A286T was also nearly 4-fold more resistant to SDZ 90-215 in 
measurements of cell death (Figure 4.5D).  Collectively, these findings suggest that SDZ 





 An X-ray crystal structure of Vrg4 shows a large central substrate-binding cavity 
that opens to the Golgi lumen (Parker and Newstead, 2017).  In this structure, C29 and 
A286 were positioned near each other in the middle of transmembrane helices 1 and 9 
near the base of the cavity.  C29 is adjacent to a conserved and functionally critical Y28 
residue that makes direct contact with the ribose portion of the substrate GDP-mannose 
deep within the cavity (Parker and Newstead, 2017).  A286 is one turn of helix 9 away 
from K289, which contacts the second phosphate of GDP-mannose and is part of the 
signature GALNK motif conserved among mannose-selective nucleotide sugar 
transporters.  In transport assays, the A286D substitution exhibited a 6-fold higher 
apparent Km for GDP-mannose and no change in Vmax (Gao et al., 2001).  The A286T 
and C29Y substitutions possibly cause resistance to SDZ 90-215 by diminishing affinity 
of the inhibitor without diminishing affinity of substrates.  The conformation of Vrg4 that 
opens to the cytoplasm where SDZ 90-215 is likely to bind has not been determined 
experimentally, but it is predicted to contain a substrate-binding cavity that is similar in 
size and shape owing to an internal duplication and topological inversion of a domain 
within the protein (Parker and Newstead, 2017).  To determine whether the large SDZ 
90-215 (1,126 D) can plausibly fit within this cavity, the structures of SDZ 90-215 and 
Vrg4 were uploaded into SwissDock and modeled.  SwissDock generated models of SDZ 
90-215 occupying nearly all of the central cavity of Vrg4 (Figure 4.6A) with a favorable 
free energy (∆G = -9.04).  SwissDock generated similarly favorable models of GDP-
mannose (605 D) deep within the central cavity of Vrg4 (∆G = -9.35) that closely 
resembled the experimentally determined structure.  Therefore, SDZ 90-215 likely binds 










Figure 4.6:  CMB402 can dock onto Vrg4 from S. cerevisiae and inhibit growth of 
pathogenic Candida species.   
(A) A model of SDZ 90-215 (yellow) docked into the large central cavity of Vrg4 
(translucent gray) was generated using SwissDock and viewed from the Golgi lumen or 
the plane of the bilayer.  (B) Wild-type strains of S. cerevisiae (BY4741), C. glabrata 
(BG2) (Cormack and Falkow, 1999), and C. albicans (CAI4) (Fonzi and Irwin, 1993) 
were diluted into fresh YPD containing the indicated concentrations of SDZ 90-215 then 
optical density at 650 nm was measured after 24 hr.  The symbols represent 3 biological 
replicates and the best-fit curves were obtained by non-linear regression to the standard 


















decreased mannosylation of sphingolipids and N-glycans, slowed cell proliferation, and 
eventual cell death.  
 SDZ 90-215 was found previously to inhibit in vitro growth of the pathogenic 
yeasts Candida albicans, C. tropicalis, C. guilliermondii, and C. krusei and also to cure 
several types of C. albicans infections in mouse models without toxicity to the animals 
(Emmer et al., 1994).  To compare and extend those findings, we determined the IC50’s 
of SDZ 90-215 on S. cerevisiae (strain BY4741) and C. glabrata (strain BG2) in addition 
to C. albicans (strain CAI4).  In YPD culture medium at 30°C, both S. cerevisiae and C. 
glabrata exhibited approximately 7-fold increase in IC50 relative to that of C. albicans 




 This study provides strong evidence that auxin-induced depletion of AID-tagged 
target proteins is a broadly effective strategy for analyzing protein function on a 
proteome-wide scale.  At least 70% of essential proteins with C-termini exposed to the 
cytoplasm or nucleoplasm could be depleted functionally, as detected by slower growth 
of cultures, when tagged with AID and exposed to low concentrations of auxin (25 µM).  
The susceptible proteins included non-transmembrane proteins as well as polytopic 
transmembrane proteins in the plasma membrane, Golgi complex, endoplasmic 
reticulum, and mitochondrion.  When C-terminal AID-tags are sequestered within these 
organelles, functional depletion was almost always abolished as expected due to OsTir1 





essential transmembrane proteins that we studied carefully, the IC50 for auxin ranged 
from 0.3 to 430 µM, spanning more than 1,000-fold.  The source of the variation likely 
involves unexpected complexity in the microenvironments surrounding AID-tags, which 
could vary substantially among targets.  Different genes may require very different levels 
of depletion to produce a growth phenotype.  For instance, even before adding auxin, the 
sensitivity of Lcb1-AID and Lcb2-AID strains to an on-target inhibitor (myriocin) was 
increased 1.2-fold and 7.3-fold, respectively, relative to untagged wild-type strain.  Thus, 
the latter strain was likely to be closer to the phenotypic threshold.  Very low auxin 
concentrations might deplete Lcb2-AID below the point where it limits growth while 
being insufficient to deplete Lcb1-AID to the phenotypic level because of its near wild-
type level of function.  Similar reasoning could explain why the IC50s of Kei1-AID 
strains for auxin and an on-target inhibitor (aureobasidin A) are 9-fold and 6-fold lower 
than those of Aur1-AID strains.  The amount of auxin required to observe a growth defect 
in any given AID-tagged strain will depend in part on the degree of depletion required to 
become limiting for growth, which is target specific. 
 Interestingly, we observed that TAP-tagging alone diminished resistance to on-
target inhibitors by 1.3-fold to 2.7-fold for the five strains studied in detail.  TAP-tagging 
had little or no reported effect on expression (Ghaemmaghami et al., 2003), but clearly 
can have significant effects on protein function.  About 25% of essential proteins could 
not survive with just a C-terminal TAP-tag (Ghaemmaghami et al., 2003) and were not 
studied here.  About 8% of TAP-tagged essential proteins could not be AID-tagged here, 
possibly due to the ~2-fold lower expression we observed for most AID-tagged proteins 





expression (unpublished results) and therefore may enable AID-tagging of proteins with 
less perturbation.  These findings suggest that many TAP- and AID-tagged essential 
proteins have significantly damped function, providing a useful alternative to the 
collection of untagged proteins with damped expression (Breslow et al., 2008).   
 Here we report that auxin and NAA both have off-target effects as inhibitors of 
TORC1 signaling, especially at high concentrations.  Knockout mutants lacking positive 
regulators of TORC1 became hypersensitive to known on-target inhibitors (rapamycin 
and caffeine) as well as auxin and NAA, while hyperactivating mutations in Tor1 largely 
reversed these hypersensitivities.  Additionally, just 1 hr exposure to auxin or NAA 
altered phosphorylation of downstream effectors of TORC1.  Because NAA had greater 
activity against TORC1 and lesser activity against AID-tagged proteins than auxin, extra 
caution should be used when interpreting results with high concentrations of NAA.  
While novel inhibitors of TORC1 and its mammalian ortholog mTORC1 are potentially 
useful as immunosuppressants, the AID-tagged strains generated here may useful for 
discovering auxin-like analogs that have decreased off-target activities and increased 
selectivity for AID-tags. 
 Acute depletion of AID-tagged proteins with auxin can be instrumental in 
deciphering gene function before secondary responses and compensatory effects become 
manifest (Holland et al., 2012).  Mild depletion of AID-tagged proteins can sensitize cells 
to on-target inhibitors, and thus facilitate screening and discovery of small molecule 
inhibitors (SMIs) akin to earlier sensitization strategies that involve haploinsufficiency or 
damped expression.  A screen of 1,776 compounds using complete collections of 





mannose transporter Vrg4 as a possible target of SDZ 90-215 and the ABC-family 
transporter Yor1 as a possible SDZ 90-215 efflux pump (Hoepfner et al., 2014).  Here we 
present additional data confirming that SDZ 90-215 targets Vrg4: (1) Vrg4-TAP and 
Vrg4-AID strains were hypersensitive to SDZ 90-215, (2) auxin synergized with SDZ 90-
215 only on the latter strain, (3) overexpression of Vrg4 caused resistance to SDZ 90-
215, (4) amino acid substitutions near the substrate-binding sites of Vrg4 caused 
resistance to SDZ 90-215, (5) the biological function of Vrg4 in mannosylation of a 
secretory protein was inhibited by exposure of cells to SDZ 90-215, and (6) SDZ 90-215 
can be accommodated within the large central cavity observed in an X-ray crystal 
structure of Vrg4.  Though the central cavity was open to the lumen of the Golgi complex 
in this conformation of Vrg4, the conformation that opens to the cytoplasm where SDZ 
90-215 likely binds is predicted to be similar due to the internal duplication and 
topological inversion of a five-transmembrane domain to generate the full-length ten-
transmembrane polytopic protein (Parker and Newstead, 2017).   
 Vrg4 is essential in S. cerevisiae, C. glabrata, and C. ablicans for mannosylation 
reactions in the Golgi complex, and hence for normal synthesis of mannan in the cell wall 
and sphingolipids in the cell membrane (Nishikawa et al., 2002).  Because these 
functions are unique to fungi, Vrg4 inhibitors are expected to exhibit antifungal 
properties. SDZ 90-215 was found previously to have potent antifungal activity against 
several pathogenic yeasts with low toxicity in mouse (Emmer et al., 1994).  As a natural 
product synthesized by a species of filamentous fungus in the genus Septoria, SDZ 90-
215 and related cyclopeptides may be natural antifungals that are optimized to target 





MATERIALS AND METHODS 
Plasmids, Yeast strains, and genetic screens 
 TAP-tagged strains of S. cerevisiae in the BY4741 background (Ghaemmaghami 
et al., 2003) were purchased from Dharmacon Inc., grown to log phase in YPD medium, 
transformed with the MfeI-digested linearized plasmid pAIDA2(6FLAG) depicted in 
Figure 4.1 using the lithium acetate method, and plated onto synthetic complete medium 
lacking uracil and containing 2% dextrose (SCD-ura agar medium) to select for 
transformants using conventional procedures (Sherman et al., 1986).  From each 
transformation, four independent colonies were picked, purified by streaking onto SCD-
ura agar medium, and tested for correct AID-tagging of by assessing growth on SCD-his 
agar medium.  Three validated colonies from each transformation were then arrayed in 
96-well culture dishes and tested for growth defects in SCD medium containing 100 µM 
auxin.  The concordance rate among the three isolates was over 99%, and therefore a 
single representative was chosen and arrayed into the master set of 96-well dishes.  The 
master set containing 15% glycerol was frozen and stored at -80°C.  Additional strains of 
S. cerevisiae, C. glabrata, and C. albicans are listed in Table 4.1. 
 The pAIDA2(6FLAG) plasmid was derived from plasmid pNHK53 (Morawska 
and Ulrich, 2013) which bears the URA3 selectable marker and OsTIR1 expression 
cassette as follows.  pNHK53 was digested with XmaI plus AscI to remove a 8 bp 
segment of the polylinker and then ligated to a similarly digested 1,519 bp fragment of 
synthetic DNA that contained the transcription terminator from the HIS3 homologous 
gene of Schizosaccharomyces pombe, a unique MfeI cleavage site, a TAP-AID*-6FLAG 





2013), a stop codon and unique AflII cleavage site, and a transcription terminator from 
the CYC1 gene of S. cerevisiae (see Figure 4.1A).  The AID* segment within 
pAIDA2(6FLAG) was later removed and replaced with a codon-optimized AID* 
segment by digestion with BsiWI plus AflII and ligation of a synthetic DNA fragment.  
Both plasmids and their sequences are available upon request. 
 To identify mutants of S. cerevisiae that confer resistance to SDZ 90-215, the 
haploid BY4741∆8 strain (Hoepfner et al., 2012) lacking eight genes involved in drug 
resistance (SNQ2, PDR5, YOR1, PDR1, PDR2, PDR3, YAP1, YRM1) was mutagenized 
with 2.5% ethylmethanesulfonate to 20% viability and then 2x107 viable cells were 
plated onto SCD agar medium containing 2.5 µM SDZ 90-215.  After 2 days incubation 
at 30°C, sixty independent colonies were picked, re-tested, and subjected to whole 
genome sequencing as described previously (Hoepfner et al., 2012).  Single-end reads 
were mapped to the S288C reference genome using BWA.  All sixty SDZ 90-215-
resistant strains contained either the C29Y or A286T substitution mutations in the gene 
encoding Vrg4.  
 
Determination of IC50 and synergy. 
 All chemical compounds were obtained from Sigma-Aldrich Inc. apart from 
aureobasidin A (Takara Inc.) and SDZ 90-215 (Novartis Inc.).  The IC50 of S. cerevisiae 
strains was determined by diluting stationary phase cultures 1000-fold into fresh SCD 
medium containing 2-fold serial dilutions of the indicated compounds in 96-well dishes 
(200 µL final volume), incubating at 30°C for 24 hr, then resuspending and measuring 





Raw data were fit to the standard sigmoid equation y = ODmin + (ODmax – 
ODmin)/(1+(x/IC50)^slope) by non-linear regression with Kaleidagraph™ software.  The 
four parameters were tabulated and the IC50s from three replicate experiments were 
averaged.  In checkerboard assays where strains were exposed to two serially diluted 
compounds simultaneously, the IC50’s for each compound alone were determined as 
described above and then the combination index (CI) was calculated as the IC50 from the 
diagonal of optical densities that contain approximately 1:1 ratio of the two compounds 
in terms of IC50 units (Lehar et al., 2009).  When CI equals 1, the two compounds 
behave additively as if they were the same compound acting on the same target.  When 
CI is significantly less than 1, the two compounds exhibit synergy.  Compounds with the 
same target or different targets within a single pathway often exhibit synergy (Lehar et 
al., 2007). 
 
Western blotting and in-gel invertase assays. 
 For western blotting, cells were lysed via fast alkaline lysis in 0.5 M NaOH with 
1.85% β-mercaptoethanol (BME) in ice water for 10 minutes.  The protein was then 
precipitated by addition of trichloroacetic acid (TCA) to a final concentration of 10% 
(w/w) and washed once with water.  Protein pellets were suspended in SDS sample buffer 
(0.1 M Tris-HCl, pH 6.8, 4% SDS, 0.2% bromophenol blue, 20% glycerol, 2% BME), 
incubated at 37 °C for 30 minutes, separated on 10% polyacrylamide gels with SDS, 
transferred to Hybond, and then blocked and probed with antibodies as described 
previously (Mehta et al., 2009).  Primary antibodies were used as follows:  anti-TAP 





hemagglutinin (HA) mouse monoclonal antibodies (Covance, Princeton, NJ) at 1:10,000 
dilution, or anti-phospho S6 (Ser-235/236) mouse monoclonal antibodies (Cell Signaling, 
Danvers, MA) at 1:5000 dilution, anti-PGK1 mouse monoclonal antibodies (Abcam) at 
1:10,000.  
 In-gel invertase assays were adapted from (Huffaker and Robbins, 1982).  Briefly, 
log-phase cultures in YPD medium plus 500 mM KCl were pelleted, washed, and 
suspended in the same medium but with reduced glucose (0.05%) to induce invertase 
expression.  SDZ 90-215 was added to varying concentrations and cultures were 
incubated at 30°C for 3 hr.  The cells were pelleted, washed once with 20mM sodium 
azide and once with TPB buffer (8.25 mM Tris-HCl pH 7, 30 mM diethylbarbituric acid, 
0.1 mM phenylmethanesulfonyl fluoride) before being resuspended in 20 µL TPB buffer.  
Acid-washed glass beads were added to the cells before vortexing to break the cells 
before 50 μL of TPB buffer containing 15% glycerol and 0.01% bromophenol blue was 
added.  The samples were centrifuged, and the supernatant was loaded onto pre-cast 10% 
polyacrylamide gel lacking SDS (Bio-Rad).  After electrophoresis with Tris-borate buffer 
(8.25 mM Tris base, 80 mM boric acid, pH 7.5), the gel was incubated for 10 minutes in 
cold sucrose solution (0.1 M sucrose in 0.1 M sodium acetate, pH 5.1) at 4°C.  The gel 
was then transferred to sucrose solution at 37°C and incubated for another 10 min. The 
gel was rinsed twice with water, and transferred to a Pyrex dish, where TTC solution (1 
mg/mL 2,3,5-triphenyltetrazolium chloride in 0.5 M NaOH) was added and brought to 
boiling on a hot plate in the hood until color developed.  Finally, the gel was washed with 






Docking of SDZ 90-215 to Vrg4. 
 The structures of SDZ 90-215 (CID=158437) and Vrg4 (PDB=5OGE) were 
downloaded from NCBI databases and uploaded into SwissDock (Grosdidier et al., 
2011).  The lowest free energy models were visualized using UCSF Chimera v1.13 
(Petterson et al., 2004).   
 
Statistical tests of significance. 
 Student’s T-tests were implemented on many datasets, as indicated in the figures 



















Table 4.1: Strains used in Chapter 4 
Strain Background Genotype Source 
K1251 BY4741[a] MATa Gaiver et al. (2002) 
AK060 BY4741 MATa gtr1::NatR Kim and Cunningham (2015) 
AK061 BY4741 MATa gtr2::NatR Kim and Cunningham (2015) 
AK062 BY4741 MATa ego1::NatR Kim and Cunningham (2015) 
AK063 BY4741 MATa ego3::NatR Kim and Cunningham (2015) 
AK018 BY4741 MATa pib2::NatR Kim and Cunningham (2015) 
AK104 BY4741 MATx TOR1(I954S) Kim and Cunningham (2015) 
AK102 BY4741 MATx gtr1::NatR TOR1(I954S) Kim and Cunningham (2015) 
AK106 BY4741 MATx pib2::KanR TOR1(I954S) Kim and Cunningham (2015) 
AK108 BY4741 
MATx gtr1::NatR pib2::KanR 
TOR1(I954S) Kim and Cunningham (2015) 
NS269 BY4741 MATa LCB1-TAP::HIS3 This Study 
NS270 BY4741 
MATa LCB1-TAP-AID-
6XFLAG::TIR1::URA3 This Study 
NS271 BY4741 MATa LCB2-TAP::HIS3 This Study 
NS272 BY4741 
MATa LCB2-TAP-AID-
6XFLAG::TIR1::URA3 This Study 







6XFLAG::TIR1::URA3 This Study 
NS275 BY4741 MATa KEI1-TAP::HIS3 This Study 
NS276 BY4741 
MATa KEI1-TAP-AID-
6XFLAG::TIR1::URA3 This Study 
NS283 BY4741 MATa VRG4-TAP::HIS3 This Study 
NS284 BY4741 
MATa  VRG4-TAP-AID-
6xFLAG::TIR1::URA3 This Study 
NS250 BY4741 MATa VRG4(A286T)::URA3 This Study 
BG2 C. glabrata 
 
Cormack and Falkow (1999) 
CAI4 C. albicans 
 
Fonzi and Irwin (1993) 
NS277 BY4741 MATa MCD4-TAP::HIS3 This Study 
NS278 BY4741 
MATa MCD4-TAP-AID-
6XFLAG::TIR1::URA3 This Study 
NS279 BY4741 MATa ALR1-TAP::HIS3 This Study 
NS280 BY4741 
MATa ALR1-TAP-AID-
6XFLAG::TIR1::URA3 This Study 
NS281 BY4741 MATa PMA1-TAP::HIS3 This Study 
NS282 BY4741 
MATa PMA1-TAP-AID-
6XFLAG::TIR1::URA3 This Study 







6XFLAG::TIR1::URA3 This Study 
NS287 BY4741 MATa VHT1-TAP::HIS3 This Study 
NS288 BY4741 
MATa VHT1-TAP-AID-
6XFLAG::TIR1::URA3 This Study 
NS289 BY4740 MATa CKA1-TAP::HIS3 This Study 





6XFLAG::HygR This Study 
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The Golgi apparatus plays a crucial cellular role by providing a centralized 
location for glycosylation and the sorting and processing of proteins and lipids in 
eukaryotes. In order for these processes to function normally, a homeostatic balance of all 
components of all reactions within the Golgi must be carefully maintained. Alteration of 
the composition of proteins, cofactors, substrates, or byproducts within the Golgi can 
have downstream consequences in the fates of the cell. This is evidenced by the 
numerous human disorders that arise from deregulation of Golgi homeostasis. In this 
dissertation, we have characterized two proteins, Erd1 and Gdt1, which provide important 
roles in the maintenance of homeostasis of the Golgi apparatus in yeast, supporting the 
crucial cellular process of glycosylation. Based on the data presented in Chapter 2, both 
of these genes have the potential to relieve stress from glycosylation via the removal of 
byproducts.   
Erd1 is required for the recycling of inorganic phosphate (Pi), released from 
nucleotide phosphates after the transfer of glycosyl groups from nucleotide sugars during 
glycosylation. This phosphate cleavage is required to prepare the nucleotide for exchange 
with additional nucleotide sugars, which can be used for additional glycosylation 
reactions (Capasso and Hirschberg 1984). The existence of a phosphate exporter in the 
Golgi membrane has been long hypothesized, but the protein responsible has never been 
identified. While the data presented in Chapter 2 provides strong evidence that Erd1 is 
functioning in vivo as the transporter of phosphate across the Golgi membrane, it still 
remains possible that it is only functioning in a regulatory role of this activity. Therefore, 





determine how the kinetics of transport effects the rate of reaction of 
glycosyltransferases. 
The future study of Erd1 should begin with purification of the protein for the 
purposes of in vitro transport studies and structural determination. Generation of a crystal 
structure for this protein could help determine key amino acids within the active site of 
the protein that could be mutated and assessed for relevance to the activity of the protein. 
Furthermore, this could enable the generation of co-crystals with Pi groups in order 
to establish the ability of the protein to bind Pi. The purified protein could also be 
reconstituted into liposomes for the purpose of transport studies, which could definitively 
demonstrate the ability to transport Pi across a membrane and the kinetics of this activity. 
The mechanism of action, such as dependency of a proton or metal gradient or membrane 
charge could be determined in these transport assays as well.  
Interestingly, the absence of ERD1 in yeast resulted in secretion of the Pi into the 
media. Previous reports demonstrated that erd1Δ yeast have deficiencies of glycosylation, 
but since there are no homologs to Erd1 in metazoan species, it is possible that this 
activity is conducted by an as yet undiscovered transporter that is unrelated to Erd1. 
Another possibility is that, for metazoans, the normal course of action for these species is 
to eliminate excess Pi via secretion into the bloodstream, where it can be reabsorbed into 
other cells by plasma membrane transporters. If this is the case, it is likely that the 
concentration of Pi in the trans Golgi significantly exceeds that of the cis Golgi.  
To test this hypothesis, future experiments could be conducted on mammalian cell 
culture utilizing fluorescence indicator protein for inorganic phosphate (FLIPPi) sensors. 





plants, to create live-cell imaging of localized concentrations of Pi (Sun et al. 2008; 
Mukherjee et al. 2015). This technology utilizes an inorganic phosphate binding protein 
(PiBP) from cyanobacteria fused to two fluorescent proteins to create a FRET-based Pi-
sensor (Sun et al. 2008). Transgenic strains may then be generated that express the Pi 
sensor within different cellular compartments, such as the Golgi complex. Combining 
ratiometric analysis with confocal microscopy can then enable the determination of 
relative concentrations of Pi in various cellular compartments (Sun et al. 2008). This 
technology has not yet been implemented in mammalian cells, and may require some 
modification before it can be successfully utilized.  
This work also characterized the Golgi protein Gdt1, which has also been 
demonstrated to be important for glycosylation (Colinet et al. 2016; Potelle et al. 2016). 
Importantly, Gdt1, similarly to the vacuolar protein Vcx1, was determined to function as 
a reversible exchanger of H+ and Ca2+ that is regulated by calcineurin. This is in 
agreement with other publications that have demonstrated that Gdt1 is able to undergo 
pH-dependent transport Ca2+ and Mn2+ when heterologously expressed in the membranes 
of bacteria (Potelle et al. 2016; Thines et al. 2018). Additionally, it has been previously 
reported that loss of TMEM165, the mammalian homolog of Gdt1, disrupts pH 
homeostasis in addition to causing glycosylation deficiencies that can be rescued through 
supplementation with Mn2+ (Potelle et al. 2016). When combined with a knockout of 
SPCA1, loss of TMEM165 results in synthetic lethality (Blomen et al. 2015).   
The revelation that there is a highly conserved H+/Ca2+ exchanger in the Golgi 
was unexpected, since there is presumably no need for it. The reversibility of the 





of a proton leak that has been identified in the Golgi when the V-ATPase is inactivated 
(Schapiro and Grinstein 2000). The exchanger could continue transporting Ca2+/Mn2+ into 
the Golgi in exchange for H+ until the pH gradient between the Golgi and cytoplasm is 
neutralized. The reversibility of Gdt1 may also provide insight into the evolutionary 
purpose of the protein. Due to the importance of homeostatic regulation of Ca2+, Mn2+ 
and the pH of the Golgi, Gdt1/TMEM165 may be conserved to function as a sensor of 
these factors. If any one of the three factors reach a concentration too high or too low, the 
reversible exchange activity of Gdt1/TMEM165 could enable correctional adjustment, 
without requiring degradation or synthesis of other proteins. For example, if the 
concentration of Mn2+ becomes too high in the Golgi lumen, Gdt1/TMEM165 would 
become more likely to transport Mn2+, along with H+, into the cytoplasm while still 
transporting Ca2+ into the Golgi lumen. In this way, exchangers like Gdt1/TMEM165 are 
incredibly important in maintaining homeostasis of ion concentrations within organelles. 
It had previously been shown that expression of TMEM165 was upregulated 
during lactation, but the effects of loss of this expression had not been studied (Reinhardt 
et al. 2014). The work presented in Chapter 3 provides the first insight into the 
importance of TMEM165 in the process of lactation. Loss of TMEM165 in the lactating 
mammary gland results in deficiencies of lactose synthesis that decreases the osmotic 
potential of the milk. This decreases the volume and nutritious quality of the milk itself, 
ultimately resulting in low weight gain of the pups that are nursing from the TMEM165-
deficient mother. The Ca2+ and Mn2+ composition of the milk suggests that loss of 
TMEM165 decreased the transport of these metals into the Golgi and therefore the 





Generation of crystal structures and determination of the kinetics of transport of 
both TMEM165, and its yeast homolog, Gdt1, still remains to be completed in the future. 
The stoichiometry of transport will be particularly important in determining whether the 
activity of Gdt1/TMEM165 contributes to a charge imbalance that would have to be 
corrected by some other mechanism. Movement of only one proton out of the Golgi 
while moving a divalent cation like Ca2+ or Mn2+ make the Golgi lumen more positive. 
Alternatively, if two protons are transported to the cytoplasm for every metal transported 
into the lumen, the net charge would remain unchanged. The mechanism by which 
calcineurin regulates the activity of Gdt1, as well as Vcx1, remains to be identified. 
Further genetic screening is required to find the direct target of calcineurin that influences 
the activity of these exchangers. Since calcineurin is required for response to pH-induced 
stress in fungi (Nakamura et al. 1993), it is possible that it inhibits Gdt1 and Vcx1 by 
modulating the pH of the cytoplasm or Golgi, thereby modifying the pH gradient.     
A recent study determined that when V-ATPase activity is lost, calcineurin is 
required for the rapid internalization of the proton pump Pma1, which is responsible for 
removal of protons from the cytoplasm, from the plasma membrane. This occurs via a 
mechanism mediated by Rim8 and Rsp5 (Velivela and Kane 2017). This study also 
provided evidence that internalization of Pma1 not only prevents cellular loss of protons, 
but it also compensates for loss of V-ATPase activity by re-distributing Pma1 to acidify 
other cellular compartments, such as the endosome (Velivela and Kane 2017). As the 
data presented in Chapter 2 show, loss of V-ATPase activity causes Vcx1 and Gdt1 to 
function in reverse-mode, acidifying the vacuole and Golgi at the expense of Ca2+, 





concentration of Ca2+, activating the calcineurin response pathway, and triggering 
internalization of Pma1 to compensate. This model would be consistent with the data 
presented in Chapter 2, as calcineurin activation during high Ca2+ stress would internalize 
Pma1, and decrease the pH of the cytoplasm, limiting the pH gradient by which Gdt1 and 
Vcx1 function.  
Additionally, it has not yet been determined whether calcineurin similarly effects 
TMEM165 in mammalian cells. Since some studies have shown that supplementation 
with galactose or Mn2+ can restore glycosylation to TMEM165-deficient cells and/or 
patients, similar analyses should also be conducted in mice to determine if similar 
supplementations can restore normal lactose synthesis and litter weight gain to nursing 
pups. Supplementation can be achieved by providing the mice with high-galactose food 
or regular injections.    
A potentially versatile tool provided in this dissertation is the establishment of a 
method for screening the collection of auxin inducible degron (AID) tagged essential 
genes to find specific targets of small molecule inhibitors, described in Chapter 4. The 
study of essential genes is difficult, since the inability to eliminate the genes requires 
generation and analysis of point mutations, which can be very arduous, or analysis of 
heterozygous strains, which has limited efficacy due to the presence of one functional 
allele in the strain. The AID-tagged collection of yeast enables the user to rapidly and 
reversibly target a given protein for degradation by addition of auxin. This enables the 
strain to be analyzed for acute effects of protein loss. An example of this method being 
utilized is presented in Chapter 2, where an AID-tagged version of Vrg4 was utilized to 





thus eliminating the source of the Pi secreted in the absence of Erd1. Due to the essential 
nature of Vrg4, this experiment would have otherwise been unachievable, as 
glycosylation would not be sufficiently blocked in a strain that was heterozygous for 
VRG4.   
The further versatility of the system was established in Chapter 4, where it was 
shown that the AID tag sufficiently dampened the expression of a protein to increase the 
sensitivity of the strain to an inhibitor of the tagged protein. This means that the whole 
collection can be screened for hypersensitivity to a drug to identify candidate genes and 
pathways that may be targeted by the drug. Further analysis can be conducted using the 
checkerboard assays outlined in Chapter 4, which look for synergism or antagonism 
between auxin and a given drug when used in combination on an AID-tagged strain. 
When the two drugs display synergism, they are likely targeting similar proteins or 
pathways, and thus, this method may be utilized to elucidate targets and mechanisms of 
drugs and antifungals, as demonstrated with SDZ 90-215 being confirmed as an inhibitor 
of Vrg4.  
While the AID collection and the methods described in Chapter 4 may be utilized 
identifying targets of new antifungals and inhibitors for future use in research and 
medicine, they may also be adapted for use in other scientific pursuits. For example, a 
longstanding question, regarding essential genes, is how to distinguish between genes 
that are required for cell survival and those that are required for cell proliferation. This 
may be more easily distinguished by introducing auxin to the collection and screening for 
strains that have an increased incidence of cell death, such as through the use of staining 





(Madeo et al. 1997). If the auxin-induced depletion of an essential protein does not 
exhibit increased cell death, it is likely that the protein is required for growth, but not 
survival. Similarly to the use of the AID-tagged Vrg4 strain in Chapter 2, individual 
strains from this collection, even ones with known and fully characterized functions, may 
be analyzed in the presence of auxin to elucidate pathways and mechanisms that are 
otherwise masked or blocked by the activity of essential genes with no commercial 
inhibitors. This potentially opens the door for numerous lines of research and 
experimentation that would otherwise be prevented by the inability to block the activity 
of an essential gene.  
Glycosylation has been well characterized during the decades-long study of the 
process and the hundreds of genes involved. However, an increasing number of 
congenital disorders of glycosylation have been identified in the recent past (Scott et al. 
2014), emphasizing the requirement for additional research into the pathways that 
influence glycosylation and treatments that could aid the growing number patients with 
these congenital disorders. The data presented in this dissertation provide insight into 
some of the genes that influence glycosylation. The methods presented may be utilized in 
the future for further mechanistic analysis of the pathways involved in glycosylation and 
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